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Abstract 
Mitochondria play a central role in oxidative stress-induced cell death. By increasing the 
production of reactive oxygen species, such as H2O2, oxidative stress causes 
mitochondrial fragmentation and apoptosis. It was hypothesised that Transient Receptor 
Potential Melastatin 2 (TRPM2) channels play a role in mitochondrial fragmentation and 
cell death. The rationale behind this hypothesis was the published evidence that 
oxidative stress stimulates TRPM2 channels, resulting in an increase in the cytosolic 
levels of Ca2+ and Zn2+, and that both these ions are detrimental to mitochondrial health 
and cell survival. To test the hypothesis, human umbilical vein endothelial cells 
(HUVECs) and endothelial cells isolated from wild-type and TRPM2 knock-out mice 
were used. TRPM2 actions were suppressed using pharmacological agents and small 
interfering RNA (siRNA). Fluorescent reporters were used to examine changes in 
intracellular ion distribution and organelle morphology. Molecular biology, biochemical 
and imaging techniques were used to examine the dynamics of ions and organelles.  
 
Exposure of HUVECs to H2O2 or high glucose stress led to TRPM2 activation, resulting 
in extracellular Ca2+ entry, lysosomal membrane permeability (LMP) and the release of 
lysosomal free Zn2+. Unexpectedly, this was accompanied by the accumulation of Zn2+ 
in the mitochondria. The rise in mitochondrial Zn2+ led to extensive mitochondrial 
fragmentation, mitochondrial outer membrane permeabilisation (MMP) and cell death. 
Silencing of TRPM2 channels with siRNA prevented intracellular Zn2+ redistribution, 
mitochondrial fragmentation and cell death. Endothelial cells derived from TRPM2 
knock-out mice were resistant to oxidative stress-induced mitochondrial fragmentation.  
Biochemical and immunostaining experiments revealed an unexpected presence of 
TRPM2 channels in mitochondria, where they mediated mitochondrial Zn2+ uptake. 
Accumulation of Zn2+ in the mitochondria led to mitochondrial fragmentation by 
promoting the recruitment of cytoplasmic Drp1, an enzyme responsible for mitochondrial 
fission. Taken together, the results of this thesis revealed a novel mechanism for how 
oxidative stress can cause excessive mitochondrial fragmentation and cell death: the 
mechanism involves activation of TRPM2 channels leading to increased Ca2+ entry, 
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LMP and release of lysosomal Zn2+; Zn2+ thus released is taken up by the mitochondria, 
leading to Drp1 recruitment, mitochondrial fragmentation and finally cell death.  
 
Since mitochondrial fragmentation is associated with several age-related chronic 
illnesses, including neuronal (Alzheimer’s, Parkinson’s), cardiovascular (atherosclerosis, 
myocardial infarction) and metabolic/inflammatory (diabetes) disorders, these results 
suggest that the TRPM2 channel is a novel target that could be explored for therapeutic 
intervention of age-related illnesses.     
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 │Introduction 1
Diabetes is a major risk factor for cardiovascular disease. Increase in blood glucose 
levels is associated with endothelial dysfunction, where mitochondria play a key role. 
High glucose has been shown to induce overproduction of reactive oxygen species 
(ROS) and thereby induce mitochondrial fragmentation and dysfunction of endothelial 
cells. However, the exact mechanism for how ROS induces mitochondrial fragmentation 
is not fully understood. The TRPM2 channel is a ROS sensitive ion channel that 
regulates intracellular Ca2+ and Zn2+ dynamics. The overall aim of this thesis is to 
examine the role of TRPM2 channels and intracellular changes in Ca2+ and Zn2+ 
dynamics on mitochondrial dynamics and endothelial cell viability. The aim of this 
chapter is to provide an overview of ROS, TRPM2 channels and mitochondrial 
dynamics. 
 
 Historical overview  1.1
Free radicals such as superoxide (O2
•−), hydroxyl (OH•) and nitric oxide (NO•) are 
derived from normal aerobic essential metabolism (Droge, 2002; Harman, 1956). 
Several decades ago, Harman noted that organisms (animals and plants) with a higher 
metabolic rate have a much shorter lifespan compared to those with a slower 
metabolism (Harman, 1956). However, the link between metabolism and aging was 
unclear. Harman introduced the free-radical theory of aging and degenerative diseases 
(Harman, 1956). This theory suggests that the generation of endogenous oxygen free 
radicals contributes to the process of cellular damage (Harman, 1956). However, the 
hypothesis of endogenous oxidants was controversial until superoxide dismutases 
(SODs) were discovered in 1968 (McCord and Fridovic, 1969). SODs are a family of 
enzymes which catalyse the dismutation of the superoxide radical anion (O2
•−) to H2O2 
and oxygen (McCord and Fridovic, 1969). The discovery of SODs (McCord and 
Fridovic.I, 1969) and their mechanism provided support to Harman’s hypothesis 
(Harman, 1956) that an organism would live longer if it had low oxidative stress or a 
higher level of antioxidants to mitigate oxidative stress. 
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Since the discovery of SODs, many studies have focused on superoxide radicals (O2
•−) 
and SODs and their physiological and pathophysiological roles. Superoxide radicals 
have been implicated in a variety of diseases including neurodegenerative diseases 
(Reiter, 1995), diabetes (Maritim et al., 2003), cancer (Church et al., 1993), 
inflammatory diseases (Salin and McCord, 1975) and ischemia (McCord et al., 1985). 
However, more recent studies have found that superoxide radicals can function in signal 
transduction in mammalian cells as well as regulating cell division and proliferation, 
migration and angiogenesis (Buetler et al., 2004; Werner, 2004). 
 
Later studies have shown that mitochondria are a major source of O2
•− and H2O2 
production (Ku et al., 1993; Sohal et al., 1990). Mitochondrial generation of oxidative 
stress from the kidneys, heart and liver has been correlated with maximum life span 
potential (MLSP). The higher the metabolic rate, the higher the endogenous production 
of ROS in mitochondria from shorter-lived animal species compared to mitochondria 
from longer-lived animal species (Ku et al., 1993; Sohal et al., 1990). While these 
findings supported a free-radical theory of aging, no positive relationship was found 
between antioxidant defences and MLSP in species (Ku et al., 1993; Sohal et al., 1990). 
These findings have led to the view that the differences in aging rates may be due to 
differences in levels of oxidant production rather than antioxidant levels (Ku et al., 1993; 
Sohal et al., 1990). 
 
A rise in the level of ROS has been linked to mitochondrial DNA fragmentation, 
membrane lipid damage and permeability changes, mitochondrial dysfunction and cell 
death (apoptosis) (Madesh and Hajnoczky, 2001; Richter, 1993; Wei et al., 2001). It 
was recognised that many cellular genes are activated to stimulate or suppress 
oxidative stress-induced apoptosis; these include genes encoding bcl-2, p53, TRPM2, 
RP-2, RP-8 and APO-1/FAS (Richter, 1993). It was also found that oxidative stress-
induced cell death triggers extracellular Ca2+ entry and a rise in cytosolic levels (Farber, 
1990). However, the exact mechanisms are unclear (Farber, 1990). Numerous studies 
have focused on the role of Ca2+ or Zn2+ ions in organelle stress-induced cell death 
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(Boya et al., 2003; Boya and Kroemer, 2008; Malaiyandi et al., 2005; Manna et al., 
2015; Sun et al., 2012; Wiseman et al., 2007). 
 
 Oxidative stress 1.2
ROS are molecular oxygen (O2) metabolites which have higher reactivity than O2 (Finkel 
and Holbrook, 2000). They include unstable oxygen radicals such as superoxide anion 
radicals (O2
•−), hydrogen peroxide (H2O2) and hydroxyl radicals (HO
•) (Finkel and 
Holbrook, 2000). ROS are continually produced during normal essential metabolism 
(Finkel and Holbrook, 2000). ROS at low levels (physiological level) play an important 
role in regulating cellular metabolic processes and other cellular processes including 
cell proliferation, differentiation and migration (Uttara et al., 2009; Waris and Ahsan, 
2006). However, excessive ROS production is associated with a wide range of 
pathological conditions such as type 2 diabetes, neurodegenerative diseases, 
atherosclerosis and chronic inflammatory processes (Uttara et al., 2009; Waris and 
Ahsan, 2006). An imbalance between ROS production and antioxidants in favour of 
ROS is called oxidative stress (Uttara et al., 2009; Waris and Ahsan, 2006). Oxidative 
stress can be increased due to many environmental factors such as chemotherapeutic 
agents, cytokines and radiation, including ultraviolet (UV), ultrasound and microwave 
radiation (Sies, 1997; Waris and Ahsan, 2006). ROS are produced at several sites 
within the cell. These include the cytoplasm, mitochondria and endoplasmic reticulum. 
 
1.2.1 Cytoplasmic ROS and NADPH oxidase 
NADPH oxidase (NOX) is an important source of intracellular ROS generation. It is a 
multimeric enzyme comprising seven different mammalian isoforms which are known as 
NOX 1-5 (Sumimoto, 2008) and Duox1 and 2 (Mouche et al., 2007). NOX uses NADPH 
as a substrate to convert molecular oxygen into ROS (Martyn et al., 2006). NOX 4 is the 
only isoform that generates H2O2 instead of superoxide (O2
•−) (Martyn et al., 2006). 
NOX proteins are expressed in different tissues such as spleen, kidney and vascular 
smooth muscle (Sumimoto, 2008). ROS production by NOX activation is regulated by 
different stimuli such as growth factors, cytokines, free fatty acids, glucose and ions, 
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including Ca2+ and Zn2+ (Jiang et al., 2011a; Li and Shah, 2004; Sumimoto, 2008). 
Elevated intracellular Ca2+ (discussed in further detail later in this thesis) could act as an 
upstream signal in NOX activation and cytoplasmic ROS generation (Sumimoto, 2008). 
Protein kinase C (PKC) is a key regulator of NOX (Cosentino-Gomes et al., 2012). Ca2+ 
activates PKC (Jiang et al., 2011a; Sumimoto, 2008). Activated PKC is translocated 
from the cytoplasm to the cell membrane and phosphorylates P47 phox (Sumimoto, 
2008) and P67phox (Jiang et al., 2011a). Phosphorylated P47phox or p67phox induces 
activation of NOX and triggers generation of superoxide anions (Jiang et al., 2011a; 
Sumimoto, 2008). As mentioned previously, superoxide is converted to H2O2 by 
superoxide dismutase (SOD) (Martyn et al., 2006). Studies have linked higher NOX 
activity to a variety of disease states such as diabetic vascular disease, 
neurodegenerative diseases (Alzheimer’s disease and Parkinson’s disease) and 
ischemic damage (Chen et al., 2011; Lambeth, 2007). Inhibition of NOX activity has 
been shown to have a protective role against diseases, indicating a significant 
pathophysiological role for excess cytoplasmic ROS (Chen et al., 2011; Lambeth, 
2007).   
 
1.2.2 Mitochondrial ROS 
The majority of intracellular ROS is generated by mitochondria during normal 
metabolism (Finkel, 2012). Generation of mitochondrial superoxide radicals occurs at 
two sites in the electron transport chain; there are complex I (NADH dehydrogenase) 
and complex III (ubiquinone-cytochrome c reductase) (Finkel and Holbrook, 2000). 
Under normal conditions, complex III is the main source of ROS. Complex III produces 
O2
•− in the mitochondrial matrix (Finkel and Holbrook, 2000). Superoxide dismutases 
(SOD1 and SOD2) convert O2
•− into H2O2. H2O2 is then eliminated by enzymes such as 
catalase (CAT) and glutathione reductase (GPX). This leads to the regeneration of 
water and molecular oxygen (Finkel and Holbrook, 2000), as shown in Figure 1.1. Thus, 
the higher the metabolism rate, the greater the ROS production (Finkel and Holbrook, 
2000). Mitochondrial biology is considered to be a potential therapeutic target, as the 
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mitochondria play important roles in cell death, inflammation, metabolism and ROS 
generation. 
 
 
Figure 1.1 Mitochondrial respiratory chain and ROS generation, redrawn from (Yu and 
Bennett, 2014) 
The electron transport chain receives electrons (e-) from NADH and FADH2. It mediates electron 
transfer from complex I to complex IV by ubiquinone (Q) and cytochrome c (cyt c). At complex 
IV, molecular oxygen is reduced by transported electrons, leading to the formation of water and 
a proton (H+) gradient across the inner mitochondrial membrane. At complex V, the proton (H+) 
gradient is used to convert ADP to ATP (ATP synthase). ROS are byproducts of the respiratory 
chain. At complex I and complex III, superoxide (O2
•−) is formed. Matrix manganese superoxide 
dismutase (MnSOD) converts O2
•− to H2O2. H2O2 is subsequently reduced to H2O by glutathione 
peroxidase (GPX) or catalase.  
 
1.2.3 Endoplasmic reticulum ROS  
The endoplasmic reticulum (ER) is an organelle that is responsible for the synthesis and 
correct folding of proteins for cell survival and normal physiological functions (Zhang 
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and Kaufman, 2008). Notably, 25% of cellular ROS are generated during the formation 
of disulphide bonds (oxidizing site) during oxidative protein folding (Wang et al., 2014; 
Zhang and Kaufman, 2008). The accumulation of unfolded and misfolded proteins in the 
ER initiates ROS accumulation and induces ER stress. Mitochondrial ROS production 
can also be enhanced by ER stress. ER stress induces Ca2+ leak from the ER stores. 
Ca2+ thus released enters mitochondria where it induces mitochondrial membrane 
depolarisation, ROS production and cell death (Denmeade et al., 2012). 
 
Recently, ER stress-inducers have been investigated as potential anticancer drugs by 
pharmaceutical companies (Denmeade et al., 2012). There are many drugs capable of 
inducing ER stress and cancer cell death; these include bortezomib, celecoxib and 
thapsigargin (Denmeade et al., 2012; Kardosh et al., 2008).    
 
 Organelles and oxidative stress 1.3
1.3.1 Oxidative stress and lysosomes  
Lysosomes are dynamic organelles discovered more than 50 years ago by Christian de 
Duve during his study on the distribution of intracellular enzymes using centrifugal 
fractionation techniques (de Duve, 2005; De Duve et al., 1955). Lysosomes contain 
hydrolytic enzymes including proteases, lipases, nucleases, glycosidases, 
phospholipases, phosphatases and sulfatases (Boya and Kroemer, 2008; Turk and 
Turk, 2009). They are responsible for the degradation of the macromolecules that come 
from autophagy or the endocytic trafficking pathway (Turk and Turk, 2009). Therefore, 
lysosomes are also referred to as “suicide bags” (Turk and Turk, 2009). It has been 
thought that lysosomes are involved not only in the degradation of macromolecules but 
also in apoptosis (Boya and Kroemer, 2008; Turk and Turk, 2009). Oxidative stress 
induces partial lysosomal membrane permeabilisation (LMP) which leads to the release 
many lysosomal proteases into the cytosol (Boya and Kroemer, 2008; Turk and Turk, 
2009). These proteases, including cathepsins such as cathepsin B, cathepsin D and 
cathepsin L, contribute to the apoptosis signalling pathway (Turk and Turk, 2009).  
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The complete breakdown of lysosomes and the release of lysosomal proteases at a 
high concentration induce necrosis. However, though it is known that oxidative stress 
induces LMP (Boya et al., 2003; Boya and Kroemer, 2008; Repnik et al., 2014), the 
underlying mechanisms are not clear. It has been thought that LMP is a result of 
oxidants’ nonspecific attack on the lysosomal membrane lipids. However, recent studies 
suggest a biochemical mechanism whereby lipases (such as phospholipase A2, 
sphingomyelinase and phospholipase C) act on lysosomal membranes (Boya and 
Kroemer, 2008; Repnik et al., 2014). These lipases are activated by the cytosolic entry 
of extracellular Ca2+. However, the identity of Ca2+ channels or the transporters 
responsible for Ca2+ entry and LMP is not known.  
 
1.3.2 Oxidative stress and mitochondria 
Mitochondria exist as a network of large and branched tubules. They are highly dynamic 
and undergo continual fusion and fission in order to maintain their function and 
morphology (Chen and Chan, 2005) (discussed in further detail later in this thesis). 
However, many studies have shown that extracellular or mitochondrial oxidative stress 
disrupts the function and morphology of mitochondria (Chan, 2006; Chen and Chan, 
2005). An imbalance between fission and fusion events is associated with a number of 
diseases such as diabetes (Archer, 2013), neurodegenerative diseases (Archer, 2013; 
Wang et al., 2009), ischemia reperfusion injury (Archer, 2013; Ong et al., 2010) and 
endothelial dysfunction (Shenouda et al., 2011). 
 
Oxidative stress leads to increased cytosolic Ca2+ concentration. This in turn activates 
other mechanisms, including Ca2+ buffering by organelles (Rosenstock et al., 2004). 
Ca2+ uptake by mitochondria is one of the mechanisms that contributes to the buffering 
of cytosolic Ca2+ (Rosenstock et al., 2004). It has been reported that an increase in Ca2+ 
uptake by mitochondria triggers a decrease in the mitochondrial membrane potential 
(Rosenstock et al., 2004). The resulting increase in Ca2+ uptake also leads to 
mitochondria permeability transition (MPT), which is a nonspecific permeability pore in 
the inner membrane of mitochondria (Rosenstock et al., 2004). A change in 
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mitochondrial membrane potential initiates cytochrome c release from the inner 
mitochondrial membrane (IMM) (Ott et al., 2002). Cytochrome c release to extra-
mitochondrial milieu occurs in a two-step process (Ott et al., 2002). In the first step, 
cytochrome c binds to two pools that attach to the IMM (Ott et al., 2002). One is loosely 
attached to the IMM through electrostatic interaction with the anionic phospholipid. This 
can be stimulated through changes in the pH or surface charge density or ionic 
strength. The second pool is tightly bound to the IMM by hydrophobic interaction, and it 
can be mobilized by the oxidation mitochondrial lipids (remodelling of membrane 
structure). Once the association of cytochrome c to the IMM is initiated, the soluble 
cytochrome c translocates to the cytoplasm where it interacts with other proteins. 
Cytochrome c binds to apoptotic protease activating factor-1 (Apaf-1) in the cytoplasm 
(Boya et al., 2003; Slee et al., 1999). The resulting protein complex activates caspase-
9, which initiates programmed cell death by activating caspase-3 and caspase-7 (Boya 
et al., 2003; Slee et al., 1999). Activated caspase-3 translocates into the nucleus and 
induces DNA fragmentation (Janicke et al., 1998). Collectively, caspases (aspartic 
proteases) destroy cytoplasmic and nuclear proteins, leading to apoptosis (Janicke et 
al., 1998). 
 
It has also been found that oxidative stress is associated with increased mitochondrial 
fragmentation, which is considered a sign of early-stage apoptosis (Karbowski and 
Youle, 2003). Oxidative stress-induced changes in the mitochondrial morphology from 
tubular to fragmented mitochondria is explained later in this chapter. 
 
1.3.3 Oxidative stress and endoplasmic reticulum  
The ER is a dynamic compartment and the main site of Ca2+ storage in the cell 
(Meldolesi and Pozzan, 1998). Most transmembrane proteins are folded in the ER as 
they enter the ER as unfolded polypeptide chains (Ron and Walter, 2007). The ER 
contains chaperons, glycosylation enzymes and oxidoreductases, which catalyse 
protein folding, glycosylation and disulphide bond formation, respectively, in the lumen 
of the ER (Haynes et al., 2004; Travers et al., 2000). However, misfolded proteins 
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accumulate in the lumen of the ER. This activates an intracellular stress response 
pathway called unfolded protein response (UPR) (Ron and Walter, 2007; Travers et al., 
2000). UPR upregulates a range of genes that are required for protein folding, ER-Golgi 
trafficking, ER-associated degradation (ERAD) and ER expansion (Haynes et al., 2004; 
Malhotra and Kaufman, 2007; Ron and Walter, 2007; Travers et al., 2000). ERAD is a 
process that promotes the degradation of misfolded protein in the cytosol by 
proteasomes involving ubiquitination of misfolded proteins (Ron and Walter, 2007). 
 
Unfolded protein accumulation in the ER induces ER stress. During ER stress, Ca2+ is 
released from the ER to the cytoplasm by BAX and BAK oligomers (Malhotra and 
Kaufman, 2007). Ca2+ released from the ER is taken up by mitochondria, leading to 
increased mitochondrial ROS production and inner mitochondrial membrane 
depolarisation and cytochrome c release (Malhotra and Kaufman, 2007).   
 
ER stress-induced cell death occurs via pro-apoptotic components such as the BCL2 
family and caspases (caspases 2, 3, 4, 7, 9 and 12) (Dahmer, 2005; Di Sano et al., 
2006; Hitomi et al., 2004). ER stress and calpain activate caspase 12, which is 
associated with the ER membrane (Tan et al., 2006). Caspase 12 activation in turn 
activates caspase 9, which activates caspase 3, finally causing cell death (Dahmer, 
2005; Hitomi et al., 2004; Tan et al., 2006), as shown in Figure 1.2. Moreover, BAX and 
BAK (discussed in further detail later in this thesis), which are pro-apoptotic BCL2 family 
members, form a pore in the membrane of the ER through which Ca2+ is released. The 
mechanism by which Ca2+ induces mitochondria mediated apoptosis has been 
described above.  
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Figure 1.2 ER stress and ROS-induced cell death, redrawn from (Novo and Parola, 2012) 
Environmental factors induce ER stress and ROS generation that increase Ca2+ release from 
the ER. The released Ca2+ is taken up by mitochondria, leading to mitochondrial ROS 
generation and mitochondrial outer membrane permeabilisation (MOMP). MOMP activates a 
pro-apoptotic pathway and increases cytochrome c (cyt c) release from mitochondria into the 
cytoplasm, leading to caspase-9 activation followed by caspase-3 activation. ROS increase in 
the ER also activates caspase 12, which in turn activates caspase 9 and caspase 3. Thus, ROS 
generated from the ER and mitochondria both contribute to apoptosis through a common 
pathway involving caspases 9 and 3. 
 
1.3.4 Oxidative stress and protein trafficking  
There are two different routes of normal intracellular protein trafficking to lysosomes. In 
the first route, proteins travel from the Golgi apparatus to late endosomes and then to 
lysosomes (Harter and Mellman, 1992; Mathews et al., 1992). In the second route, 
proteins start in the Golgi apparatus and travel to the plasma membrane and then to 
early endosomes, late endosomes and lysosomes (Harter and Mellman, 1992). 
However, recent studies have indicated that the presence of oxidative stress induces 
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the aforementioned organelle stress as well as lysosomal trafficking and fusion with the 
plasma membrane (lysosome exocytosis) (Li et al., 2012). This trafficking pathway 
during oxidative stress is Ca2+ dependent, as the exocytosis of lysosomes could be 
prevented by chelating Ca2+ with EGTA (Li et al., 2012; Rodriguez et al., 1997). Thus 
oxidative stress via intracellular Ca2+ plays a key role in the trafficking of lysosomes to 
the membrane. It has also been reported that oxidative stress affects endocytic 
trafficking. This was demonstrated by the significant decrease in the number of cell-
surface transferrin (Tf)-binding sites and increase in the recycling of internalised Tf back 
to the plasma membrane in the presence of oxidants (Cheng and Vieira, 2006).  
 
All of the above evidence indicates that cellular protein trafficking by lysosomes and 
internalisation is affected during oxidative stress. However, the relevance of these 
effects on cell physiology is unclear.      
 
 Oxidative stress and calcium ion channels 1.4
Ca2+ is an intracellular messenger that controls multiple cellular processes such as 
gene transcription, cell proliferation, differentiation, growth, membrane excitability, 
exocytosis and muscle contraction (Arundine and Tymianski, 2003; Berridge, 1993; 
Berridge et al., 1998; Clapham, 1995). Cytosolic Ca2+ can be elevated because of Ca2+ 
entry from the intracellular space or Ca2+ release from organelles. As such, calcium ion 
channels are not only found in the external membrane plasma membrane but also in  
the membranes of intracellular organelles such as the ER (Clapham, 1995), lysosomes 
(Rizzuto and Pozzan, 2006) and mitochondria (Clapham, 1995). The normal 
concentration of intracellular Ca2+ is about 100 nM; however, Ca2+ concentration can be 
elevated to 1 µM when the cell is stimulated (Fan et al., 2011). 
 
Ca2+ elevation can be achieved by different mechanisms including calcium pumps 
(Strehler and Treiman, 2004), exchangers (Blaustein and Lederer, 1999) and ion 
channels (Clapham, 2007). Plasma membrane Ca2+/ATPase (PMCA) helps to keep the 
intracellular Ca2+ at a low level by pumping Ca2+ out of the cytoplasm; 
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sacro/endoplasmic reticulum Ca2+/ATPase (SERCAs) pumps Ca2+ into 
sarco/endoplasmic reticulum to reduce cytosolic Ca2+ (Strehler and Treiman, 2004). The 
Na+/Ca2+ exchangers (NCX) (Blaustein and Lederer, 1999) exchange one Ca2+ ion for 
three Na+ ions (Blaustein and Lederer, 1999).  
 
There are several types of Ca2+ ion channels in the plasma membrane which have 
different gating mechanisms. Voltage-gated calcium ion channels are activated when 
the membrane is depolarised; they allow Ca2+ entry (Catterall, 2011). Store-operated 
channels (SOCs) are activated in response to store depletion (low concentration of ER 
Ca2+) (Putney, 2005). SOCs are made up of STIM-1 (stromal interaction molecule-1) 
and Orai1 subunits. Orai1 is a Ca2+ ion channel present in the plasma membrane 
(Feske, 2007). STIM-1 is located in the ER. In response to store depletion, STIM-1 
associates with Orai1; this association leads to the activation of Orai-1 and extracellular 
Ca2+ entry (Feske, 2007; Putney, 2005). 
 
However, the cytosolic Ca2+ concentration can be controlled by chelation of intracellular 
Ca2+ by Ca2+-binding proteins (Burgoyne, 2007). Ca2+-binding proteins are classified into 
buffering proteins and sensors (Burgoyne, 2007). Ca2+-buffering proteins have EF-
hands with which they bind Ca2+ (Burgoyne, 2007). Examples include calbindin, a Ca2+-
binding protein found in the brain (Mattson et al., 1991). Ca2+ sensors are EF-hand 
proteins that regulate the activity of other proteins (Burgoyne, 2007); examples include 
phospholipase C (PLC), IP3 receptor, the ryanodine receptor and calmodulin 
(Burgoyne, 2007; Clapham, 2007). 
 
Free Ca2+ is sequestered by intracellular organelles such as the ER and mitochondria. 
As mentioned previously, Ca2+ sequestering into the ER is mediated by the SERCA 
pump (Strehler and Treiman, 2004), whereas Ca2+ entry into mitochondria is via  
voltage-dependent anion channel 2 (VDAC2) and the mitochondrial calcium uniporter 
(MCU) located in the outer and inner membranes of the mitochondria respectively (Min 
et al., 2012; Kirichok et al., 2004). 
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Transient receptor potential (TRP) channels represent a major superfamily that 
regulates Ca2+ entry into cells. Several members of TRP channels are activated by 
oxidative stress, including transient receptor potential vanilloid 1 (TRPV1) and transient 
receptor potential melastatin 2 channel (TRPM2). The following section explains the 
function of these channels. 
 
1.4.1 Transient receptor potential (TRP) channels  
TRP channels play key roles in the calcium-signalling processes by regulating cellular 
Ca2+ by permitting Ca2+ entry through the plasma membrane and/or its release from 
intracellular stores (Nagamine et al., 1998; Nilius et al., 2007; Venkatachalam and 
Montell, 2007).  
 
The TRP family consists of two main groups and seven subfamilies based on 
differences in the amino acid sequence (Venkatachalam and Montell, 2007). Group 1 
includes the TRPC (canonical), TRPV (vanilloid), TRPM (melastatin), TRPN and TRPA 
(ankyrin) subfamilies; these subfamilies have the strongest sequence homology 
between them (Venkatachalam and Montell, 2007) (Figure 1.3). Group 2 comprises the 
TRPP (polycystin) and TRPML (mucolipin) subfamilies, which have a large loop that 
separates the first two transmembrane domains. In addition, they have significant 
sequence homology in the transmembrane segments (Venkatachalam and Montell, 
2007).  
 
 
 
 
 
 
 
 
 
14 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3 TRP-channel superfamily phylogenetic tree  
The identified subfamilies in mammals are TRPC (canonical), TRPV (vanilloid), TRPM 
(melastatin), TRPA (ankyrin), TRPP (polycystin) and TRPML (mucolipin). Boxed ion channels 
are activated by oxidative stress, and their activation induces cell death, reproduced from (Gees 
et al., 2010).  
 
 Transient receptor potential vanilloid 1 channel (TRPV1)  1.4.1.1
TRPV1 is a Ca2+-permeable, non-selective cation channel (Lishko et al., 2007). TRPV1 
channels are like other TRP channels. They consist of six transmembrane domains with 
a pore-forming loop between transmembrane domains 5 and 6 and cytoplasmic N- and 
C-termini (Lishko et al., 2007). TRPV1 is highly expressed in the hippocampus and 
cortex, and it has been found in the hypothalamus, locus coeruleus, superior colliculus, 
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spinal cord and pancreatic islet cells (Caterina et al., 1997; Ho et al., 2012; Roberts et 
al., 2004). TRPV1 can be activated by different stimuli such as low pH, noxious heat, 
capsaicin and oxidative stress (Caterina et al., 1997). Activation of TRPV1 channels 
results in an overload of cytosolic Ca2+, leading to oxidative stress mitochondrial 
damage and cell death (Amantini et al., 2007). 
 
 Transient receptor potential melastatin 2 channel (TRPM2) 1.4.1.2
The TRPM2 channel was discovered in 1998 (Nagamine et al., 1998). It was previously 
named TRPC7 (Nagamine et al., 1998) or LTRPC2 (Hara et al., 2002; Perraud et al., 
2001). It is a voltage-independent, calcium-permeable, non-selective cation channel 
(Perraud et al., 2001). It has unique gating properties conferred by the presence of a 
functional adenosine diphophoribose hydrolase domain in its C-terminus (Jiang et al., 
2011b; Kuhn et al., 2005; Lange et al., 2009; Nilius, 2007). TRPM2 is therefore referred 
to as a chanzyme, which means it is an ion channel fused to an enzymatic domain 
(Lange et al., 2009; Venkatachalam and Montell, 2007). The focus of this thesis is on 
the TRPM2 channel; therefore, this channel is discussed in more detail. 
 
The aberrant functioning of TRPM2 channels can give rise to several types of disease 
(discussed in further detail later in this thesis) (Nilius, 2007). Diseases due to ion 
channel dysfunction are called channelopathies. However, there are few reports 
showing a direct link between mutations in TRPM2 and human diseases (Nilius, 2007). 
TRPM2, however, is thought to play an important role in diseases such as diabetes 
mellitus, atherosclerosis, Parkinson’s disease and Alzheimer’s disease (Takahashi et 
al., 2011). This review focuses on the main characteristics of the TRPM2 gene, its 
expression, localisation, architecture, permeation properties and activation through 
important stimuli that can gate the channel. This review also outlines the role of TRPM2 
in diseases and the pharmacology of the channel.  
 
The TRPM2 gene 
The human TRPM2 gene is located on chromosome 21 (Nagamine et al., 1998) within 
the disease-rich 21q22.3 locus. This locus is linked to various types of inherited 
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diseases such as bipolar affective disorder and nonsyndromic hereditary deafness 
(Nagamine et al., 1998; Perraud et al., 2003; McQuillan et al., 2006). The human 
TRPM2 gene comprises 32 exons, making it approximately 100 kb long (Nagamine et 
al., 1998). The gene is highly expressed in brain cells (McQuillan et al., 2006).  
 
TRPM2 expression and localisation in the mammalian cell 
In addition to the brain, TRPM2 is expressed in various other tissues, including spleen, 
bone marrow, liver, heart, endothelium, heart, pancreas and lung (Fonfria et al., 2004; 
Takahashi et al., 2011; Togashi et al., 2006). TRPM2 is also present in several cell 
lines, including the neutrophil cell line, CRI-G1 insulinoma cells, microglia and the U937 
monocyte cell line (Kolisek et al., 2005; Togashi et al., 2006). In mammalian cells, 
TRPM2 is normally expressed at the plasma membrane. However, in some cell types, it 
is expressed in late endosomes and lysosomes (Lange et al., 2009; Sumoza-Toledo et 
al., 2011). For example, TRPM2 is expressed in the endolysosomal vesicles in dendritic 
cells (DCs), while in neutrophils, TRPM2 is expressed in the plasma membrane (Abe 
and Puertollano, 2011; Lange et al., 2009; Sumoza-Toledo et al., 2011). In the INS-1 
pancreatic β-cell line, TRPM2 is expressed in lysosomes (Lange et al., 2009; Manna et 
al., 2015). 
 
TRPM2 channel architecture  
TRPM channels have limited amino acid sequence homology to other members of the 
TRP ion-channel family (Nilius et al., 2003). It is a tetrameric protein with four subunits, 
each comprising six transmembrane (S1-S6) segments (Nilius, 2007; Takahashi et al., 
2011; Venkatachalam and Montell, 2007). The pore forming-part of the channel is made 
from loops between the S5 and S6 segments (Nilius, 2007; Nilius et al., 2003) (Figure 
1.4).  
 
There are four key TRPM2 residues that play a role in determining divalent cation 
permeation properties (Xia et al., 2008). These are Glu-960, Gln-981, Asp-987 and Glu-
1022 residues (Xia et al., 2008) (Figure 1.4). There are two conserved cysteine residues 
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at positions 996 and 1008 in the putative pore region in human TRPM2; these are 
essential for TRPM2 function (Mei et al., 2006).  
 
 
 
 
 
 
 
 
 
 
Figure 1.4 Topology of a TRPM2 subunit showing six transmembrane (TM) domains (S1-
S6) with N and C-terminal regions; redrawn from (Takahashi et al., 2011) 
The N-terminal region includes the calmodulin (CaM) binding region, while the C-terminal region 
includes the coiled-coil region, NudT9-H region and TRP region. The pore region (S5-S6) has 
residues (Glu-960, Glu-981, Asp-987 and Glu-1022) that control the permeation property of the 
TRPM2 channel.  
 
The N-terminal in TRPM2 is important for protein trafficking and for correct assembly of 
channel subunits. The TRPM2 C-terminal has a coiled-coil domain, which is about 100 
amino acids long, a linker region of about 30 amino acids and a NudT9-H domain of 
about 270 amino acids (Perraud et al., 2001). The so-called Nudix box is positioned in 
the NudT9-H domain, which consists of 22 amino acids (Perraud et al., 2001). The 
Nudix box is important for the enzymatic hydrolysis of nucleoside diphosphates 
(Perraud et al., 2001).  
 
TRPM2 permeation properties and activation  
Both whole-cell and single-channel current measurements demonstrated that TRPM2 is 
a non-selective cation channel (Perraud et al., 2001). It has a high level of permeation 
to potassium, sodium, caesium, and calcium ions (Perraud et al., 2001). Using the 
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FluoZin-3 probe, Ye and co-wrkers demonstrated TRPM2 channels can promote Zn2+ 
permeation (Ye et al., 2014). Studies have shown that oxidant activation of TRPM2 
channels and the consequent rise in cytosolic Ca2+ levels can lead to plasma 
membrane depolarisation (Wehage et al., 2002).   
 
TRPM2 channels are activated by oxidative stress (Hara et al., 2002; Wilkinson et al., 
2008). While oxidants such as H2O2 can directly activate the channel by oxidising a 
methionine (Met-214) residue located in the N-terminus of TRPM2, much of H2O2 
induced channel activation is indirect being mediated by ADP-ribose (ADPR) (see later).  
Furthermore, Ca2+, which enters through the plasma membrane channel, can 
allosterically activate the channel (Hara et al., 2002; Perraud et al., 2001).  Other 
activating intracellular signals include cyclic ADPR (cADPR) and nicotinic acid adenine 
dinucleotide phosphate (NAADP). They are thought to work as co-activators in 
combination with ADPR (Beck et al., 2006), although this is somewhat controversial 
(see later).  
 
Signals that activate TRPM2 channels 
ADPR, cADPR and NAD  
Oxidant induced production of ADPR occurs in the nucleus as well as mitochondria. 
Oxidants cause damage to DNA, triggering activation of DNA repair enzymes: poly 
(ADPR) polymerase (PARP) and poly (ADPR) glycohydrolase (PARG) (Lange et al., 
2009; Wilkinson et al., 2008). PARP catalyses the transfer of ADPR moieties from NAD+ 
to nuclear proteins by a process known as polyADP ribosylation.  PARG causes the 
release of ADPR from the polyADP-ribosylated proteins. ADPR diffuses from the 
nucleus into the cytoplasm to activate the TRPM2 channel. The other source of ADPR 
is mitochondria, where it is produced by the action of NADase on NAD+ (Ayub and 
Hallett, 2004; Wilkinson et al., 2008). NAD+ is normally restricted to the matrix of 
mitochondria because of the impermeability of mitochondrial membranes (Ayub and 
Hallett, 2004). However, during oxidative stress, when mitochondrial Ca2+ uptake 
increases, the permeability of the inner membrane to NAD+ increases due to the 
opening of the mitochondrial permeability transition pore (MPTP). This leads to an 
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increase in the access of NAD+ to the outer membrane NADase and release of ADPR 
into the cytosol through the permeable outer mitochondrial membrane (Ayub and 
Hallett, 2004).  
 
TRPM2 activation occurs when ADPR binds to the C-terminal NudT9-H domain 
(Perraud et al., 2001; Venkatachalam and Montell, 2007). This then seems to be 
followed by the hydrolysis of ADPR, presumably terminating the TRPM2 activity 
(Takahashi et al., 2011; Venkatachalam and Montell, 2007). However, the enzymatic 
activity of TRPM2 has not yet been demonstrated (Takahashi et al., 2011). Although 
NAD+ was thought to activate TRPM2 channels directly, Kolisek and co-workers have 
demonstrated that TRPM2 activation by NAD+ occurs later than ADPR activation and at 
a much higher concentration (Kolisek et al., 2005). Thus the current consensus is that 
the effect of NAD+ on TRPM2 is indirect via ADPR. Other reported activator of TRPM2 
channel is cyclic ADP-ribose (cADPR) (Kolisek et al., 2005) and NAADP (Beck et al., 
2006). However, a recent study reported that cADPR and NAADP do not enhance 
activation by ADPR, raising doubts on the role cADPR and NAADP as coactivators of 
the channel (BalazsToth and Csanady, 2010), see Table 1.1.  
 
Ca2+ 
McHugh and colleagues have reported that intracellular Ca2+ is crucial for ADPR-
mediated TRPM2 activation (McHugh et al., 2003). It was suggested that Ca2+ acts as a 
cofactor and modulator in gating TRPM2 (Kolisek et al., 2005; McHugh et al., 2003). As 
intracellular Ca2+ rises, TRPM2 sensitivity to ADPR increases. This allows gating of the 
TRPM2 channel at lower concentrations of ADPR (Kolisek et al., 2005). Other studies 
however suggest that TRPM2 gating by intracellular Ca2+ can occur without the 
involvement of ADPR (Du et al., 2009). The direct effect of intracellular Ca2+ was 
confirmed by mutating the ADPR binding site on the TRPM2 channel and using 
alternative spliced isoforms (Du et al., 2009). 
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Table 1.1 TRPM2 channel activators  
Ligand Affinity Unit Concentration 
ranges (M) 
Reference 
NAD - - 3x10-4 - 1x10-3 
 
(Hara et al., 2002; 
Heiner et al., 2003; 
Sano et al., 2001; 
Togashi et al., 
2006) 
H2O2 - - 5x10
-7 - 5x10-5 
 
(Fonfria et al., 
2004; Smith et al., 
2003; Hara et al., 
2002; Kraft et al., 
2004; Wehage et 
al., 2002) 
cADPR 5.0 pEC50 - 
 
(Kolisek et al., 
2005; Lee, 2012; 
Togashi et al., 
2006)  
ADP ribose 3.9-4.4 pEC50 - 
 
(Perraud et al., 
2001) 
NAADP 3.1 pEC50 - 
 
(Beck et al., 2006) 
 
Temperature 
Activity of the TRPM2 channel is also sensitive to temperature (Kashio et al., 2011; 
Togashi et al., 2006). Kashio and colleagues demonstrated that H2O2 is capable of 
lowering the temperature threshold for TRPM2 activation. This is a unique mechanism 
which was referred to as “sensitization” (Kashio et al., 2011). In the absence of H2O2, 
the temperature threshold for TRPM2 activation is in the supraphysiological range 
(Kashio et al., 2011). The H2O2 sensitization is mediated by the oxidation of Met-214 
residue located in the N-terminus of the channel. Mutation of this residue to alanine 
prevents sensitization completely (Kashio et al., 2011). 
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Figure 1.5 Signalling mechanisms for TRPM2 activation and inducing cell death 
H2O2 can cross the plasma membrane, leading to direct activation of TRPM2 channels. H2O2 
activation of the channel, however, is largely brought about by the production of ADPR in 
mitochondria and the nucleus. It causes production of ADPR from NADH in the mitochondria by 
activating NADase. In the nucleus, ADPR is generated by the activation of PARP/PARG 
pathway in response to H2O2 induced DNA damage. H2O2 lowers the temperature threshold 
required for TRPM2 activation. TRPM2 activation promotes Ca2+ influx across the plasma 
membrane and/or Ca2+ release from lysosomes. Ca2+ can allosterically activate the channel by 
acting on the cytosolic domain of the channel. A rise in intracellular free Ca2+ eventually leads to 
cell death.   
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Pharmacology of TRPM2 channels 
To date, there are no specific TRPM2 inhibitors. However, there are several blockers 
which work effectively but not specifically on TRPM2. These blockers are antifungal 
imidazoles, such as clotrimazole and econazole, and flufenamic acid (FFA), which is a 
non-steroidal anti-inflammatory compound (Hill et al., 2004). FFA is widely used and 
completely inhibits the TRPM2 channel at 200 µM (Jiang et al., 2011b; Lee et al., 1996). 
AMP is considered as an ADPR negative feedback regulator (Kolisek et al., 2005). 
Thus, AMP can inhibit ADPR-mediated gating of the TRPM2 channel (Kolisek et al., 
2005). 2-aminoethoxydiphenyl borate (2-APB) is also an effective blocker that induces 
partial inhibition at a low concentration (10 µM) but complete inhibition at a higher 
concentration (100 µM) (Togashi et al., 2008). ACA (N-(p-Amylcinnamoyl) anthranilic) is 
another potent inhibitor of TRPM2 channels (Kraft et al., 2006). In addition, TRPM2 
function can be inhibited by the PARP inhibitor (N-(6-oxo-5,6-dihydro-phenanthridin-2-
yl)-N,N-dimethylacetamide) (PJ34). PJ34 protects from H2O2 activation of TRPM2 
channels, intracellular Ca2+ elevation and cell death (Fonfria et al., 2004) (Table 1.2).  
 
Table 1.2 TRPM2 channel inhibitors  
Ligand Affinity Unit Inhibitory 
concentration 
range (M) 
Reference 
flufenamic acid - - 5x10-5 - 1x10-3 
 
(Hill et al., 2004a; 
Togashi et al., 
2008) 
clotrimazole  - - 3x10-6 - 3x10-5 
 
(Hill et al., 2004b) 
econazole - pIC50 3x10
-6 - 3x10-5 
 
(Hill et al., 2004b) 
2-APB 6.1 pIC50 - 
 
(Togashi et al., 
2008) 
ACA 5.8 pIC50 - 
 
(Kraft et al., 2006) 
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TRPM2 and diseases  
As mentioned previously, tissue damage can occur through activation of TRPM2 by 
oxidative stress. This could lead to different pathophysiological conditions, such as 
autoimmune disease, neurodegenerative disorders (Parkinson’s disease and 
Alzheimer’s), atherosclerosis and diabetes mellitus (Abe and Puertollano, 2011).  
 
Oxidants also play a role in the regulation of macromolecules and circulating cells within 
the vasculature (Johnson et al., 1989). ROS are generated at the site of inflammation 
and injury (Di et al., 2012). The TRPM2 channel mediates oxidative stress-induced 
endothelial hyperpermeability (Dietrich and Gudermann, 2008; Hecquet and Malik, 
2009). Understanding the role of TRPM2 in ROS induced Ca2+-entry in endothelial cells 
may lead to more effective pharmacologic intervention of endothelial pathophysiology 
through manipulation of TRPM2 function (Dietrich and Gudermann, 2008). Thus, 
TRPM2 and oxidative stress play an important role in the pathophysiology of vascular 
diseases. 
 
TRPM2 is expressed in pancreatic β-cells. Activation of TRPM2 channels has been 
linked to the regulation of insulin secretion and consequent reduction of blood glucose 
levels (Uchida et al., 2011). TRPM2 channels also mediate and H2O2-induced apoptosis 
of insulin-secreting β-cells (Lange et al., 2009; Manna et al., 2015). Thus TRPM2 
channels are thought to play a key role in diabetes progression (Uchida et al., 2011).  
 
In neurodegenerative diseases, which are complex disorders, a multitude of factors, 
such as environmental triggers, interact with genetic susceptibility genes (Hermosura et 
al., 2008). It has been reported that Western Pacific amyotrophic lateral sclerosis (ALS) 
and parkinsonism–dementia (PD) are tightly associated with environmental factors such 
as low levels of Ca2+ and Mg2+ in soil or water (Hermosura et al., 2008). Hermosura et 
al. reported that a genetic variant of the TRPM2 gene might be responsible for the 
diseases. The variant channel contains the P1018L mutation in the S5-S6 loop of the 
channel.  Functional analysis revealed that, compared with the wild-type channel, the 
P1018L mutant channel inactivates rapidly. The authors suggest that attenuation of 
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intracellular Ca2+ contributes to the diseases via a mechanism that is unclear. 
Interestingly, knock-out of TRPM2 channels in mice does not produce either of the two 
disease phenotypes. The authors conclude that future studies using P1018L transgenic 
mice may provide the answers to the puzzle.  
 
TRPM2 is expressed in many cell types of the immune system including dendritic cells, 
monocytes and macrophages (Di et al., 2012). It has been reported that phagocyte 
NADPH oxidase and ROS generation play an important role in host defence (Di et al., 
2012). However, overproduction of ROS induces inflammatory injury. Di et al. found that 
the TRPM2 channel mediates NADPH oxidase-mediated ROS production in 
phagocytes. The results revealed that TRPM2 inactivation inhibits NADPH oxidase 
activity and protects from tissue injury (Di et al., 2012).  
 
H2O2 is important in some diseases such as cancer because of its ability to cause cell 
death. In addition, it has been reported that ROS signalling pathways are involved in 
increasing anti-tumour activity (Alexandre et al., 2006). Thus, H2O2-mediated 
mechanisms can be targeted for the development of cancer therapeutics (Alexandre et 
al., 2006).  
 
Although there have been numerous reports implicating Ca2+ in cell death, recent 
findings with neuronal and pancreatic β-cells indicate a role not only for Ca2+, but also 
for Zn2+, (Manna et al., 2015; Ye et al., 2014). Therefore, the next section discusses 
Zn2+ regulation by oxidative stress and its role in cell death.    
 
 Zn2+ homeostasis and oxidative stress  1.5
Zinc is the second most abundant trace element in the human body (Frederickson et al., 
2005; Vallee and Falchuk, 1993). It plays an important role in normal growth, protein 
metabolism, membrane integrity, wound healing, gene expression and collagen 
synthesis (Islam and Loots, 2007). It is mostly bound to proteins and enzymes where it 
supports their structure and function. Since free Zn is cytotoxic, it is largely buffered by 
the Zn2+-buffering protein metallothionein (MT)-1 (Frederickson et al., 2005; Vallee and 
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Falchuk, 1993; Wiseman et al., 2007). However, unbound zinc also plays an important 
role as a signalling molecule in cell function (Frederickson et al., 2005). Zinc deficiency 
leads to abnormalities in the skin and hair and in immune function (Frederickson et al., 
2005). Zinc is highly available in the pancreatic β cells and in the brain (10 µg of zinc 
per gram of wet tissue) compared with its availability in other organs. The average 
estimated intracellular concentration is approximately 150 µM of total Zn2+ 
(Frederickson, 1989; Wallwork, 1987). However, zinc at high concentrations has a 
cytotoxic affect which has been linked to various diseases including neurodegenerative 
diseases (Parkinson’s disease and Alzheimer’s disease), atherosclerosis and type 1 
diabetes (Frederickson et al., 2005; Manna et al., 2015; Morris and Levenson, 2012; 
Vallee and Falchuk, 1993; Wiseman et al., 2007).  
 
Zn2+ homeostasis is affected by environmental factors such as oxidative stress (Frazzini 
et al., 2006). Intracellular Zn2+ rise occurs due to Zn2+ entry via transporters or ion 
channels (Frazzini et al., 2006; Morris and Levenson, 2012). Zn2+ can also be released 
from an intracellular source such as the Zn2+-sequestering protein MT-1 (Wiseman et 
al., 2007). It was reported that oxidative stress leads to Zn2+  release from the MT-1 
protein in the cytoplasm and overexpression of MT-1 prevents H2O2-induced apoptosis 
through sequestration of free Zn2+ (Wiseman et al., 2007). However, a recent report 
demonstrated that H2O2-induced apoptosis of pancreatic β-cells can be fully prevented 
by the inhibition or knock-out of TRPM2 channels (Manna et al., 2015). Manna et al. 
(2015) suggested that MT-1 is unlikely to play a role in oxidative stress-induced cell 
apoptosis. It is possible that supra-physiological concentrations of H2O2 (>1 mM) might 
be required to release Zn2+ from the MT-1 protein to cause cell death (Wiseman et al., 
2007), while lower concentrations of H2O2 might cause cell death via a TRPM2-
dependent, MT-1-independent  pathway (Manna et al., 2015).      
 
It has been also reported that excess intracellular Zn2+ can be removed by the 
mitochondria (Frazzini et al., 2006; Morris and Levenson, 2012). However, a rise in the 
mitochondrial Zn2+ concentration can lead to a marked reduction in mitochondrial 
function and drive mitochondrial ROS generation (Frazzini et al., 2006; Morris and 
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Levenson, 2012). Accumulation of Zn2+ in the mitochondria promotes release of pro-
apoptotic factors including Apoptosis Inducing Factor (AIF) and cytochrome c and cell 
death (Frazzini et al., 2006; Morris and Levenson, 2012). The combination of oxidative 
stress and Zn2+ accumulation thus appears to induce ROS production and cell damage 
(Frazzini et al., 2006; Morris and Levenson, 2012).     
 
It used to be thought that Zn2+ dynamics play a minor role in pathophysiology compared 
with Ca2+ dynamics (Inoue et al., 2015). However, studies have shown that many Ca2+-
permeable channels, such as voltage-dependent calcium channels (VDCCs), N-methyl-
D-aspartate receptors (NMDA) and TRPM2, are also permeable to Zn2+ (Inoue et al., 
2015; Morris and Levenson, 2012; Yu et al., 2012). Since Zn2+ is cytotoxic, it was 
suggested that Zn2+ could make significant contributions to pathophysiological 
processes (Inoue et al., 2015).     
 
As Zn2+ is crucial for normal physiology, studies have focussed on how zinc is 
transported into and out of the cell. In 1995, zinc transporter 1 (ZnT1), the first member 
of the mammalian zinc transporter gene was identified (Palmiter and Findley, 1995). 
There are two families of proteins involved in zinc transport, namely the ZnT family (9 
members) and Zip family proteins (14 members) (McMahon and Cousins, 2000). The 
ZnT family proteins allow zinc efflux from cells or zinc influx into intracellular vesicles 
(McMahon and Cousins, 2000). The Zip family proteins increase intracellular zinc by 
mediating zinc entry from an extracellular source or zinc release from an intracellular 
compartment (McMahon and Cousins, 2000). Most ZnT proteins have been found in the 
intracellular compartments such endosomes, lysosomes, Golgi apparatus and 
endoplasmic reticulum, with the exception of ZnT1, which is expressed in the plasma 
membrane (Kukic et al., 2014; Palmiter and Findley, 1995). Although the majority of Zip 
proteins have been found in the plasma membrane, Zip7 is located in the Golgi 
apparatus (Cousins et al., 2006; Huang et al., 2005).   
 
As mentioned previously, TRPM2 is activated by oxidative stress. Using FluoZin-3-AM 
as a Zn2+ probe, studies have shown that TRPM2 channels in the plasma membrane 
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can induce Zn2+ entry into cells (Yu et al., 2012). Very little free Zn2+ is normally present 
in the cytoplasm, with the majority of Zn2+ being bound to proteins (e.g. 
metallothioneins) or sequestered into organelles such as lysosomes (Sensi et al., 2009). 
Manna et al. reported that Ca2+ entry due to plasma membrane TRPM2 activation leads 
to lysosomal Zn2+ release and Zn2+-induced β-cell death (Manna et al., 2015). However, 
it has proven difficult to demonstrate Zn2+ permeation through TRPM2 channels using 
patch clamp electrophysiology because Zn2+ at 30 µM and higher was found to 
inactivate the channel (Yang et al., 2011) and higher concentrations of Zn2+ are required 
to generate enough driving force to measure Zn2+ currents.   
 
 Mitochondria  1.6
Mitochondrial morphology was revealed for the first time by electron microscopy in the 
early 1950s (Palade, 1953), when they were described as bean-shaped organelles 
(Chan, 2006; Okamoto and Shaw, 2005). Mitochondria are double membrane structures 
with an outer and inner membrane (Chan, 2006; Okamoto and Shaw, 2005). The inner 
membrane is folded into cristae (Chan, 2006; Okamoto and Shaw, 2005). Mitochondria 
have a range of morphologies from small spheres to long tubular structures (Chan, 
2006; Okamoto and Shaw, 2005). The mitochondrial diameter is ~0.5 µm, while its 
length ranges from 1 to 10 µm (Chan, 2006; Okamoto and Shaw, 2005). A healthy 
mitochondrial network is essential for the survival of all eukaryotic cells. However, the 
network’s structural integrity is constantly threatened by environmental and metabolic 
stresses. Mitochondria have the ability to cope with these threats by undergoing 
continuous cycles of fission and fusion (Archer, 2013; Dorn, 2015; Friedman and 
Nunnari, 2014; Youle and van der Bliek, 2012). As mitochondria are the most common 
organelles involved in programmed cell death due to oxidative stress, the following 
sections discuss the dynamics of mitochondria and how they change in response to 
pathological insults. 
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1.6.1 Dynamic shape of mitochondria 
Mitochondrial shape, size and number are controlled by a balance between fission and 
fusion mechanisms (Bleazard et al., 1999; Chen et al., 2003; Sesaki and Jensen, 1999; 
Smirnova et al., 2001). Cells with more fusion than fission have longer and fewer 
mitochondria. Cells with more fission than fusion have smaller and more numerous 
mitochondria or fragmented mitochondria (Bleazard et al., 1999; Chen et al., 2003; 
Sesaki and Jensen, 1999; Smirnova et al., 2001).    
 
 The fusion machinery 1.6.1.1
The fission of mitochondria is balanced by sufficient mitochondrial fusion (Chen et al., 
2003; Santel and Fuller, 2001). Fusion machinery is maintained by a two-step process, 
where the outer membrane and the inner membrane fuse in separate events involving 
three large GTPases: two mitofusins, Mitofusin1 (Mfn1) and Mitofusin2 (Mfn2), both of 
which are located in the outer membrane and responsible for outer membrane fusion 
(Chen et al., 2003; Santel and Fuller, 2001), and optic atrophy 1 (OPA1), which is 
located in the inner membrane and intermembrane space and is responsible for inner 
membrane fusion (Figure 1.6). These three proteins are the key proteins described to 
date. 
 
Mitofusins 1 and 2 (Chen et al., 2003) promote mitochondrial fusion by cooperating or 
working individually (Chen et al., 2005). Their role in mitochondrial fusion has been 
studied using gene knock-out mice for Mfn1 and Mfn2 or by silencing Mfn1 or Mfn2 
expression (Chen et al., 2005). A deficiency of Mfn1 or Mfn2 reduces the level of 
mitofusion significantly (Chen et al., 2005). However, the function of mitofusins is 
redundant (Chen et al., 2003). In other words, mitochondrial fragmentation due to a lack 
of Mfn1 can be rescued by overexpression of Mfn2, and, conversely, a lack of Mfn2 can 
be rescued by overexpression of Mfn1 (Chen et al., 2003). Furthermore, cells lacking in 
both Mfn1 and Mfn2 show severe mitochondrial fragmentation and a complete loss of 
tubular mitochondria (Chen et al., 2005). OPA1 is a crucial protein for the fusion of the 
inner mitochondrial membrane. Reducing OPA1 expression by RNA interference (RNAi) 
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induces mitochondrial fragmentation plus abnormalities and defects in cristae structure 
(Chen et al., 2005; Griparic et al., 2004). However, overexpression of OPA1 also 
induces mitochondrial fragmentation, but this is Drp1-dependent (Chen et al., 2005). 
mRNA splicing generates a long isoform and one or more short isoforms of OPA1. The 
combination of long and short isoforms is crucial for mitochondrial fusion (Song et al., 
2007). However, overexpression of OPA1 could lead to an imbalance between the long 
and short isoforms of OPA1, leading to inappropriate mitochondrial fragmentation and 
poor maintenance of tubular mitochondrial morphology (Chen et al., 2005).    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6 Mitochondrial fusion machinery, redrawn from (Mishra and Chan, 2014) 
Three different proteins contribute to the fusion machinery: mitofusin1 and 2 (Mfn1 and Mfn2) 
and optic atrophy 1 (OPA1). Mfn1 and Mfn2 are transmembrane GTPases embedded in the 
outer mitochondrial membrane (OMM). They participate in the fusion of OMM. OPA1 is a 
dynamin-related protein embedded in the inner mitochondrial membrane (IMM) facing the 
intermembrane space. It contributes to the fusion of IMM.   
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 The fission machinery 1.6.1.2
During apoptosis, the tubular mitochondria fragment into small and numerous 
mitochondria (Liesa et al., 2009). This fragmentation occurs because of increasing 
mitofission or decreasing mitofusion or both, and it leads to a change in the 
mitochondrial phenotype (Frank et al., 2001; Liesa et al., 2009). The most studied 
proteins involved in mitochondrial fragmentation are dynamin-related protein 1 (Drp1) 
and fission protein 1 homolog (FIS1) (James et al., 2003). These proteins are located in 
the mitochondrial outer membrane. Inhibition of the activity of Drp1 GTPase with 
dominant negative Drp1K39A prevents mitochondrial fragmentation during apoptosis 
(Frank et al., 2001; James et al., 2003). Overexpression of FIS1 induces mitochondrial 
fragmentation and cell apoptosis (James et al., 2003). Whether there are any fission-
inducing proteins associated with the inner mitochondrial membrane is not known (Suen 
et al., 2008).   
 
Drp1 is a regulator of mitochondrial fission in most eukaryotic organisms. It is a soluble 
protein that is expressed in different tissues such as heart, brain, kidney and pancreas 
(Smirnova et al., 1998; Yoon et al., 1998). Drp1 consists of an N-terminal GTPase, a 
medial domain (MD) and a C-terminal GTPase effector domain (GED) (Elgass et al., 
2013). Drp1 proteins are recruited from the cytosol to the outer membrane of the 
mitochondria where they form a ring or spiral structure around the mitochondria, leading 
to the division of the mitochondrial membrane (Liesa et al., 2009). There are several 
mitochondrial proteins located in the outer mitochondrial membrane which act as a 
recruiter or receptor of Drp1; these include mitochondrial FIS1 mitochondria fission 
factor (MFF) and mitochondrial dynamics proteins (MIDs; MiD49 and MiD51) (Loson et 
al., 2013) (Figure 1.7). 
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Figure 1.7 Mitochondria fission machinery, redrawn from (Mishra and Chan, 2014) 
Dynamin-related protein 1 (Drp1) and its receptors (fission protein 1 (FIS1), mitochondrial 
fission factor (MFF) and mitochondrial dynamics proteins of 49 and 51 kDa (MiD49 and MiD51)) 
play a role in the fission mechanism. Drp1 is a large soluble GTPase in the cytosol. It is 
transported onto mitochondria and forms a ring at the division site of the outer mitochondrial 
membrane (OMM). The receptor proteins FIS1, MFF, MiD49 and Mid51 mediate Drp1 
recruitment and mitochondrial fission. 
 
1.6.2 Mitochondrial fragmentation and disease  
The correct regulation of fission and fusion events is essential for mitochondrial function 
in ATP generation, Ca2+ signalling and regulation of apoptosis (Dorn, 2015; Friedman 
and Nunnari, 2014; Youle and van der Bliek, 2012). The disruption of the fusion-fission 
equilibrium contributes to a wide range of diseases, in particular the late-age onset 
diseases (Archer, 2013; Dorn, 2015) such as neuronal (Parkinson’s, Alzheimer’s) 
diseases, cardiovascular disease, diabetes and cancer (Archer, 2013; Friedman and 
Nunnari, 2014; Youle and van der Bliek, 2012). This disruption is attributed to the 
increase in cellular oxidative stress due to an increased production of ROS by the aging 
cell. Oxidative stress-induced mitochondrial fragmentation has been reported in 
neuronal (Grohm et al., 2012), cardiac (Cohen and Tong, 2010) and renal (Brooks et al., 
32 
 
2009) cells exposed to ischemia/reperfusion injury, failing pancreatic β-cells (Molina et 
al., 2009), dysfunctional endothelial cells (Shenouda et al., 2011), insulin-resistant 
muscle cells (Jheng et al., 2012) and proliferating cancer cells (Rehman et al., 2012).  
 
Importantly, many reports have indicated that inhibition of mitochondrial fragmentation 
can rescue the healthy phenotype (Chen et al., 2003; Rahn et al., 2013; Wakabayashi 
et al., 2009). These findings suggest that mitochondrial dynamics represent a valid drug 
target for a wide range of age-related illnesses. However, targeting the proteins involved 
in the fusion and fission events for therapeutic purposes may prove difficult because 
knock-out of these proteins has been shown to be embryonically lethal (Chen et al., 
2003; Rahn et al., 2013; Wakabayashi et al., 2009).  
 
 Mitochondria as a drug target for diabetes complications 1.6.2.1
Diabetes mellitus, characterised by high blood glucose levels, can cause many vascular 
complications. Diabetic microvascular diseases cause nerve damage, terminal renal 
failure and blindness. Diabetic macrovascular damage leads to vascular diseases and 
its complications (Diabetes Control Complications Trial, 1995). One of the 
manifestations of cells exposed to hyperglycaemic conditions is ROS generation and 
consequent increase in mitochondrial fragmentation. However, the exact mechanism by 
which hyperglycaemia induces endothelial mitochondrial fragmentation and cell damage 
is not clear. Studies have indicated that high glucose-induced mitochondrial ROS 
production is also capable of inducing changes in the replication of the cell (Ono et al., 
1988), mitochondrial permeability transition (MPT) and cell apoptosis (Buttke and 
Sandstrom, 1994).  
 
Abnormal mitochondrial dynamics are associated with a variety of human diseases 
(Archer, 2013; Dorn, 2015; Friedman and Nunnari, 2014; Youle and van der Bliek, 
2012). Thus, mitochondrial dynamics represent a therapeutic target against which 
pharmacologic or molecular modulators could be developed. Therefore, in the future, 
researchers could start targeting proteins involved in mitochondrial fragmentation and 
excessive mitochondrial ROS production. Indeed, a recent study has shown that a small 
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peptide inhibitor (P110) designed to inhibit the enzyme activity of Drp1 was able to 
prevent mitochondrial fragmentation. The inhibitor was able to do so by interfering with 
the protein-protein interaction between Drp1 and FIS1 (Qi et al., 2013). Another study 
has shown that pharmacological inhibition may be used to target mitochondrial ROS 
production and reverse the metabolic response in order to prevent tissue damage 
(Chouchani et al., 2014). However, no study has thus far shown whether targeting ion 
channels will prevent mitochondrial ROS production and mitochondrial fragmentation 
induced by high glucose.  
 
 Apoptosis 1.7
Oxidative stress and mitochondria play an important role in apoptosis. As mentioned 
earlier, mitochondria are the major site of ROS generation and they are also targets of 
ROS. ROS accumulation induces alteration in the mitochondrial membrane leading to a 
cascade of apoptotic events. However, there is another pathway of apoptosis known as 
extrinsic apoptosis (Elmore, 2007). This pathway is mediated by death receptor ligands. 
Extracellular stress such as that from chemotherapeutics and radiation can induce 
extracellular signals that stimulate ligands, including tumour necrosis factor (TNF) and 
Fas ligands, to bind specific transmembrane receptors (Elmore, 2007). These receptors 
are called death receptors (DR) (Elmore, 2007). The ligands interact with their cognate 
receptors forming complexes (e.g., FasL/FasR, TNF-α/TNFR1) called death initiation 
signalling complexes (DISC) (Elmore, 2007; Scaffidi et al., 1999). DISC lead to the 
activation of a caspase cascade, including activation of caspases -8 and -3, and induce 
cell death (Elmore, 2007).     
 
Apoptosis is classified according to morphological changes and enzymological criteria 
(Elmore, 2007). It was described for first time with little knowledge of morphological 
changes in 1970s by Kerr, Wyllie and Currie (Kerr et al., 1972). Apoptosis is an 
essential process for normal development (Elmore, 2007). Dysregulation of apoptosis 
due to excess ROS is associated with a variety of diseases such as neurodegenerative 
diseases, autoimmune diseases, cardiovascular diseases and cancer (Elmore, 2007).  
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1.7.1 Apoptosis mechanism 
As this study focuses on TRPM2 ion channels, mitochondrial fragmentation and cell 
death, this part of the introduction discusses the possible signalling pathways 
associated with mitochondria-dependent apoptosis (i.e., the intrinsic pathway). The 
mechanism of this pathway is regulated by the Bcl-2 family of proteins and controlled 
mitochondrial membrane permeability (Elmore, 2007). The anti-apoptotic proteins Bcl-2 
and Bcl-XL inserted in the outer mitochondrial membrane prevent cytochrome c release 
(Elmore, 2007; Kroemer and Reed, 2000). Under normal conditions, the pro-apoptotic 
members of the Bcl-2 family Bid and Bax, are located in the cytoplasm (Elmore, 2007; 
Kroemer and Reed, 2000). During stress, the cytosolic Bid is cleaved by caspase-8 and 
its active form (tBid) is translocated to the mitochondria. Then, in response to death 
stimuli (i.e., cell stress), Bax is translocated to the mitochondria and forms a channel or 
permeability-transition pore by itself (Elmore, 2007) or, in combination with VDAC, forms 
large channels (Kroemer and Reed, 2000). These channels promote cytochrome c 
release into the cytoplasm following death signalling (Elmore, 2007). The released cyt c 
binds to Apaf-1, and the complex leads to the activation of caspase 9, caspase-3 
activation and apoptosis (Elmore, 2007) (Figure 1.8). The permeabilisation of the outer 
and inner mitochondrial membrane induces ATP depletion, loss of mitochondrial 
membrane potential (Δψm) and Ca2+ release (Elmore, 2007; Kroemer and Reed, 2000). 
 
1.7.2 Morphological changes  
Changes in the morphology of the cell during apoptosis have been documented by 
using light and electron microscopy (Kerr et al., 1972; Kroemer and Reed, 2000). During 
early apoptosis, cells are smaller in size (shrinkage), the cytoplasm is dense and the 
chromatin is condensed (Kerr et al., 1972; Kroemer and Reed, 2000). At the subcellular 
level, proteins are cleaved and the nucleus is fragmented (Kerr et al., 1972; Kroemer 
and Reed, 2000). As apoptosis advances, the cell gets fragmented into small bodies 
called “apoptotic bodies” (Kerr et al., 1972). 
 
35 
 
Apoptosis also triggers specific alternation in the plasma membrane as 
phosphatidylserine is redistributed from the inner to the outer leaflet of the plasma 
membrane (Brumatti et al., 2008). This alteration during apoptosis is due to an increase 
in intracellular Ca2+ concentration (Brumatti et al., 2008). This alteration can be detected 
with the most widely used marker Annexin V (apoptosis marker) (Brumatti et al., 2008). 
Annexin V is a recombinant phosphatidylserine-binding protein that interacts with 
phosphatidylserine residues (negatively charged phospholipids) exposed to the 
extracellular phase (Brumatti et al., 2008).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8 Proposed model of the molecular mechanism by which a death stimulus 
activates mitochondria-mediated apoptotic pathway 
During stress stimulus, Bax is translocated from the cytoplasm to the mitochondria and forms a 
channel consisting of Bax or Bax and VDAC. The channel pore promotes cytochrome c release 
into the cytoplasm, where it binds Apaf-1 which in turn causes activation of caspase-9 and -3, 
resulting in cell apoptosis. 
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 Endothelium in health and diseases 1.8
A study from the World Health Organization estimated that diabetes mellitus affects 
more than 170 million people in 2002. The prediction is that this number will increase to 
366 million by 2030 (Rathmann and Giani, 2004). Type 1 diabetes and type 2 diabetes 
both exhibit similar clinical features, primarily including hyperglycaemia. Type 1 diabetes 
is caused by the failure of pancreatic β cells leading to insulin deficiency, whereas type 
2 diabetes is caused by insulin resistance (American Diabetes Assocation, 2009). 
Diabetes mellitus can cause serious health problems and the dysfunction of various 
organs including the eyes, nerves, kidneys, heart and blood vessels (Amer Diabet, 
2009). Vascular complications are divided into macrovascular complications (i.e., 
cardiovascular disease) and microvascular complications (i.e., retinopathy, neuropathy 
and nephropathy) (Duby et al., 2004; Jay et al., 2006; Li and Shah, 2003).  
 
Endothelial cells form the inner lining of blood vessels and provide a protective barrier 
between the vessel wall and the circulating blood (Sumpio et al., 2002).  The 
endothelium has an important role in releasing endothelium-induced relaxing factors 
including nitric oxide (NO) and endothelium-derived hyperpolarisation factor (EDHF) 
(Cai and Harrison, 2000; Kietadisorn et al., 2012). NO is synthesized by endothelial 
nitric oxide synthase (eNOS) from L-arginine and molecular oxygen. It plays an 
important role in maintaining smooth muscle relaxation and vascular function (Cai and 
Harrison, 2000; Kietadisorn et al., 2012). eNOS is localised at the plasma membrane 
caveolae in its inactive form (bound to caveolin 1 (Cav-1)) (Kietadisorn et al., 2012). 
Upon disassociation from Cav-1, eNOS becomes active. The functional form of eNOS, 
referred to as coupled eNOS, is a dimer (Kietadisorn et al., 2012). For optimal activity, 
eNOS requires tetrahydrobiopterin (BH4) (Cai and Harrison, 2000; Kietadisorn et al., 
2012). BH4 is an important cofactor that helps in the conversion of L-arginine to NO 
(Cai and Harrison, 2000; Kietadisorn et al., 2012). However, in diabetes, eNOS is 
inactive because it largely exists in its monomeric form (i.e., uncoupled) due to BH4 
deficiency (Cai and Harrison, 2000; Kietadisorn et al., 2012). Electrons are normally 
transferred from the reductase domain via the heme group of eNOS to L-arginine. The 
deficiency in BH4 leads to transfer electrons to molecular oxygen rather than to L-
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arginine. This leads to the production of O2
•− rather than NO. O2
•− thus generated reacts 
with NO to form peroxinitrite (ONOO-). ONOO- oxidizes BH4 and generates more O2
•− 
production leading to endothelial dysfunction (Cai and Harrison, 2000; Kietadisorn et al., 
2012) (Figure 1.9). It has been reported that increased synthesis of BH4 can restore 
eNOS function in diabetes (Cai et al., 2005). eNOS deficiency induces endothelial 
dysfunction which is a marker for atherosclerosis (Davignon and Ganz, 2004). At the 
cellular level, eNOS deficiency induces mitochondrial fragmentation, enlarged 
lysosomes and increased mitochondrial ROS production (Ueda et al., 2015).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.9 Schematic representation of endothelial nitric oxide signalling, redrawn from 
(Kietadisorn et al., 2012) 
In a non-inflammatory state, eNOS is bound to the caveolin-1 (Cav-1) and is localised at the 
plasma membrane in its inactive form. Ca2+ uptake leads to eNOS activation, dissociation from 
the caveolar membrane and release into the cell. BH4 binds to the oxidase domain of eNOS 
and activates the enzyme to generate nitric oxide (NO) from L-arginine. NO diffuses to the 
underlying smooth muscle leading to relaxation. However, during stress, the bioactivity of BH4 
is reduced, which leads to reduced NO generation, increased superoxide production and 
endothelial dysfunction.   
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As the oxidative stress in diabetes is the cause of cardiovascular complications, 
previous studies have focused on using antioxidant supplementation to improve the 
function of endothelial cells. The use of vitamin C (250 mg) and vitamin E (600 mg) as 
antioxidants failed to reduce the risk of heart failure (Heart Protection Study 
Collaborative, 2002). Moreover, the use of a high dose (>400 IU/ day) of vitamin E may 
raise mortality (Miller et al., 2005). Feron et al. (2001) used atorvastatin to enhance 
eNOS activity. Low-density lipoprotein (LDL) cholesterol increases the interaction 
between Cav-1 and eNOS. This leads to a decrease in NO generation and an increase 
in endothelial cell dysfunction. However, atorvastatin has been found to induce a 
reduction in Cav-1 expression which in turn promotes NO production (Feron et al., 
2001). Furthermore, it has been reported that diabetes-induced zinc deficiency leads to 
diabetic complications (Islam and Loots, 2007). Chelating zinc with the Zn-buffering 
protein MT-1 helps in reducing diabetes-related complications and DNA damage (Islam 
and Loots, 2007). Thus, targeting ROS signalling events could represent a potential 
approach in reducing the risk of diseases caused by the overproduction of ROS.  
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 The aims of the current study  1.9
i. To generate a TRPM2 construct containing an extracellular human influenza 
hemagglutinin (HA) epitope to investigate the cellular distribution and trafficking of 
TRPM2 channels. 
ii. To investigate the role of TRPM2 channels in intracellular dynamics of Ca2+ and 
Zn2+ and mitochondrial fragmentation during high glucose stress on endothelial 
cells.  
iii. To investigate the role of TRPM2 channels, Ca2+ and Zn2+ in high glucose-induced 
endothelial cell death. 
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 Hypothesis of current study  1.10
High glucose induced oxidative stress induces mitochondrial fragmentation and cell 
death through TRPM2 channel activation and intracellular Zn2+ elevation.  
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  Overview of the thesis 1.11
In this thesis I inserted an HA tag into the S1-S2 loop of TRPM2 channels and 
evaluated the function and expression of the resulting construct, TRPM2-HA. I then 
examined how TRPM2 channel activation by oxidative stress affects mitochondrial Zn2+ 
uptake, mitochondrial fragmentation and cell death. 
 
Chapter 2 outlines the materials and methods used in this study. 
 
Chapter 3 shows that the insertion of human influenza hemagglutinin-tag into the 
TRPM2 channel did not affect the structure, function or subcellular localisation of the 
channel. 
 
Chapter 4 demonstrates that exposure of endothelial cells to H2O2 or high glucose 
conditions led to lysosomal membrane permeability (LMP), resulting in a marked 
decrease in lysosomal Zn2+ and redistribution of Zn2+ to mitochondria. The resultant rise 
in mitochondrial Zn2+ led to extensive mitochondrial fragmentation. The silencing of 
TRPM2 channels with siRNA prevented intracellular Zn2+ redistribution and 
mitochondrial fragmentation. Chapter 4 also demonstrates that a fraction of TRPM2 
channels is localised to the mitochondria, where they control mitochondrial fission. Zn2+ 
released from lysosomes enters mitochondria via TRPM2 channels and increases 
mitochondrial fragmentation by promoting the recruitment of cytoplasmic Drp1. The data 
imply a novel mechanism for how oxidative stress leads to excessive mitochondrial 
fragmentation mediated by mitochondrial TRPM2 ion channels. 
 
Chapter 5 illustrates the relevance of TRPM2 and Zn2+ redistribution to H2O2 and high 
glucose-induced mitochondrial ROS production and endothelial cell death. Blockers of 
TRPM2, TRPM2-targeted siRNA and chelation of Zn2+ significantly inhibited oxidative 
stress-induced cell death. The mechanism involves activation of TRPM2 channels 
leading to increased Ca2+ entry, intracellular Zn2+ release and mitochondrial ROS 
production. Chapter 5 also shows that there is a link between oxidative stress and the 
level of TRPM2 channel expression at the plasma membrane.  
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Chapter 6 provides a summary of the work and an outline of future directions.  
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 │ Materials and methods 2
 Materials  2.1
2.1.1 Molecular biology materials  
Supercompetent XL1-Blue cells purchased from Agilent Technologies (USA) were used 
for transformation. The QlAprep Spin Miniprep Kit, Qiagen HiSpeed Plasmid Midi Kit 
and Gel Extraction Kit were purchased from Qiagen, UK. All oligonucleotide primers 
used for pcDNA3.1-HA-TRPM2 sequencing and for inserting the HA-epitope were 
custom-made by Sigma-Aldrich® (Table 2.1). Phusion High Fidelity DNA Polymerase, 
Dpn I, 10× DNA ligase buffer and T4 DNA ligase were purchased from New England 
BioLabs (UK). The HF buffer used in the PCR was purchased from Stratagene 
(Cambridge, UK). Avian myeloblastosis virus reverse transcriptase (AMV-RT) and 
random primers were obtained from Promega. Taq DNA polymerase was from New 
England BioLabs. siRNA-1 (ON-TARGETplus Human TRPM2 (7226)) was from Thermo 
Scientific; siRNA-2 for human TRPM2 (5′- GAAAGAAUGCGUGUAUUUUGUAA -3′) was 
custom-made by Dharmacon; scrambled siRNA was from Ambion. DNA marker 
(HyperLadder I) was purchased from Bioline (London, UK). Luria-Bertani (LB) broth was 
purchased from Fisher Bioreagents (USA) and LB agar was purchased from Sigma-
Aldrich® (USA). Ampicillin was purchased from Sigma-Aldrich®. Sequencing of 
pcDNA3.1-HA-TRPM2 was carried out by Beckman Coulter Genomics (UK).  
 
  Plasmid clones  2.1.1.1
Human TRPM2 cDNA in the pcDNA3.1 vector was kindly provided by Dr. Lin-Hua-Jiang 
of the University of Leeds, UK. TRPM2-HA clone lacking two codons was generated by 
Tim Munsey (University of Leeds, UK). hERG-HA was generated by Dr. David Elliot 
(University of Leeds, UK) and has been described before (Karnik et al., 2013). TRPM2-
EE and TRPM2-FLAG were from Dr. Lin-Hua Jiang and have been described before 
(Mei et al., 2006). pMito-Cherry was constructed from pMito-CFP (Clontech) by Honglin 
Rong (University of Leeds, UK). Drp1-GFP clone containing shRNA to knock-down the 
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endogenous Drp1 (Slupe et al., 2013), and its dominant negative (K38A) version, was a 
kind gift from Dr. Stefan Strack (University of Iowa, USA). Lamp1-GFP was obtained 
from Dr, P. Boquet (Institut National de la Santé et de la Recherche Médicale, France).   
 
Table 2.1 Primers used  
A- Primers used for pcDNA-HA-TRPM2 plasmid sequencing 
 
B- Primers (5’phosphorylated) used for insertion of two missing amino-acids into the 
HA-epitope 
Primers                          Sequence ‘5-3’ 
 
 
                       Forward primer 
 
 
P’-GTCCCAGACTACGCTCACCTCCAA 
                       Reverse primer 
 
P’-GTCGTAGGGGTAGATTTCCTGGGC 
 
C- PCR primers of TRPM2  
Primers                          Sequence ‘5-3’ 
 
 
                       Forward primer 
 
 
        CCATCCGTGACCTTCTCATT 
                       Reverse primer 
 
        CTCTGAGCCCAGATGATTCC 
 
    Name of primer 
 
               Primer sequence ‘5-3’ 
                                T7  
 
             TAATACGACTCACTATAGGG 
Sequence 1 
 
TCCTCTCTCTGGACTTCAT 
Sequence 2 
 
ACATGAAGTTTGTGTCTCAC 
Sequence 3 
 
GCACTCATCTCCAACAAGCCT 
 
Sequence 4 
 
GCCGAGTACATACTGGATGA 
Sequence 5 
 
GACGCCATGGTGGACCTG 
 
Sequence 6 
 
 ACTTGCTGAAGTGCGGCA 
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D- PCR primers of human actin 
Primers                          Sequence ‘5-3’ 
 
 
                       Forward primer 
 
 
        CCTCGCCTTTGCCGATCC 
                       Reverse primer 
 
        GGATCTTCATGAGGTAGTCAGTC 
 
2.1.2 Cell biology materials 
 Cell lines 2.1.2.1
HEK293- MSRII cells were obtained from Glaxo-Smith-Kline (Stevenage, UK). HEK293 
cells were obtained from ATCC (ATCC CRL-1573). HEK293 cells stably expressing 
TRPM2 under the control of tetracycline were provided by Dr. AM Scharenberg 
(Washington University, USA). HUVECs were obtained from Lonza (USA).  HeLa cells 
were obtained from the European Cell Culture Collection (Cambridge, UK). INS-1 cells 
were a kind gift of CB Wollheim (University Medical Centre, Geneva, Switzerland). Lung 
microvascular endothelial cells (lung ECs) were isolated from 8-10 week old wild-type 
(C57BL/6) and TRPM2 knock-out (TRPM2 KO) mice by immuno-selection.  
 
 Cell culture medium and growth factors 2.1.2.2
Cell culture media DMEM (Dulbecco’s Modified Eagle Medium) + GlutaMAX-1, RPMI-
1640 + GlutamaxTM and DPBS (Dulbecco’s phosphate buffered saline) were purchased 
from Invitrogen (Gibco Life Technologies, UK). EGM-2 was purchased from Lonza 
(USA). FBS (foetal bovine serum) was purchased from Sigma-Aldrich®.  
 
For transfection 
Lipofectamine® 2000 was purchased from Life Technologies™. 
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 Molecular probes and pharmacological reagents 2.1.2.3
LysoTracker® Red DND-99, MitoTracker® Red CMXROS and ER-tracker™ Red, 
BAPTA-AM (1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid), Opti-MEM®, 
Pluronic®F127, Fura-2-AM, Fluo4-AM and Fluozin3™-AM, Hoechst 33342, H2DCFDA 
were purchased from Life Technologies™. MitoSOX™ Red was purchased from 
Thermo Fisher. DAPI (4,6-diamidino-2-phenylindole)-Fluoromount-G™ was purchased 
from Southern Biotech. Annexin V-GFP was a kind gift from Prof. Christoph Borner, 
Institute for Molecular Medicine, University of Freiburg (Geissler et al., 2013). Alexa 
Fluor488 conjugated transferrin was purchased from Invitrogen. n-(p-amylcinnamoyl) 
anthranilic acid (ACA), PARP Inhibitor VIII, PJ34 were purchased from Calbiochem. 
G418 (Geneticin sulphate) was purchased from Invitrogen (UK) and stored as 50 µg/ml 
at -20°C. Zeocin and Blasticidin were purchased from InvivoGen. All other chemicals 
were either from Sigma-Aldrich® or Calbiochem.  
 
Ca2+ and Zn2+ indicator dyes 
In this study, two Ca2+ indicator dyes were used which are Fura-2-AM and Fluo-4-AM. 
Fura-2-AM is a ratiomentric dye widely used for quantitative intracellular Ca2+ 
measurements (Martin et al., 2006; Paredes et al., 2008). Affinity of Fura-2 for Ca2+ is 
within the range of endogenous resting levels of Ca2+ (KD 145 nM) (Martin et al., 2006). 
This dye chemically modified to its acetomethoxy (AM) ester form to enable it to cross 
the cell membrane (Paredes et al., 2008). Once inside the cell, cytosolic esterases 
cleave the AM group trapping fluorescent Fura-2 within the cell (Paredes et al., 2008). 
However, Fura-2 has been shown to interact with Zn2+ with a hundred-fold higher affinity 
than Ca2+ (Martin et al., 2006; Paredes et al., 2008).  
 
Fluo-4-AM is a fluorescent cytosolic Ca2+ probe. Its affinity for Ca2+ (KD 345 nM) is lower 
than that for Fura-2-AM (Gee et al., 2000). Fluo-4-AM is a useful probe for fluorescent 
imaging because it is excited by a single wavelength (Gee et al., 2000) while Fura-2 is 
excited by dual wavelength (Martin et al., 2006) (see section 2.2.2.13). It has been 
reported that Ca2+ sensitive dyes are less specific to their target than dyes that target 
Zn2+ (Martin et al., 2006). 
47 
 
FluoZin-3-AM is a membrane permeable fluorescent probe used to detect Zn2+. It has a 
very high affinity for Zn2+ (KD 15 nM) and is highly specific for Zn
2+ (Zhao et al., 2008). 
Ca2+ and Mg2+ at physiological levels do not appear to disrupt FluoZin-3’s ability to bind 
Zn2+ (Zhao et al., 2008). Moreover, increasing the concentration of Ca2+ up to 10 mM 
does not prevent FluoZin-3 from detecting low concentrations (~100 pM) of Zn2+ (Zhao 
et al., 2008).   
 
In the present study the above fluorescent probes were used in conjunction with 
chelators of Ca2+ (BAPTA-AM) and Zn2+ (TPEN and clioquinol). Table 2.2 lists the 
reagents used and their properties.  
 
Table 2.2 Ca2+ and Zn2+ intracellular chelators 
Chelator Affinity Reference 
BAPTA-AM KD values of BAPTA-AM 
Zn2+: 7.9 x 10-9 M 
Ca2+: 1.1 x 10-7 M  
(Qian and Colvin, 
2015) 
TPEN  Affinities (KA) for various metal ions are as follows. 
Mn2+:1010.27 M-1 
Fe2+ : 1014.61 M-1  
Zn2+: 1015.58 M-1  
Mg2+: 101.7 M-1   
Ca2+: 104.4 M-1 
(Arslan et al., 
1985) 
Clioquinol KD values of clioquinol 
Zn2+: 7 × 10-8 M 
Cu2+: 1.2 × 10-10 M 
(Di Vaira et al., 
2004) 
 
 Antibodies 2.1.2.4
Primary antibodies 
Rat anti-HA high affinity monoclonal antibody (clone 3F10) (1:500) was purchased from 
Roche. Rabbit polyclonal anti-CD31 (1:300) was purchased from Abcam. Mouse 
monoclonal anti-LAMP-1(1:5000) was purchased from BD Biosciences. Mouse 
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monoclonal anti-VDAC-1 (1:100,000) was purchased from Abcam. Rabbit polyclonal 
anti-calnexin (1:5000) was purchased from Abcam. Mouse monoclonal anti-EE (1:1000) 
was purchased from Covance. Mouse monoclonal Anti-FLAG M2 (1:500) was 
purchased from Sigma-Aldrich®. Mouse monoclonal anti-cathepsin B (1:100) was 
purchased from Calbiochem. Rabbit monoclonal anti-cytochrome c (1:100) was 
purchased from Cell Signalling. The numbers in parenthesis following the antibodies 
indicate dilutions used. 
 
Secondary antibodies 
Anti-rat Cy3-conjugated secondary antibody (1:500), anti-mouse Cy3-conjugated 
secondary antibody (1:500) and anti-rabbit Cy3-conjugated secondary antibody (1:500) 
were purchased from Jackson ImmunoResearch. Alexa Fluor594 mouse anti-HA IgG 
(1:300), Alexa Fluor488 donkey anti-mouse IgG (1:500) and Alexa Fluor488 donkey anti-
rabbit IgG (1:500) were purchased from Life Technologies™. HRP-conjugated goat anti-
rat IgG (1:1000), HRP-conjugated goat anti-mouse IgG (1:10000) and HRP-conjugated 
goat anti-rabbit IgG (1:10000) were purchased from Sigma-Aldrich®. Goat anti-rat IgG 
10 nm gold (1:50) was purchased from Agar Scientific.  
 
 Plates and pipettes 2.1.2.5
6-, 24- and 69-well plates were purchased from Sarstedt. The FluoroDishTM glass 
bottomed cell culture dishes were purchased from World Precision Instruments. 
 
2.1.3 Buffer and solutions  
Table 2.3 Buffers and solutions used  
 
    A- 10x phosphate buffered saline (PBS) 
     Ingredients (stock solution)           Quantity per 1 L 
NaCl (MW:58.44) 80 g 
KCl   (MW:74.55) 2  g 
KH2PO4 (MW:136.09) 2  g 
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Na2HPO4 (MW:141.96) 11.48 g 
 
    B- Tris-saline 
           Ingredients              Quantity per 50 ml 
1 M Tris pH7.4 2.5 ml 
3 M NaCl 2.5 ml 
H2O 45  ml 
 
 
    C- Ice-cold transfer buffer 
(Store at 4°C) 
           Ingredients                       Quantity 
10x TGS (BIO-RAD) 1 part 
Methanol 2 part 
H2O 7 part 
 
D- 1.5 mM Ca2+ standard buffered saline (SBS), pH7.4 
           Ingredients            Quantity per 1 L 
130mM NaCl 7.60 g 
 5mM KCl 0.37 g 
1.2mM MgCl2 2 ml of 1M 
8mM Glucose 1.44 g 
10mM HEPES 2.38 g 
1.5mM CaCl2 1.5 ml of 1 M 
 
E-  0 mM Ca2+ (SBS), pH7.4 
           Ingredients             Quantity per 1 L 
130 mM NaCl 7.60 g 
 5 mM KCl 0.37 g 
1.2 mM MgCl2 2 ml of 1M 
8 mM Glucose 1.44 g 
10 mM HEPES 2.38 g 
0.4 mM EDTA 0.15 g 
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F- KCl buffer 
(Store at 4°C) 
           Ingredients             Quantity per 100 ml 
125 mM KCl 0.931 g 
2 mM K2HPO4 0.0348 g 
5 mM HEPES 0.119 g 
5 mM MgCl2 0.5 ml of 1 M  
0.02 mM EDTA 0.744 g 
5 mM succinic acid 0.081 g 
5 mM glutamate 0.0735 g 
0.05 mM ATP pH 7.0 0.00275 g 
 
G-  KCl free buffer 
(Store at 4°C) 
           Ingredients           Quantity per 100 ml 
2 mM K2HPO4 0.0348 g 
5 mM HEPES 0.119 g 
5 mM MgCl2 0.5 ml of 1 M  
0.02 mM EDTA 0.744 g 
5 mM succinic acid 0.081 g 
5 mM glutamate 0.0735 g 
200 µM EGTA 0.0076 g 
0.05 mM ATP pH 7.0 0.00275 g 
 
2% Paraformaldehyde (PFA) 
0.1 g paraformaldehyde powder (Sigma-Aldrich®) was added to 1 ml 0.05 M NaOH pre 
warmed at 60°C. After dissolving, 50 µl of 1M HCl, 0.5 ml 10x PBS and 3.5 ml Milli-Q 
water were added and mixed. pH paper was used to check that the pH was ~7.0. 
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 Methods 2.2
2.2.1 Molecular biology methods 
 Insertion polymerase chain reaction (PCR) 2.2.1.1
The PCR used in this study was to add two missing codons of the HA-epitope into an 
incomplete construct generated by Tim Munsey. Phusion DNA polymerase was used for 
PCR. 
 
 Oligonucleotides  2.2.1.2
The length of the primer: the number of the primer bases was around 18-22 (N), which 
is short enough to bind easily to the template and long enough to be sufficiently specific.  
GC content: the number of guanosine and cytosine bases in the primer was kept around 
40-60% of the primer sequence.  
Tm of the primer = 81.5+0.41 (GC%)-674/N 
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Figure 2.1 A schematic of the PCR used to insert two missing amino acids (DV) into the 
HA-epitope 
In cycle 1, during denaturation, the DNA was separated into two single strands. During 
annealing, the reverse primer bound to the forward strand while the forward primer bound to the 
reverse strand. Following cycle 1, the length of each original strand was raised by one amino 
acid codon. In cycle 2, during denaturation and annealing, the DNA was separated and the 
primers bound to each single strand. Cycles 3-30 were repeated to generate multiple copies of 
the strands with amino acid codons added, one at either end. The ends of the PCR products 
were joined together by incubating the PCR products with T4 DNA ligase after digestion and gel 
extraction. This gave rise to a plasmid with complete HA-epitope that could be transformed into 
XL I-Blue cells.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
54 
 
 PCR reaction 2.2.1.3
The PCR reaction mix (20 µl) was prepared according to the instructions of the 
manufacturer of the DNA polymerase enzyme used. The PCR mix (see Table 2.3) was 
heated to 98C to denature the template DNA and to allow separation of the strands. 
Temperature was then lowered to the Tm “annealing temperature”. This temperature 
allowed the primers to anneal to their target site on the template strand. Extension at 
68-72C allowed the DNA polymerase to make new copies of the DNA strands by 
extending the primers. The final extension at 72C allowed completion of any 
incomplete stands. Finally, the samples were held at 4-10C.  
 
Table 2.4 Components of the reaction mixture 
PCR reaction mix components Final concentration  
DNA template 10 ng 
5× Phusion HF buffer 1× 
Forward primer 0.5 µM 
Reverse primer 0.5 µM 
dNTPs 200 µM 
Phusion DNA Polymerase 2 units/ µl 
 
 Digestion of template DNA 2.2.1.4
Template DNA was digested using Dpn I restriction enzyme. 25 µl of PCR product, from 
a total volume 50 µl, was incubated with 1 µl of Dpn I (10 units/µl) for one hour at 37°C. 
 
 Gel electrophoresis 2.2.1.5
Agarose gel electrophoresis is a way of separating, analysing and semi-quantifying 
DNA fragments. It can also be used to check the specificity of the primers used for DNA 
amplification. 2 µl of DNA after digestion with Dpn I was analysed by 1% agarose gel 
electrophoresis.  
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 Agarose gel preparation 2.2.1.6
1% agarose gel was prepared by dissolving 1 g agarose in 100 ml of 1×TAE buffer by 
microwaving. It was then left it to cool down to about 60°C. 5 µl (10 mg ml-1)/100 ml of 
ethidium bromide (Sigma; E-8751) was added and mixed. The molten gel was poured 
into a gel tray, a comb was inserted and the gel was left to set for 1 hr at room 
temperature. The comb was removed after the gel was set.    
 
 Sample preparation and electrophoresis 2.2.1.7
An electrophoresis tank was filled with 1x TAE buffer and the gel placed into the tank. 6 
µl of DNA marker (HyperLadder I) was loaded into the first well in order to estimate the 
size of DNA run in parallel lanes. DNA samples were loaded into individual wells (1 µl of 
6x sample buffer mixed with 2 µl of DNA and 3 µl of autoclaved water). The gel was run 
at 60 mV for about 2 hr. The DNA bands were visualised on a Bio-Rad UV 
transilluminator.   
 
 Gel extraction 2.2.1.8
After the large scale digested PCR product (25 µl) was run on the agarose gel, the gel 
was placed under a UV illuminator. This was to help in identifying the fragments of 
interest stained with ethidium bromide. The band was isolated using a clean scalpel and 
placed in an Eppendorf tube. DNA from the gel slice was extracted and purified using a 
QlAquick Gel Extraction Kit, following the protocol provided by the manufacturer. 
 
 Ligation 2.2.1.9
8 µl of purified PCR product was incubated with 1 µl of 10× ligase buffer and 1 µl (1 U) 
of T4 DNA ligase. The mixture was incubated for 2 hr at room temperature.  
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 Transformation plasmid DNA 2.2.1.10
XL1-Blue competent cells were thawed on ice (100 µl). 5 µl of the ligated PCR product 
was added to competent cells. The mixture was incubated on ice for 20-30 min and then 
heat-shocked for 40 sec in a water bath at 42°C. Next, the mixture was incubated on ice 
for 2 min. Five volumes of pre-wormed LB were added to the cell suspension and 
incubated for 1 hr at 37°C in a shaking incubator at 225-250 rpm. The sample was 
centrifuged at 7,000 rpm for 1 min in a Heraeus microcentrifuge. 150 µl was then 
removed from the sample and the pellet was re-suspended into the remaining medium. 
The transformation mixture was plated onto a pre-warmed LB-ampicillin agar plate and 
incubated overnight at 37°C.  
 
LB-agar was prepared by suspending 8.75 g of LB agar in 250 ml of water and 
sterilizing by autoclaving. The molten agar was cooled to 45°C. Ampicillin was added to 
a final concentration of 100 µg/ml and poured into petri-dishes (~25 ml per plate). The 
plates were stored at 4C up to 4 weeks. 
 
 Plasmid preparation  2.2.1.11
Single colonies from the transformed plate were inoculated into LB medium (5-100 ml) 
containing 50 µg/ml ampicillin and grown overnight at 37C and 200 rpm. Miniprep and 
midiprep kits were used to purify plasmid DNA from bacterial cultures. A miniprep kit 
(QlAprep Spin Miniprep Kit) was used for small scale plasmid DNA preparation, while a 
midiprep kit (Qiagen HiSpeed Plasmid Midi Kit) was used for the large scale plasmid 
preparation, according to the instruction of the manufacturer.  
 
 Sequencing 2.2.1.12
DNA prepared from several clones on the transformed plate was custom-sequenced 
and the resulting sequence was aligned against the reference sequence using 
ClustalW2 (see Appendix).   
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 RT–PCR to determine mRNA levels   2.2.1.13
RNA preparation 
RT-PCR for TRPM2 and actin (housekeeping gene) was performed on RNA isolated 
from cells transfected with desired siRNA. The cell pellet derived from two wells of a 6-
well plate was lysed with 1 ml Trizol reagent (Sigma-Aldrich®). The lysate was passed 
through the pipette several times. The sample was incubated for 5 min at 15-30°C. 0.2 
ml of chloroform:isoamyl alcohol (24:1) per 1 ml Trizol was added. The tube was shaken 
by hand for 15 sec and then incubated for 2-3 min at 15-30°C, before centrifugation at 
12,000 xg for 15 min at 2-8°C. After centrifugation, the colourless upper aqueous phase 
was transferred to a fresh tube. 0.5 ml of isopropyl alcohol was added to precipitate 
RNA. The sample was incubated for 10 min at 15-30°C and then centrifuged at 12,000 
xg for 10 min at 2-8°C. After centrifugation, the pellet was washed with 75% ethanol 
(prepared in RNase-free water) and then left to air-dry for 5-10 min. RNA was dissolved 
in 10 µl RNase-free water by incubating for 10 min at 55-60°C. 
 
RT reaction and PCR reaction 
5 µg of total RNA in a 10 µl volume was heated for 5-10 min at 65°C and then chilled on 
ice. cDNA was synthesised from 5 μg of total RNA using 1 μg random primers and 5 
units of AMV reverse transcriptase in 20 µl volume. 6 µl of the cDNA product was 
subjected to 33 cycles of PCR using 1 unit of Taq DNA polymerase and 100 ng of each 
primer in a final volume of 20 µl. Each PCR cycle comprised 95°C for 30 sec, 65°C for 
45 sec and 72°C for 60 sec, with a final extension at 72°C for 5 min. The primers used 
for TRPM2 and for human actin are shown in Table 2.1. PCR products were analysed 
using 1% agarose gel electrophoresis.  
 
2.2.2 Cell biology techniques 
 Cell culture  2.2.2.1
HEK293-MSRII cells, HEK-TRPM2tet cells, HEK293, HEK293FT and HeLa cells were 
cultured in DMEM medium supplemented with 10% FBS, 100 units/ml penicillin and 100 
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µg/ml streptomycin. G418 at 50 µg/ml was used for HEK293-MSRII cells. Zeocin at 200 
µg/ml and blasticidin at 0.4 µg/ml was used for HEK-TRPM2Tet cells. HUVECs at 
passages 3-6 and ECs (isolated from mice by immunoselection using CD146 antibody-
coated magnetic beads (Miltenyi Biotec) (Li et al., 2014)) were cultured in Endothelial 
cell Basal Medium (EBM-2) supplemented with 2% FBS, human epidermal growth 
factor (hEGF), human fibroblast growth factor-B (hFGF-B), gentamicin sulphate, 
amphotericin-B (GA-1000), hydrocortisone, ascorbic acid and heparin. INS-1 cells were 
cultured in RPMI 1640+GlutamaxTM medium supplemented with 10% FBS, 1 mM 
sodium pyruvate, 50 µM 2-mercaptoethanol, 10 mM HEPES, 100 units/ml penicillin and 
100 µg/ml streptomycin. Cells were cultured in 25 cm2 and 75 cm2 culture flasks in a 
humidified incubator with 5% CO2 and 95% air at 37ºC. Growth media were replaced 
every 3 days for all cell lines. The cells were passaged at 75% confluency. HUVECs 
were used between passage numbers 3 and 6, while other cell lines were used until 
passage number 40.  
 
 Isolation of lung endothelial cells  2.2.2.2
Generation of TRPM2 KO mice has been described (Zou et al., 2013). Mice were bred 
and maintained under UK Home Office licence and ethical procedures. Mice were killed 
by cervical dislocation. Lung microvascular endothelial cells (lung ECs) were isolated 
from 8-10 week old wild-type (C57BL/6) and TRPM2 knock-out (TRPM2 KO) mice by 
immunoselection with anti-CD146 antibody coated magnetic beads (Miltenyi Biotec) 
according to the protocol described (Li et al., 2014).  
 
Isolation of single cell suspension (1 mouse) 
The lungs were harvested and collected into ice-cold HBSS (10 ml). In a tissue culture 
hood, the tissue was transferred to a petri-dish containing 3 ml of 1 mg/ml collagenase 
in HBSS. The lungs were minced to 1 mm2 pieces using a scalpel blade. The pieces of 
tissue were suspended in 10 ml of 1 mg/ml collagenase and incubated in a shaking 
water-bath at 37°C for 45 min. Tissue aggregates were broken down by repeated 
pipetting of the suspension. The cell suspension was filtered through a 70 µM sieve into 
a 50 ml Falcon tube. The sieve was rinsed with 10 ml PBS-BSA (3.3 ml 7.5% BSA 
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(Sigma) plus 46.7 ml PBS) and the tissue was discarded. The sample was centrifuged 
at 1200 rpm for 5 min to pellet cells. The cell pellet was washed once with PBS-BSA.  
 
Incubation of the isolated cells with LSEC (CD146) microbeads 
After centrifugation and PBS-BSA wash, the cell pellet was suspended in 100 µl PBS-
BSA and transferred to 1.5 ml Eppendorf tube (on ice). 15 µl of LSEC microbeads was 
added and incubated by using a tube rotator at 4°C (cold room) for 20 min. 1 ml of PBS-
BSA was added and the sample was centrifuged at 4000 rpm for 5 min. The 
supernatant was discarded and the pellet was resuspended in 500 µl PBS-BSA. 
 
Loading onto MiniMACS (MS) magnet column 
A MiniMACS magnet was attached to the MultiStand and the MiniMACS (MS) column 
was inserted (wings to the front). A 15 ml Falcon tube was placed under the MS column. 
500 µl of PBS-BSA was applied and run through the MS column. Then, the cell 
suspension was applied onto the MS column (unbound cells were able to pass through). 
The column was washed three times by adding 500 µl PBS-BSA buffer each time. To 
collect the bound cells, the MS column was removed from the separator and placed into 
a 15 ml Falcon tube. 500 µl of PBS-BSA was added to the MS column and cells flushed 
out immediately into a 15 ml tube by applying the plunger of the column. The isolated 
cells were centrifuged at 4000 rpm for 5 min and the supernatant was removed. The cell 
pellet was suspended in 600 µl EGM-2 medium and plated into 2 wells of a 6-well plate 
coated with 1% fibronectin (Sigma) (each well contained 2.5 ml EGM-2 medium). 
Medium was replaced with 2 ml of fresh medium after 6 hr of incubation when the cells 
adhered to the plate. After 24 hr, medium was replaced with fresh medium and 
incubated for 3 days.   
   
 Transfection 2.2.2.3
All transfections were performed using Lipofectamine 2000. Cells were allowed to 
attach to 13 mm glass cover-slips or 35 mm FluoroDishTM glass bottomed dishes (live 
cell imaging), sterilised and pre-coated with 0.01%  poly-L-lysine (diluted 1:10; Sigma 
P4832) (HEK293 cells) or 0.1% gelatin (HUVECs) or 2 µg/ml fibrinectin (lung ECs). 
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HEK293-TRPM2tet cells were treated for 48 hr with 1 µg/ml tetracycline to induce 
expression of TRPM2 channels (Manna et al., 2015). On the day of transfection, cell 
confluency was approximately 50-70%.  
 
Transfections were performed on cells grown in a 24-well plate or 35 mm FluoroDishTM. 
For each well of a 24-well plate, 0.5 µl of Lipofectamine 2000 was added to 25 µl Opti-
MEM, and 0.3-0.4 µg of plasmid DNA was added to 25 µl Opti-MEM (in separate tubes) 
and incubated for 5 min at room temperature. For transfection in 35 mm FluoroDishTM, 1 
µl Lipofectamine 2000 was added to 50 µl Opti-MEM and 0.8 µg of plasmid DNA per to 
50 µl Opti-MEM and incubated for 5 min at room temperature. The Lipofectamine 2000-
Opti-MEM and plasmid DNA-OptiMEM were mixed, and the resulting transfection 
mixtures were incubated for 30 min at room temperature. The mixtures were added to 
the cells containing 450 µl (in the 24-well plate) or to 900 µl of Opti-MEM (in the 35 mm 
FluoroDishTM). Cells were incubated for 6-7 hr at 37ºC after transfection. Then, the 
medium was replaced with complete medium and incubation continued for 48-72 hr, 
during which cells were treated as required before imaging.  
 
For siRNA-TRPM2 transfection  
1 µl of Lipofectamine 2000 was added to 50 µl Opti-MEM (A), and 1 µl of 50 µM human 
TRPM2 siRNA was added to 50 µl Opti-MEM (B), and incubated for 5 min at room 
temperature. (A) was mixed with (B) and incubated for 30 min at room temperature. The 
resulting mixture (C) was added to the cells containing Opti-MEM and incubated for 7 hr 
at 37ºC; see Table 2.4. Then, medium was changed to complete medium and 
incubation continued for 48-72 hr.   
 
Table 2.5 The required siRNA resuspension volumes  
 Mixtures (C) 
(each well) 
Medium serum free 
(each well) 
Total 
(each well) 
24 well plate 50 µl 450 µl 500 µl 
35 mm FluoroDish 100 µl 900 µl 1000 µl 
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For scrambled siRNA  
13 µl of Lipofectamine 2000 was added to 650 µl Opti-MEM serum-free medium (A) and 
1 µl of scrambled siRNA was added to 600 µl Opti-MEM serum free medium (B); both 
(A) and (B) were incubated for 5 min at room temperature. Then, 300 µl of (A) was 
mixed with 300 µl of (B) and incubated for 30 min at room temperature. The mixtures 
(C) were added to the cells containing Opti-MEM and incubated for 3 hr at 37ºC; see 
Table 2.5.  The medium was changed to complete medium and incubation continued for 
48 hr.  
 
Table 2.6 The required scrambled siRNA resuspension volume     
 Mixtures (C) 
(each well) 
Opti-Mem (each well) Total 
(each well) 
24 well plate 40 µl 80 µl 120 µl 
35 mm FluoroDish 100 µl 200 µl 300 µl 
 
 Immuno-fluorescence staining 2.2.2.4
Transfected cells on pre-treated glass cover-slips were washed three times with 
phosphate-buffered saline containing calcium and magnesium, 1 mM each (PBS). Cells 
were fixed with 2% PFA for 10 min at room temperature. Where required, cells were 
permeabilised by adding 0.25% Triton X-100/10 mM Tris/150 mM NaCl, pH7.4 and 
incubating for 5 min. Triton-X100 permeabilises the plasma membrane and allows the 
antibody to access the intracellular targets (Marty et al., 2014). The fixative was 
quenched by adding 300 µl of Tris-saline to each well. Cells were washed three times 
with PBS. Nonspecific binding sites were blocked with 1% ovalbumin/PBS for 1 hr 
before incubation for 1-2 hr with the desired primary antibody diluted in 1% 
ovalbumin/PBS. Cells were then washed thrice with PBS and incubated in the dark with 
appropriate secondary antibodies diluted in 1% ovalbumin/PBS. After washing, cover-
slips were dipped into Milli-Q water, excess water was removed, and the cover-slips 
were mounted onto microscope slides in 7 µl DAPI-Fluoromount-G, dried overnight in 
the dark at room temperature and imaged.   
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 Live cell staining with fluorescence probes  2.2.2.5
Intracellular Zn2+ redistribution 
Intracellular distribution of Zn2+ was assessed by live imaging after staining the cells 
with FluoZin-3 for Zn2+ and the organelles with vital stains. HUVECs grown on 
FluoroDishTM dishes were washed with EBM-2 medium and incubated at 37C for 2-4 hr 
in the dark in EBM-2 containing 1 µM FluoZin-3-AM and 0.02% (w/v) Pluronic F-127 ± 1 
mM H2O2 ± pharmacological treatment (150 µM 2-APB or 10 µM PJ-34). Cells were 
then washed twice (15 min each) with EBM-2 and incubated at 37C for 30 min with 
organelle marker dyes: MitoTracker Red CMXROS (200 nM) or LysoTracker Red DND-
99 (200 nM) or ER-Tracker (1 µM) diluted in EBM-2. After washing with EBM-2, cells 
were imaged. HEK-293 cells were similarly loaded with the dyes, but using the DMEM 
medium.  
 
To examine the effect of glucose, HUVECs were incubated in EGM-2 or EGM-2 
containing 33 mM glucose or 5 mM glucose plus 28 mM mannitol for 24 hr at 37C. 
Cells were then loaded with FluoZin-3-AM for 4 hr and further incubated in the 
respective media. Organelles were labelled with markers as above during the last 30 
min of incubation. The total incubation time including all steps was 48 hr. To examine 
zinc pyrithione (Zn-PTO) induced Zn2+ redistribution, cells were incubated in EGM-2 or 
EGM-2 containing 0.7 µM ZnCl2 plus 50 µM pyrithione for 2 hr at 37C, prior to washing 
and loading FluoZin-3-AM (2 hr) and organelle markers. To examine the effect of H2O2, 
cells were incubated with H2O2 (see figure legends for concentrations) for 2-3 hr at 
37C, prior to loading FluoZin-3-AM (2 hr) and organelle markers. Where appropriate, 
cells were co-treated with TRPM2 channel inhibitors including 150 µM 2-APB or 10 µM 
PJ-34 or metal chelators including 0.3 µM TPEN, or pre-transfected with siRNA (see 
relevant figure legends for details). Images were captured at 37ºC using Zeiss LSM700 
confocal microscope fitted with a 63× oil objective. Co-localisation of Zn2+ fluorescence 
and organelle fluorescence and number of lysosomes were determined using the Imaris 
software.  
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Intracellular Ca2+ staining 
HUVECs were cultured in 35 mm FluorodishTM glass bottomed dishes. Cells were 
washed with EBM-2 medium not containing growth factors. Then, 1 ml of indicator dye 
(1 ml EBM-2 medium mixed with 1 µl 1 mM Fluo-4-AM and 1 µl 20% w/v pluronic F-127) 
with or without 1 µM calcium ionophore A23187 was added. Cells were incubated for 1 
hr at 37ºC in the dark. The cells were washed twice with EBM-2 medium not containing 
growth factors; each wash required 15 min incubation at 37ºC in the dark. For organelle 
staining, samples were loaded with 200 nM LysoTracker or 200 nM MitoTracker diluted 
in EBM-2 medium not containing growth factors. Images were captured at 37ºC using a 
Zeiss LSM700 confocal microscope fitted with a 63× oil objective.  
 
 Mitochondrial morphology assessment 2.2.2.6
Morphology of mitochondria was assessed from images of cells stained with 
MitoTracker Red or transfected with pMito-Cherry or with pMito-CFP. In some 
experiments, cells were transfected with pMito-Cherry because MitoTracker Red 
staining was diffuse in the presence of H2O2, making changes in mitochondrial 
morphology difficult to assess. pMito-CFP is a cyan fluorescent mitochondrial marker. 
However, in some experiments, pMito-Cherry (red) was used to allow determination of 
its co-localisation with the green Zn2+ marker (FluoZin-3-AM).  
 
Aspect ratio (AR, ratio between the major and minor axis) and form factor (FF, degree 
of branching) were determined using ImageJ 1.44p from individual mitochondria after 
reducing nonspecific noise of the fluorescence signal as reported previously (Koopman 
et al., 2005). FF is defined as ((Perimeter2)/(4π*Area)). Mitochondrial morphology 
measurements were made from over 70 individual mitochondria taken from at least 3-4 
independent experiments. The mitochondria were counted as fragmented if the FF was 
below 2.5. A cell was considered as having fragmented mitochondria when ≥ 50% of its 
total number of mitochondria were fragmented (Trudeau et al., 2011).  
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 Mitochondrial staining of mouse aorta 2.2.2.7
Aortas isolated from 8-10 week old wild-type (C57BL/6) and TRPM2_KO mice were cut 
open longitudinally and cut into ~5 mm pieces. After two washes with SBS, pieces of 
aorta were exposed to EGM-2 containing 33 mM glucose for 72 hr before loading with 
MitoTracker Red for 30 min at 37C. After washing with SBS, they were fixed in 4% 
paraformaldehyde (1 hr), blocked overnight at 4C with 1% ovalbumin/PBS, washed 
with PBS (3 times 10 min each) and mounted onto microscope slides in DAPI-
Fluoromount-G. Control pieces were exposed to 8 mM glucose. Confocal Images were 
captured from the luminal surface using conditions described later under Image 
acquisition and analysis (see Section 2.2.2.16).   
 
 Drp1 recruitment to mitochondria 2.2.2.8
To examine glucose-induced Drp1 recruitment to mitochondria, cells were transfected 
with Drp1-GFP or DN-Drp1(K38A)-GFP with and without human TRPM2 siRNA-1 or 
TRPM2 siRNA-2. Transfected cells were incubated in EGM-2 or EGM-2 containing 33 
mM glucose or 5 mM glucose plus 28 mM mannitol for 24 hr at 37C. 0.3 µM TPEN was 
included in some experiments and incubation continued for a further 24 hr. For H2O2, 
cells transfected with Drp1-GFP or DN-Drp1(K38A)-GFP with and without human 
TRPM2 siRNA-1 were incubated with 1 mM H2O2 for 2-3 hr. Cells were then washed 
with EBM-2 and incubated at 37C for 30 min with MitoTracker Red (200 nM) diluted in 
EBM-2. After washing, cells were imaged in EBM-2 for Drp1-GFP and MitoTracker Red.  
 
 Determination of lysosomal membrane permeability (LMP) and 2.2.2.9
mitochondrial membrane permeability (MMP) 
The extent of LMP was assessed by determining the decrease in the number of 
LysoTracker positive lysosomes following various treatments and also by examining the 
cells for cytoplasmic release of cathepsin B. LysoTracker positive lysosomes per cell 
were counted using the Imaris software.  
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Cells on pre-treated glass cover-slips were treated with 1 mM H2O2 in the presence or 
absence of 150 µl 2-APB for 4 hr at 37°C. Cells were fixed and permeabilised as 
described above in Section 2.2.2.3. To determine LMP, cells were immunostained with 
mouse anti-cathepsin B antibody and anti-mouse Cy3-conjugated secondary antibody. 
MMP was determined by immunostaining the cells with rabbit anti-cytochrome c 
antibodies and anti-rabbit Cy3-conjugated secondary antibody. Cells were imaged with 
a confocal microscope. Changes in the red fluorescence per cell were quantified using 
ImageJ.  
 
 Cell death assay  2.2.2.10
Cell death was assessed by staining the dead cells with propidium iodide (PI) and live 
cells with Hoechst 33342 as described previously (Manna et al., 2015). Cells were 
treated with medium alone (control) or medium with H2O2 (1 mM, 6 hr) or high glucose 
(33 mM glucose, 48 hr). Where appropriate, cells were co-treated with TRPM2 channel 
inhibitors or Zn2+ chelators, or pre-transfected with siRNA (see relevant figure legends 
for details). Cells were incubated with PI (5 µg ml-1) and Hoechst 33342 (4 µM) in EBM-
2 for 30 min before washing with EBM-2 and recording the images using confocal or 
epifluorescence microscope (EVOS® FL Cell Imaging System, Life technologies), fitted 
with a 20x/40x lens. PI positive (dead) cells were expressed as percent of Hoechst 
33342 stained (total) cells. Images were collected from at least 3 fields of view using 
appropriate filters and analysed using ImageJ.  
 
 ROS measurement 2.2.2.11
Total ROS production was determined using the cell-permeant 2',7'-
dichlorodihydrofluorescein diacetate (H2DCFDA) (Jheng et al., 2012). This dye is a 
stable nonpolar compound (Bass et al., 1983). It diffuses into the cells and where it is 
hydrolysed to yield dichlorodihydrofluorescein (DCFH) (Bass et al., 1983). Intracellular 
ROS oxidises DCFH to the fluorescent compound DCF (Bass et al., 1983). The intensity 
of the fluorescence is proportional to the amount of ROS (Bass et al., 1983). 
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Cells grown in a 96-well plate were treated with high glucose (33 mM glucose, 48 hr) or 
5 mM glucose plus 28 mM mannitol (control). Where appropriate, cells were co-treated 
with Zn2+ chelators (0.3 µM TPEN) or antioxidant (10 mM NAC) or pre-transfected with 
human TRPM2 siRNA or scrambled siRNA. To examine zinc pyrithione (Zn-PTO) 
induced effects, cells were incubated in EGM-2 or EGM-2 containing 0.7 µM ZnCl2 plus 
50 µM pyrithione for 1 hr. Where required, cells were co-treated with a Zn2+ chelator 
(0.3 µM TPEN) or antioxidant (10 mM NAC) or pre-transfected with human TRPM2 
siRNA. Following the various treatments, cells were incubated with 10 µM H2DCFDA 
diluted in EBM-2 for 30 min at 37˚C followed by three washes with EBM-2. Cells were 
imaged using EVOS® FL Cell Imaging System (Life technologies) fitted with a 40× lens. 
Images were analysed with ImageJ software. The results were expressed as the mean 
fluorescence intensity/cell.  
 
 Mitochondrial ROS measurement 2.2.2.12
Mitochondrial ROS was determined by staining cells with the MitoSoxTM Red fluorescent 
dye. MitoSoxTM Red is a fluoroprobe used to detect superoxide generation from 
mitochondria in different pathophysiological conditions (Mukhopadhyay et al., 2007). 
Staining can be detected and quantified using confocal microscopy and flow cytometry 
(Mukhopadhyay et al., 2007).    
 
Cells were grown on cover-slips in a 24-well plate. Cells were treated with high glucose 
(33 mM glucose, 48 hr) or 5 mM glucose plus 28 mM mannitol (control). Where 
appropriate, cells were co-treated with antioxidant (10 mM NAC) or pre-transfected with 
human TRPM2 siRNA or scrambled siRNA. They were then incubated with 1 µM 
MitoSoxTM Red diluted in appropriate medium for 30 min at 37˚C followed by three 
washes with the medium. Cells were fixed with 2% PFA and blocked with PBS-1% 
ovalbumin for 1 hr at room temperature. Images were captured using a confocal 
microscope with a 63× lens and analysed by ImageJ. 
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 Intracellular Ca2+ and Zn2+ measurements 2.2.2.13
Intracellular changes in [Ca2+] and [Zn2+] were monitored using Fura-2-AM and FluoZin-
3-AM respectively (Al-Shawaf et al., 2010). HUVECs or HEK-TRPM2tet cells, grown in 
96-well plates, were incubated with Fura-2-AM (2 µM) or FluoZin-3-AM (3 µM) in SBS 
containing 0.02% Pluronic F-127 for 1 hr at 37°C. After washing twice with SBS for 30 
min, 200 µl of SBS was added to each well. Fluorescence was recorded using the 
Flexstation® II multi-mode microplate reader (Molecular Devices, California, USA). 
Fluorescence was measured at 5-10 sec intervals using excitation wavelengths of 340 
and 380 nm and an emission wavelength of 510 nm for Ca2+. [Zn2+]i was monitored at 
530 nm (excitation wavelength 490 nm). After taking several control measurements for 
1 min, 50 μl of the desired reagents made up at 5-fold the required final concentration 
were added to wells. For Ca2+, the ratio of fluorescence intensities at 340 and 380 nm 
(F340/F380) was calculated. For Zn2+, changes in emission at 530 nm were measured. 
HUVECs were pre-treated with 1 mM H2O2 for 2 hr and washed with SBS prior to Zn
2+ 
fluorescence measurements. For Ca2+ free conditions, the extracellular solution was 
Ca2+-free SBS containing 0.4 mM EGTA. 
 
 Subcellular fractionation  2.2.2.14
For subcellular fractionation, a Lysosome Enrichment Kit for Tissues and Cultured Cells 
(Catalog Number 89839; Thermo Scientific) was used. HEK-293-MSR cells (2 x 75 cm2 
flasks) transfected with pCDNA3.1-TRPM2-HA were harvested by centrifugation at 850 
xg for 2 min.  
 
The cell pellet (~200 mg wet weight) was gently resuspended in 600 µl of extraction 
buffer (LER-A, supplemented with 1% protease inhibitor cocktail, Roche) and incubated 
on ice for 2 min. The suspension was homogenised in a ball-bearing homogeniser 
(Isobiotech, 16 micron clearance) using 20 passages. The efficiency of cell lysis was 
checked using a light microscope by placing 5 µl of lysate onto a glass slide. To the 
lysate, 600 µl LER-B (also supplemented with 1% protease inhibitor cocktail) was 
added. The samples were centrifuged at 600 xg for 10 min at 4°C to remove the nuclei 
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and debris. The supernatant containing lysosomes, mitochondria and cytosol was 
subjected to density gradient centrifugation. 
 
Samples preparation for density gradient centrifugation  
All steps were performed in the cold room or on ice. Five gradients were prepared by 
mixing gradient dilution buffer (1 LER A:1 LER B) with Optiprep medium, as outlined in  
Table 2.6.  
 
Table 2.7 The required Opti-prep volume and concentration for density gradient 
centrifugation     
Optiprep medium 
volume (µl) 
Gradient dilution 
buffer volume (µl) 
Final volume (µl) Optiprep final 
concentration (%) 
283.3 716.7 1000 17 
333.3 666.7 1000 20 
191.7 308.3 500 23 
450 550 1000 27 
250 250 500 30 
 
OptiPrep density gradient solutions were carefully pipetted into 5 ml ultracentrifuge 
tubes in the following order: 30%, 27%, 23%, 20% and 17%. The supernatants from the 
cell extracts were mixed with Optiprep (4:1) to make the final Optiprep concentration 
15%. 1 ml of this was overlaid on the top of the gradient, and the tubes were centrifuged 
in SW 55 Ti rotor in a Beckmann ultracentrifuge at 40,000 rpm at 4°C for 4 hr. After 
centrifugation, two distinct bands were seen in the gradient; see Figure 2.1. 500 µl 
fractions collected from the top were diluted with 1 ml PBS and centrifuged at 14000 xg 
at 4°C for 1 hr. After centrifugation, supernatants of each fraction were collected and 
labelled as cytosolic fractions. Pellets containing the organelles were resuspended in 30 
µl of 1×SDS sample buffer.  
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For mitochondrial imaging 
Mitochondrial fraction (see Figure 2.2) was collected and diluted in KCl buffer. The 
sample was centrifuged at 14000 xg at 4°C for 1 hr. The pellets containing mitochondria 
were resuspended in KCl buffer and the supernatant was discarded.  
 
 
 
 
 
 
 
 
 
Figure 2.2 Samples preparation and density gradient centrifugation 
Cell suspension was homogenised in a ball-bearing homogeniser to break the cells; debris and 
nuclei were removed by centrifugation. Five Optiprep solutions containing different 
concentrations of Optiprep were sequentially loaded in an ultracentrifugation tube, with high 
concentration at the bottom. Post-nuclear supernatant diluted with Optiprep was overlaid on the 
top of the density gradient. After centrifugation, two distinct bands were seen in the tube: the top 
band containing lysosomes (fraction 1-3) and the bottom band containing mitochondria (fraction 
6-8). All fractions were collected and prepared for western blot analysis.  
 
 Western blot analysis  2.2.2.15
Sample preparation 
To determine TRPM2-HA expression in HEK-MSR cells, the cells were cultured in a 24-
well plate for 24 hr, transfected with TRPM2-HA and incubated for 48 hr. Cells were 
washed three times with PBS, scraped and then transferred into an Eppendorf tube. 
Cells were centrifuged for 5 min at 1,000 rpm at 4ºC. Supernatant was discarded and 
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the cell pellet re-suspended in 50 µl of 1× SDS sample buffer. After incubation for 5 min 
at 95ºC, samples were centrifuged at 13,000 xg for 5 min. 
 
SDS-PAGE  
Table 2.8 Gel preparation 
A- 10% running gel  
Solution Components Component volumes (ml) per gel 
Milli-Q water 1.9 
30% acrylamide mix (Sigma) 1.7 
1.5 M Tris (pH8.8) (Thermo Fisher) 1.3 
10% SDS (Sigma) 0.05 
10% ammonium persulfate (Sigma) 0.05 
TEMED (Sigma) 0.002 
The mixture was loaded in between the gel plates, overlaid with water-saturated butanol 
and allowed to stand for 30 min; see Table 2.7A.  
 
B- 5% stacking gel 
Solution Components Component volumes (ml) per gel  
Milli-Q water 0.68 
30% acrylamide mix (Sigma) 0.17 
1.0 M Tris (pH6.8) (Thermo Fisher) 1.3 
10% SDS (Sigma) 0.01 
10% ammonium persulfate (Sigma) 0.01 
TEMED (Sigma) 0.001 
Butanol was discarded and the running gel was overlaid with the 5% stacking gel; see 
Table 2.7B. Combs were placed and left to set for 1 hour. 
 
Electrophoresis, western transfer and antibody labelling 
Equal amounts of cell lysate protein were loaded into the wells of the gel. The gels were 
run at 160 V for 70 min. Proteins were transferred electrophoretically onto a 0.45 µm 
nitrocellulose membrane (BIO-RAD) at 50 mA for 90 min. Membranes were blocked 
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with Marvel dry milk (5%) in PBS containing 0.05% Tween-20 (PBS-T) for 1 hr at room 
temperature before incubating with HRP-conjugated primary antibodies. Alternatively, 
primary antibodies (non-HRP conjugated) diluted in the blocking buffer were added to 
the blots and then incubated at 4°C overnight. After washing with PBS-T for 1 hr at 
room temperature, the membranes were incubated for 1 hr at room temperature with 
appropriate HRP-conjugated secondary antibody diluted in the blocking buffer. After 
washing with PBS-T for 1 hr at room temperature, with several changes of PBS-T, the 
bound proteins were stained with a chemiluminescence reagent. For the source and 
dilutions of antibodies see Section 2.1.2.4. 
 
Staining and developing 
Lumigen PS-Atto solution A (400 µl) was mixed with Lumigen PS-Atto solution B (400 
µl) and left in the dark for 2 min. The membrane was positioned on a glass plate, protein 
side up. PS-Atto was pipetted onto the membrane making sure that the membrane was 
completely covered with the mixture of solutions (A) and (B). The membrane was left in 
the dark for 2 min. As much residue was drained off as much as possible, and the plate 
covered in cling film. The film was exposed starting from one min to several min, and 
developed using X-ray film developer and fixer. Alternatively, chemiluminescence on the 
blots was captured using G-BOX Chemi XX6. 
 
 Zn2+ uptake by mitochondria  2.2.2.16
Zn2+ uptake by mitochondria was determined as described previously (Malaiyandi et al., 
2005). Mitochondria were isolated from HEK-293-TRPM2tet cells (~200 mg wet cell 
pellet) induced to express TRPM2 channels using the Optiprep density gradient 
centrifugation method, as described above. Mitochondrial fractions (6-8) were washed 
and resuspended in KCl-based buffer (see Table 2.2F). After loading with 50 µM 
FluoZin-3-AM for 20 min at 37ºC in substrate-free KCl free buffer containing 200 µM 
EGTA (see Table 2.2G), 100 µl of the suspension was placed in a FluoroDishTM glass 
bottomed dish. After 7 min, 900 µl of KCl buffer was added and the fluorescence 
(excitation 490 nm/emission 530 nm) recorded continuously at 37°C using LSM 700 
Zeiss confocal microscope; see Figure 2.2. After control recordings, 30 µl ZnCl2 plus or 
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minus 200 µM H2O2 diluted in KCl buffer was carefully added and the recording of the 
field continued for 15 min. Background fluorescence was collected from mitochondria 
free regions. Increase in fluorescence was quantitated using ImageJ. 
 
 
 
 
 
 
 
 
Figure 2.3 Sample preparation for mitochondrial imaging 
Mitochondrial fractions were collected, centrifuged and washed with KCl buffer. The pellet was 
resuspended with FluoZin-3-AM prepared in KCl free buffer and incubated for 20 min at 37°C. 
Then, the suspension was placed in an empty FluoroDish glass bottomed dish. After 7 min, KCl 
buffer was added and Zn2+ uptake by isolated mitochondria was recorded.   
 
 Image acquisition  2.2.2.17
The images were captured randomly for presentation and analysis. Where necessary, 
images were cropped to illustrate details of subcellular structural changes.  
 
Images of immunofluorescent live cells were collected with a LSM700 or LSM810 Zeiss 
inverted laser scanning confocal microscope equipped with an oil-immersion 63×/ NA 
1.3 objective lens. DAPI (345 nm excitation, 458 emission) was excited with a diode 
laser at 405 nm, fitted with a 420-440 nm emission filter. MitoTracker Red, LysoTracker 
Red, ER Tracker Red, MitoSOX Red, Mito-Cherry and Cy3 (548 nm excitation, 562 nm 
emission) were excited using a He-Ne laser fitted with 543 nm filters. Alexa Fluor488, 
FluoZin-3, Fluo4, pMito-CFP, Drp1-GFP and Lamp1-GFP (494 nm excitation, 519 nm 
emission) were excited with an Argon laser at 488 nm, fitted with a 500-530 nm 
emission filter.  
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 Data analysis 2.2.2.18
Co-localisation analysis was performed using the Imaris software (Bitplane). ImageJ 
was used for quantification of mitochondrial morphology, Zn2+ uptake by isolated 
mitochondria and ROS levels. All experiments were performed at least 3 times (n) and 
the values presented as mean ± SEM. n/N in figure legends indicates the number of 
independent experiments (n) over the number of cells (N) analysed. Statistical 
significance was assessed using the Student’s t-test (Microsoft Excel) or One-way 
Anova, (OriginPro .1) followed by Tukey post-hoc test. Probability (P) values are 
indicated with , , , , which correspond to values of 0.05, 0.01, 0.001 and 
0.0001 respectively.  
 
2.2.3 Electrophysiology techniques 
 Procedures of whole cell patch-clamp recording of TRPM2 channel 2.2.3.1
currents  
HEK293 cells were co-transfected with 400 µg TRPM2-HA and 100 ng EGFP (marker 
for transfected cells). Transfected cells were seeded onto cover-slips after transfection. 
24-48 hr later, transfected cells were chosen for patch-clamp recording based on EGFP 
fluorescence.    
 
Patch clamp recordings were made at room temperature, using Axopatch200B amplifier 
(Axon Instruments) and Digidata 1332A (Axon Instruments). The extracellular solution 
contained: 147 mM NaCl, 2 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 10 mM HEPES and 13 
mM glucose, pH 7.4. Cells were held at -40 mV and voltage ramps with a 1 sec duration 
from -120 mV to 80 mV were applied every 5 sec. 20 µM N-(p-Amylcinnamoyl) 
anthranilic acid (ACA) was applied at the end of the recording. Data analysis was 
carried out using pClamp9 software (Axon Instruments). Patch-clamp experiments were 
performed by Dr. Lin-Hua Jiang, Faculty of Biological Science, University of Leeds. 
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 │ Generation, expression and functional evaluation of HA 3
tagged TRPM2 ion channels  
  Introduction 3.1
The TRPM2 channel is a plasma membrane ion channel. However, its expression has 
also been reported in lysosomes (Lange et al., 2009; Sumoza-Toledo et al., 2011; Sun 
et al., 2012). Its activation by oxidative stress has been linked widely to cell death due to 
Ca2+ entry (Kaneko et al., 2006; Manna et al., 2015; McHugh et al., 2003; Sun et al., 
2012). Trafficking of TRPM2 ion channels to the plasma membrane and to lysosomes is 
not known. Likewise little is known about how the plasma membrane TRPM2 channels 
are internalised and what their fate is following internalisation.  
 
Emerging evidence suggests that the TRPM2 channel functions both at the plasma 
membrane and the lysosome. Moreover, some cells have more channels in the 
lysosomal membranes than in the plasma membrane.  For example, TRPM2 expression 
in dendritic cells is largely seen in the endosomal vesicles (punctate cytoplasmic 
distribution), whereas in neutrophils, TRPM2 expression was mainly found in the 
plasma membrane (Sumoza-Toledo et al., 2011; Zeng et al., 2010). The question is, 
how do TRPM2 channels reach lysosomes? In general, there are two different routes 
for intracellular trafficking to lysosomes. In the first route, proteins travel from the Golgi 
apparatus to late endosomes and then to lysosomes (Harter and Mellman, 1992; 
Mathews et al., 1992), while, in the second route, proteins travel from the Golgi 
apparatus to the plasma membrane and then to early endosomes, late endosomes and 
lysosomes (Harter and Mellman, 1992). Investigation of TRPM2 trafficking requires 
antibodies to the channel protein, ideally to an extracellular loop (Karnik et al., 2013; 
Mankouri et al., 2006). However, the commercial TRPM2 antibody (Bethyl laboratories, 
catalog #A300-413A) is not suitable to label TRPM2 channels at the plasma membrane, 
as the antibodies are directed to an intracellular segment. In addition, these commercial 
TRPM2 antibodies produce significant nonspecific labelling in both 
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immunohistochemistry and western blotting (observation in Sivaprasadarao’s 
laboratory).  
 
The present chapter aims to introduce an epitope (Fritze and Anderson, 2000; Karnik et 
al., 2013; Mankouri et al., 2006) into the extracellular loop of TRPM2 channels. There 
are many common tags that are often fused to protein of interest and can be detected 
with commercially available antibodies; examples of such tags include Influenza 
haemagglutinin A (HA), FLAG and Myc (Fritze and Anderson, 2000; Jarvik and Telmer, 
1998). However, insertion of a tag without disturbing the structure, function or 
subcellular localisation can be challenging (Jarvik and Telmer, 1998; Reinhard et al., 
2013). In this chapter, an HA tag was inserted into the S1-S2 loop of TRPM2 channels 
using recombinant techniques, and its expression and function were evaluated using 
cell biology techniques and whole-cell patch clamp recordings respectively.   
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 Results 3.2
3.2.1 An investigation into the specificity of commercial anti-TRPM2 
antibodies 
To study the trafficking pathway of TRPM2 ion channel in health and disease, specificity 
of a commercial polyclonal rabbit anti-TRPM2 antibody (Bethyl Laboratories, catalog 
#A300-413A) was first examined. For this, HUVECs (which express TRPM2 channels 
natively) and HEK-293 cell lines (which do not express native TRPM2 channels) were 
used. The results in Figure 3.1 indicate that the commercial anti-TRPM2 antibody 
shows significant nonspecific labelling in HEK-293 cells that do not express native 
TRPM2. Moreover, this antibody was raised against an intracellular epitope; thus it is 
less suitable for direct detection of plasma membrane expression of TRPM2 channels.  
 
 
 
 
 
 
 
Figure 3.1 Nonspecific labelling of TRPM2 by anti-TRPM2 antibodies 
HEK-293 cells and HUVECs were fixed with 2% PFA, permeabilised, and incubated with the 
polyclonal rabbit anti-TRPM2 (1:100) antibody. Cells were then stained with Cy3-conjugated 
anti-rabbit secondary antibody (1:500). Cells were imaged by confocal microscopy, scale bar, 
10 µm. Representative images are shown; experiment was done twice. 
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3.2.2 Insertion of an extracellular HA epitope into the TRPM2 channel 
As shown in Figure 3.1, TRPM2 antibody is not suitable to selectively label TRPM2 
channels and study TRPM2 trafficking. Introduction of HA epitope into a TRPM2 
channel would help in studying the localisation and trafficking of the channel. Therefore, 
an attempt was made to insert an HA-epitope (YPYDVPDYA) into the first extracellular 
loop, between segment 1 and segment 2 of TRPM2, by Timothy Munsey, University of 
Leeds. The construct in the pcDNA3 vector was sequenced and aligned with hTRPM2 
using the ClustalW2. Unfortunately, it was found that two amino acids, an aspartate (D) 
and valine (V), were missing from the HA sequence (YPYDVPDYA). In order to insert 
the missing amino acids, primers were designed and PCR was carried out (see Figure 
2.1) as described before (Sivaprasadarao and Findlay, 1993). After treating with Dpn I, 
the PCR product was analysed using agarose gel electrophoresis (Figure 3.2A). There 
is a clear indication of a band on the agarose gel, with a size between 8000–10000 bp.  
 
The PCR product (Figure 3.2A) was cut from the agarose gel and purified using a 
commercial gel extraction kit. Recovery of DNA in the purified fraction was assessed by 
agarose gel electrophoresis (Figure 3.2B). A single band was seen on the gel. The 
purified product was incubated with T4 DNA ligase to join the DNA ends.  
 
The ligated PCR product was transformed into competent XL I-Blue cells. Single 
colonies were picked and incubated in 5 ml culture tubes overnight at 37°C for small 
scale plasmid preparation, following the protocol of QlAprep Spin Mini-prep Kit. The 
plasmid preparations from five clones were analysed by agarose gel electrophoresis 
(Figure 3.2C). Two of these clones, 1 and 5, were fully sequenced, and aligned against 
the expected sequence of TRPM2-HA (see appendix). The sequences around the HA 
(Figure 3.2D) confirmed in both the clones the presence of D and V amino acids, the 
two amino acids that had been missing in the original construct made by Tim Munsey.  
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Figure 3.2 Insertion of an extracellular HA epitope into TRPM2 
(A) Agarose gel electrophoresis of the PCR product. Lane 1, 25 µl of PCR product digested with 
10 units of Dpn; lane M, DNA ladder. 
(B) Agarose gel electrophoresis of the purified PCR product. PCR product in Figure 3.1A was 
cut out of the gel under UV transilluminator and purified using Gel Extraction kit. 2µl of the 
purified DNA electrophoresed on 1% agarose gel. 
(C) Minipreps of clones generated from transformation of the ligated PCR product from (B). The 
purified ligated PCR product was transformed into XL-I Blue cells and small scale plasmid DNA 
prepared (minipreps) from five clones and electrophoresed on 1% agarose gel (Lanes 1-5). 
(D) Partial sequences of two minprep plasmid DNA samples.  Sequence alignment of the 
pcDNA3-hTRPM2-HA (test) with the DNA (query) from Clone 1 (Lane 1) and Clone 5 (Lane 5) 
produced by ClustalW2. Green boxes indicate the inserted codons. Only the relevant portion of 
the DNA sequence is shown.  
(E) Schematic of the location of HA-epitope (red) in extracellular loop 1 (grey) between segment 
1 and segment 2 indicating D and V residues (green) in HA.  
(F) Schematic of the topology of TRPM2 subunit showing the site of the hemagglutinin (HA) 
epitope insertion. 
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3.2.3 Examination of the HA-tagged TRPM2 protein expression in different 
cell lines 
The above data confirmed insertion of the HA epitope into pcDNA3-TRPM2 channel 
(Figure 3.2). Epitope tagged proteins and antibodies have since been widely used to 
study the movement of proteins between different cellular compartments (Jarvik and 
Telmer, 1998). However, insertion of a tag may affect expression, cellular location or 
function of a protein (Jarvik and Telmer, 1998). To investigate the expression of a HA-
tagged TRPM2 channel, cell biology experiments (immuno-fluorescent staining and 
western blot analysis) were carried out. HEK-MSR cells were transfected with the 
TRPM2-HA construct. 48 hr post transfection, the cells were fixed with 2% PFA with and 
without permeabilisation. Cells were first treated with PBS-1% ovalbumin to block 
nonspecific binding sites and then incubated with rat anti-HA antibody and stained with 
Cy3 conjugated secondary antibody. It was expected that non-permeabilised cells will 
show staining of TRPM2-HA at the plasma membrane, while permeabilised cells will 
indicate total TRPM2-HA expression. Figure 3.3A shows no detectable expression of 
TRPM2-HA at the plasma membrane in non-permeabilised cells; some cells, however, 
showed intracellular staining which could be attributed to accidental permeabilisation of 
cells during the experiment.  Permeabilised cells showed clear staining which indicates 
that the HA-epitope inserted into TRPM2 is effectively recognised by the anti-HA 
antibodies (Figure 3.3B). Expression of TRPM2-HA was also confirmed by western blot 
analysis of transfected cells, where a band corresponding to the molecular weight of 
~170 KDa is seen (Figure 3.3C); the size roughly corresponds to the theoretical 
molecular weight of TRPM2-HA which is 173515.78. No bands were seen in the non-
transfected control cell lysate. TRPM2-HA could also be successfully expressed in other 
cell types including HUVECs, HeLa and INS-1 cells (Figure 3.3D). 
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Figure 3.3 Expression of TRPM2-HA in different cell lines 
(A-B) Expression of TRPM2-HA in HEK-MSR cells. Cells were transfected with pcDNA3-
TRPM2-HA. Cells were fixed with 2% PFA and permeabilised (B) or non-permeabilised (the cell 
stained was accidentally permeabilised) (A) with 0.25% Triton X-100. Cells were incubated with 
rat anti-HA and stained with Cy3 conjugated anti-rat secondary antibody. Images were taken by 
confocal microscope, scale bar, 10 µm, n=3.  
(C) Western blot analysis of lysate from HEK-MSR cells, not transfected (control) and 
transfected with pcDNA3-TRPM2-HA. Immunostaining for the HA epitope revealed TRPM2-HA 
expression. Band at a molecular weight of ~170 kDa corresponds to the calculated size 
TRPM2-HA protein, n=3. Numbers on the left of the blot indicate size of marker proteins in kDa.    
(D) TRPM2-HA expression in different cell lines. Different cell lines as indicated were 
transfected with TRPM2-HA. Cells were fixed with 2% PFA, permeabilised with 0.25% Triton X-
100 and stained with AlexaFluor488 conjugated anti-rat secondary antibody. Images were taken 
by confocal microscope, scale bar, 10 µm, n=3. In all cases, representative images are shown. 
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3.2.4 Insertion of HA-tag does not affect cell membrane expression of 
TRPM2 channel 
It is not clear from the above data whether the HA-tagged TRPM2 channels are 
expressed at the plasma membrane. This could be because HA-tagging prevents 
trafficking of the channel to the plasma membrane, or because its steady-state levels at 
the plasma membrane are too low to be detectable by immunostaining. To address this, 
internalisation of anti-HA antibodies was examined, along with the marker, the 
transferrin (Tfn) receptor. Internalisation of a transferrin receptor can be detected by 
confocal microscopy when the cells are pulsed with fluorescent transferrin, which binds 
the receptor and undergoes endocytosis into clathrin-coated vesicles (Mukherjee et al., 
1997; Rajendran et al., 2010). If anti-HA antibodies bind TRPM2-HA at the plasma 
membrane and undergo internalisation, one would expect to see the antibodies in 
intracellular vesicles. If the vesicles also contain fluorescent transferrin, the results could 
suggest internalisation of TRPM2-HA into clathrin-coated vesicles. Thus HEK-TRPM2 
cells were transfected with pcDNA3-TRPM2-HA and incubated with AlexaFluor488-
conjugated Tfn (marker of the Tfn receptor) for 15 min at 37°C. The cells were then 
washed and incubated with AlexaFluor594-conjugated anti-HA antibodies. Live cell 
imaging (Figure 3.4) showed co-localisation of internalised TRPM2-HA channels with 
Tfn (yellow puncta). These data indicate that the internalised TRPM2-HA channels 
localise to distinct endosomes and are likely internalised by clathrin-mediated 
endocytosis. The results suggest that insertion of an HA epitope does not affect TRPM2 
expression at the plasma membrane, although no distinct plasma membrane labelling 
could be seen when non-permeabilised cells were stained.  
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Figure 3.4 Internalised TRPM2-HA channels localise to transferrin-positive vesicles 
HEK-MSR cells were transfected with pcDNA3-TRPM2-HA. Cells were incubated with 50 µg/ml 
AlexaFluor488 conjugated Tfn for 15 min at 37°C and then incubated with AlexaFluor594 anti-HA 
(1:300) for 15 min at RT. Cells were washed with SBS and imaged as a video by confocal 
microscopy at 37°C. The image represents a snapshot from the video (the CD is attached to the 
back cover of the thesis), n=2. Scale bar, 10 µm. Boxed regions are expanded, scale bar, 5 µm; 
representative images are shown. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Expanded  
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3.2.5 Lysosomal TRPM2 expression 
Previous studies have shown that TRPM2 ion channel is not only a plasma membrane 
ion channel but also a lysosomal ion channel (Lange et al., 2009). Immuno-fluorescent 
staining was carried out to test whether insertion of the HA-epitope affects location of 
TRPM2-HA expression in lysosomes. HEK-TRPM2 cells were transfected with pcDNA3-
TRPM2-HA. The cells were fixed, incubated with rat anti-HA and mouse anti-CD63 
(lysosomal marker) primary antibodies and stained with Cy3 conjugated anti-mouse 
secondary antibody and AlexaFlour488-conjugated anti-rat secondary antibody. Confocal 
images in Figure 3.5 indicate intracellular expression of TRPM2-HA (green) that 
colocalises with CD63 (red). These data indicate that the HA-tag does not affect 
lysosomal trafficking of TRPM2 protein.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5 Expression of TRPM2-HA channels in lysosomes 
HEK-MSR cells were transfected with pcDNA3-TRPM2-HA, fixed with 2% PFA, and 
permeabilised with 0.25% Triton X-100. Cells were incubated with rat anti-HA (1:500) and 
mouse anti-CD63 (1:500), one after the other, and stained with Cy3-conjugated anti-rat 
secondary antibody (1:500) and AlexaFlour488 conjugated anti-mouse (1:500) secondary 
antibodies. Cells were imaged by confocal microscopy, scale bar, 10 µm, n=3. Boxed regions 
are expanded, scale bar, 5 µm. 
 
Expanded  Merge 
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3.2.6 Insertion of HA-tag does not affect the function of TRPM2 channel 
The aim of this experiment was to test whether the insertion of HA-tag into the S1-S2 
loop affects the function of TRPM2 channel. Tetracycline-induced (+TRPM2-FLAG) and 
not-induced (-TRPM2-FLAG) HEK-TRPM2tet cells were used as positive and negative 
controls. ADPR was applied though the patch pipette to activate the channels, and ACA 
was used to inhibit the ADPR-activated currents. As shown in Figure 3.6, there were no 
currents in not-induced cells. In tetracycline-induced cells, there was a robust current 
that was fully blocked by ACA. Currents of similar magnitude were detected in HEK-293 
cells transfected with pcDNA3-TRPM2-HA. These results indicate that the insertion of 
an HA-epitope into TRPM2 channels does not perturb its function.  
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Figure 3.6 Effect of HA on the function of TRPM2 channels 
(A-B) Whole-cell current measurements were made from induced (+TRPM2-FLAG) and not-
induced (-TRPM2-FLAG) HEK-TRPM2tet cells. (A) Current-voltage relationships without and 
with cytosolic 1 mM ADPR recorded from not-induced (-TRPM2-FLAG) HEK-TRPM2tet cells. (B) 
Currents recorded from induced (+TRPM2) HEK-TRPM2tet cells; recording was performed as in 
(A). ADPR-induced currents were inhibited by the application of 10 mM N-(p-
amylcinnamoyl)anthranilic acid (ACA), n=3.  
(C) Whole-cell current measurements from HEK-293 cells transfected with pcDNA3-TRPM2-HA. 
Currents induced by 1 mM ADPR and inhibited by 10 mM ACA, n=3. 
 
I would like to acknowledge Dr. Lin-Hua Jiang, Faculty of Biological Science, University of 
Leeds for these recordings. 
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 Discussion 3.3
Previous reports have shown that altered cellular trafficking of ion channels can lead to 
diseases such as cardiovascular and neuronal diseases (Hung and Link, 2011). 
Previous work implicated TRPM2 channels in diabetes, ischemia-reperfusion injury, 
vascular endothelial damage and brain injury (Dietrich and Gudermann, 2008; Manna et 
al., 2015; Ye et al., 2014). It is conceivable that altered trafficking of TRPM2 channels 
could contribute to these disease states. However, little is known about how TRPM2 
channels traffic in a cell under normal conditions. Commercially available antibodies 
were found to be nonspecific (Figure 3.1) and are thus unsuitable for studies of TRPM2 
trafficking. Furthermore these antibodies were raised against an intracellular epitope, 
which makes them less suitable for endocytic trafficking studies. For these reasons, in 
this chapter, HA epitope was inserted into the S1-S2 extracellular loop of the TRPM2 
channel. The results show that the resulting TRPM2-HA construct is functional and 
suitable for trafficking studies.  
 
3.3.1 TRPM2-HA expression, location and function  
HA epitope was inserted into the first extracellular loop between S1 and S2 of a human 
TRPM2 sequence using PCR (Figure 3.2) and subsequent cloning of the PCR product. 
Epitope-tagged proteins and antibodies have been widely used to study the movement 
proteins between cellular compartments (Jarvik and Telmer, 1998). However, since 
insertion of a  tag may affect expression, cellular location or function of a protein (Jarvik 
and Telmer, 1998), TRPM2-HA was expressed in a variety of cell lines and subjected to 
immunostaining and functional analysis. 
 
Surface expression of TRPM2 channels was not detectable when non-permeabilised 
cells were labelled with anti-HA antibodies (Figure 3.3A). There could be several 
reasons why TRPM2-HA membrane expression was not discernible. Firstly, insertion of 
HA epitope may have prevented the channel from expression or trafficking to the cell 
surface. Secondly, the channels may move rapidly from the cell membrane to other 
organelles, so at steady-state, their levels could be too low to be detectable at the 
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plasma membrane. Finally, the epitope in the loop could be inaccessible to the antibody 
(Jarvik and Telmer, 1998).  
 
In permeabilised cells, TRPM2-HA staining was robust (Figure 3.3B), indicating that 
insertion of the HA did not affect expression of the protein. This was further confirmed 
by the western blotting of transfected cells which showed a band, the size (~170 kDa) of 
which corresponds to the molecular weight calculated from the amino acid sequence 
(Figure 3.3C). Thus insertion of the HA-epitope did not affect TRPM2 expression and 
recognition by the anti-HA antibody. Although TRPM2-HA expression could not be 
detected by the anti-HA antibody labelling, whole cell patch-clamp analysis of 
transfected cells showed ADPR-induced cation currents that were inhibited by the 
TRPM2 inhibitor, ACA (Figure 3.6). The size of the currents were similar to currents 
from TRPM2 channels lacking the HA epitope. These results indicate that insertion of 
HA epitope does not inhibit trafficking of the channel to the plasma membrane and its 
function.  
 
Besides the plasma membrane, expression of native TRPM2 channels was also 
reported in lysosomes of dendritic cells (Sumoza-Toledo et al., 2011) and  INS-1 cells 
(Lange et al., 2009; Manna et al., 2015). Using CD63 as a marker, expression of 
TRPM2-HA in lysosomes could be demonstrated (Figure 3.5). Taken together, the 
results indicate that insertion of the HA tag does not affect normal trafficking and 
function of the channel and is thus suitable to investigate TRPM2 trafficking under 
different conditions.  
 
3.3.2 Internalisation of plasma membrane TRPM2-HA channels 
Although TRPM2-HA channels could not be detected at the cell surface by 
immunostaining, patch-clamp data revealed that they traffic to the cell surface. To 
investigate if TRPM2-HA channels undergo internalisation, an antibody uptake assay 
(Mankouri et al., 2006) was used. The data from live cell imaging of HEK-TRPM2-HA 
transfected cells (Figure 3.4) revealed that TRPM2-HA channels undergo internalisation 
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into endocytic vesicles that are positive for the early endosomes marker, transferrin 
receptor. These data confirmed that TRPM2-HA ion channels are expressed at the 
plasma membrane and delivered from the cell surface to early endosomes. During 
endocytosis, many receptors including transferrin receptors are localised to clathrin-
coated vesicles (Mukherjee et al., 1997; Rajendran et al., 2010). Thus, these data also 
suggest that TRPM2-HA is internalised via clathrin-mediated endocytosis.  
 
To conclude, the results of this chapter demonstrate that insertion of an HA tag into the 
S1-S2 loop of TRPM2 channels does not affect its trafficking to the plasma membrane 
and lysosomes. The results also provide the first indication that these channels are 
likely internalised via clathrin-mediated endocytosis. Thus the TRPM2-HA construct 
made in this study should be useful for detailed studies into trafficking of the channel 
under normal conditions and in disease states. However, the inability to detect surface 
expression of TRPM2-HA channels using anti-HA antibodies makes it somewhat difficult 
to study the trafficking of plasma membrane TRPM2 channels.  
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 │TRPM2 channels regulate the integrities of lysosomes 4
and mitochondria  
 Introduction 4.1
Mitochondria are essential organelles that play key roles in cell life and cell death. They 
exist as a dynamic network and are mainly responsible for the production of energy. 
However, the structural integrity of mitochondria is constantly threatened by 
environmental and metabolic stresses. Mitochondria have the ability to cope with these 
threats by undergoing continuous cycles of fission and fusion (Archer, 2013; Dorn, 
2015; Friedman and Nunnari, 2014; Youle and van der Bliek, 2012).  
 
The fission machinery, in conjunction with mitophagy, helps remove damaged parts of 
mitochondria, and protects the cell from toxicity due to damaged mitochondria (Youle 
and Narendra, 2011). Mitochondrial fission is driven by the dynamin-related protein 1 
(Drp1) (Chan, 2012). There are several mitochondrial proteins that act as a recruiter or 
receptor of Drp1; these include mitochondrial fission protein 1 (FIS1), mitochondria 
fission factor (MFF) and mitochondrial dynamics proteins (MiDs; MiD49 and MiD51) 
(Chan, 2012; Palmer et al., 2011). Drp1 is mainly located in the cytoplasm, but is 
recruited to the mitochondrial outer membrane during fission (Chan, 2012). Fusion 
promotes joining of healthy parts of mitochondria and restores the functional network. 
Fusion occurs in two steps, wherein the outer membrane and the inner membrane fuse 
in separate events. Mitofusin1 (Mfn1) and Mitofusin2 (Mfn2), which are located in the 
outer membrane, are responsible for the fusion of the outer membrane, whereas Optic 
atrophy 1 (OPA1), which is located in the inner membrane and intermembrane space, is 
responsible for inner membrane fusion (Archer, 2013; Chan, 2012; Friedman and 
Nunnari, 2014; Youle and van der Bliek, 2012). Imbalance between the fusion and 
fission events leads to mitochondrial elongation or mitochondrial fragmentation, both of 
which affect mitochondrial function. Disruption of fusion-fission equilibrium can impair 
cell homeostasis, and contribute to a wide range of diseases, in particular the late-age 
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onset diseases (Archer, 2013; Dorn, 2015). For example, a shift in the fusion-fission 
equilibrium towards fission has been reported in neuronal (Parkinson’s, Alzheimer’s) 
diseases, cardiovascular disease, diabetes and cancer (Archer, 2013; Friedman and 
Nunnari, 2014; Youle and van der Bliek, 2012). Thus these findings suggest that 
mitochondrial dynamics represent a valid drug target for a wide range of age-related 
illnesses.  
 
The shift from fusion to fission has been attributed to the increase in cellular oxidative 
stress due to increased production of reactive oxygen species (ROS) by the aging cell. 
However, targeting the proteins involved in the fusion and fission events may prove 
difficult because knock-out of these proteins is embryonically lethal (Chen et al., 2003; 
Rahn et al., 2013; Wakabayashi et al., 2009). Compared with what is known about the 
molecular mechanism of mitochondrial fission, little is known about how oxidative stress 
regulates this process; thus a better understanding of the regulatory mechanisms may 
reveal novel drug targets. 
 
It has been well established that hyperglycemic conditions and over-production of ROS 
induce mitochondrial fragmentation by increasing the intracellular Ca2+ concentration, 
thereby leading to increased apoptosis (Dorn, 2015; Friedman and Nunnari, 2014; 
Youle and van der Bliek, 2012). Some studies reported that oxidative stress leads to 
intracellular zinc accumulation, mitochondrial dysfunction and apoptosis (Weiss et al., 
2000). The mechanisms by which Ca2+ and Zn2+ regulate these events are unclear. 
 
In this chapter, the hypothesis that oxidative stress induces mitochondrial fragmentation 
by activating the TRPM2 cation channel has been tested. The rationale behind this 
hypothesis is the knowledge that TRPM2 channels are potently activated during 
oxidative stress (Sumoza-Toledo and Penner, 2011; Takahashi et al., 2011), and the 
resulting changes in intracellular Ca2+ and Zn2+ levels affect cell homeostasis, leading to 
apoptotic cell death (Manna et al., 2015; Sumoza-Toledo and Penner, 2011; Takahashi 
et al., 2011), which is the primary cause of most late age-onset diseases. To address 
this aim, human umbilical vein endothelial cells (HUVECs) were exposed to H2O2 or 
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high concentrations of glucose (diabetic conditions) as it has been shown previously 
that high glucose leads to apoptotic cell death by increasing cellular levels of ROS. The 
role of TRPM2 channels in H2O2 and high glucose-induced mitochondrial fragmentation 
(Du et al., 1998; Manna et al., 2015) was tested using pharmacological and RNAi 
approaches. The role of TRPM2 mediated changes in Ca2+ and Zn2+ signals was tested 
using chemical chelators of these ions. The results show that by mobilising the mitotoxic 
Zn2+ from lysosomal stores to mitochondria, TRPM2 channels increase mitochondrial 
fission. Unexpectedly, besides the plasma membrane and lysosomes, TRPM2 channels 
were also found in the mitochondria. Studies into the role of mitochondrial TRPM2 
channels revealed that these channels promote mitochondrial Zn2+ accumulation 
leading to mitochondrial fragmentation.  
 
In this chapter, different concentrations of H2O2 for different cell lines were used. The 
rationale behind this is the fact that different cells respond to different concentrations of 
H2O2 in terms of their ability to induce cell death (apoptosis) and mitochondrial 
fragmentation. This may be related to differences in ROS regulation in different cell 
types (Halliwell et al., 2000). Thus, in this study, HEK-TRPM2 cells and HUVECs were 
exposed to different concentrations of H2O2 and incubated for different lengths to detect 
phenotypic changes. 
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 Results 4.2
4.2.1 Time course of H2O2-induced changes in mitochondrial morphology 
To examine H2O2-induced changes in mitochondrial morphology, HUVECs were 
transfected with pMito-CFP. Transfected cells were exposed to 3 mM H2O2 and images 
were taken at 15 min time intervals by confocal microscopy. The images in Figure 4.1 
show that oxidative stress induced branching of the mitochondrial network at the 15 min 
time point (red arrows). However, this newly formed branch disappeared at the 30 min 
time point (red arrows). These changes were then followed by progressive 
mitochondrial fission to small rounded structures (yellow arrows), some of which fused 
at early time points (purple arrow). At later time points, some of the rounded 
mitochondrial fragments began to disappear (blue arrows). These results are in 
agreement with the previous reports on neurons exposed to nitric oxide and on 
myocytes exposed to hydrogen peroxide (Barsoum et al., 2006; Fan et al., 2010). 
  
To conclude, H2O2 has a profound effect on mitochondrial morphology. Brief exposure 
to H2O2 elicited a positive response by promoting branching. Prolonged exposure, 
however, caused extensive mitochondrial fission, followed by the gradual 
disappearance of fragmented mitochondria.  
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Figure 4.1 Sequential events of H2O2-induced mitochondrial fission and fusion in 
HUVECs 
HUVECs were transfected with pMito-CFP (colour changed to green for clarity), and the 
mitochondria of two individual cells were imaged before (time = 0 min) and after H2O2 (3 mM) 
application. Confocal mages acquired at 15 min intervals are shown. Scale bar, 10 µm. 
Appearance of single mitochondrion, fission, fusion and mitochondrial disappearance events are 
indicated with arrows (red arrows indicate branching of mitochondrial network, yellow arrows 
indicate mitochondrial fission, purple arrows indicate mitochondrial fusion and blue arrows 
indicate mitochondrial disappearance). Representative images are shown; experiment was 
performed two times.  
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4.2.2 Expression of TRPM2 channels in HUVECs and RNAi silencing 
To examine whether TRPM2 channels play a role in oxidative stress-induced 
mitochondrial fragmentation in endothelial cells, firstly, TRPM2 expression and function 
were tested in HUVECs. Calcium imaging and RT-PCR gave evidence of TRPM2 
channel expression in HUVECs (Figure 4.2). Application of exogenous 3 mM H2O2 to 
HUVECs induced a rise in cytosolic [Ca2+], which was absent in the presence of TRPM2 
blockers (2-aminoethoxydiphenyl borate (2-APB) and N-(p-amylcinnamoyl)anthranilic 
acid (ACA)) (Figure 4.2A). RT-PCR performed on RNA isolated from HUVECs showed 
a band (293 bp) expected from TRPM2 messenger RNA. A similar size band was 
obtained from HUVECs transfected with scrambled (negative control) siRNA, but not 
from cells transfected with TRPM2 siRNA (Figure 4.2B). The efficiency of TRPM2-
siRNA was further confirmed by calcium imaging. Figure 4.2C shows a reduction in Ca2+ 
entry in HUVECs transfected with TRPM2 siRNA, but not scrambled siRNA. These 
findings are in agreement with the previous reports that endothelial cells express 
TRPM2 ion channels (Hecquet and Malik, 2009) that are activated by H2O2 (Hecquet 
and Malik, 2009) and inhibited by 2-APB (Togashi et al., 2008) and ACA (Kraft et al., 
2006) blockers.  
 
To conclude, these findings confirm TRPM2 expression in endothelial cells and its 
activation by H2O2. 
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Figure 4.2 Expression of TRPM2 channels in HUVECs and RNAi silencing  
(A) Functional analysis of TRPM2 expression by Ca2+ imaging. HUVECs were loaded with Fura-
2 AM, washed and incubated with TRPM2 blockers (150 µM 2-APB or 10 µM ACA) for 30 min at 
room temperature. Addition of 3 mM H2O2 (shown as horizontal bar) elicited a marked time-
dependent increase in F340/F380 fluorescence ratio (due to rise in intracellular Ca2+, Ca2+i). 
Rise in Ca2+i is absent in cells treated with the TRPM2 blockers. Symbols represent mean 
fluorescence ratio and the associated bars represent SEM, n=2.     
(B) Demonstration of silencing of TRPM2 mRNA expression by RNAi.  
Lanes 1-3: RT-PCR products from mRNA isolated from non-transfected HUVECs (lane 1) or 
HUVECs transfected with scrambled (negative control) siRNA (lane 2) or siRNA targeted to 
TRPM2 (lanes 3). The results show absence of a TRPM2 band (lane 3) in TRPM2 siRNA 
transfected samples, but not scrambled siRNA controls (lane 2). 
(C) Demonstration of RNAi silencing of TRPM2 expression by calcium imaging. Experiments 
were performed as in (A), except the cells were transfected with scrambled siRNA or siRNA 
targeted to the TRPM2 channel. The results show efficient suppression of TRPM2 expression 
by TRPM2 siRNA, which is consistent with the RT-PCR results, n=3.  
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4.2.3 Inhibition of TRPM2 channels prevents H2O2-induced mitochondrial 
fragmentation 
It was shown earlier that H2O2 induces endothelial mitochondrial fragmentation and 
activates TRPM2 ion channels. The aim of this experiment was to examine the role of 
TRPM2 ion channels in H2O2-induced mitochondrial fragmentation. To obtain a 
quantitative description of mitochondrial dynamics, HUVECs were transfected with 
pMito-Cherry, which codes for a mitochondria-directed fluorescent reporter protein. 
Cells were exposed to 1 mM H2O2 for 3 hr. The results show that the number of cells 
susceptible to H2O2-induced mitochondrial fragmentation was markedly reduced when 
TRPM2 channels were inhibited with siRNA or pharmacological agents (2-APB; TRPM2 
blocker) (Figure 4.3A and E). For objective assessment of mitochondrial morphology, 
the aspect ratios (major axis/minor axis) and the form factors (a measure of degree of 
branching) of mitochondria were measured (Yu et al., 2008). The results show that H2O2 
caused a significant reduction in both the aspect ratio and form factor of mitochondria 
and that TRPM2 inhibition significantly rescued these changes (Figure 4.3B-D).   
 
These results provide compelling evidence that TRPM2 channels mediate oxidant-
induced mitochondrial fragmentation. This is a fundamentally important finding because 
although mitochondrial dynamics has received enormous interest in recent years 
(Archer, 2013; Friedman and Nunnari, 2014; Youle and van der Bliek, 2012), the 
signalling mechanisms underlying mitochondrial fission are far from clear. 
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Figure 4.3 Inhibition of TRPM2 channels prevents H2O2-induced mitochondrial 
fragmentation  
(A) Inhibition of TRPM2 channels prevents H2O2-induced mitochondrial fragmentation.  
HUVECs were transfected with pMito-Cherry (a mitochondrial marker) and incubated with 1 mM 
H2O2 for 3 hr at 37°C in the presence and absence of a TRPM2 blocker (150 μM 2-APB). 
Alternatively, cells were co-transfected with pMito-Cherry and scrambled siRNA or siRNA 
targeted to TRPM2 channels. Representative confocal images are shown. Scale bar, 10 µm, 
n=3. Boxed regions are magnified in the lower panels. Scale bar, 5 µm.   
(B) Plots of form factor against aspect ratio calculated from ≥ 70 mitochondria, n=3.  
(C) Aspect ratio calculated from ≥ 70 mitochondria, n=3. 
(D) Form factor calculated from ≥ 70 mitochondria, n=3. 
(E) Percent cells displaying mitochondrial fragmentation determined from ≥ 100 cells, n=3.   
Bars represent means ± SEM, statistical analysis was performed by one-way ANOVA with 
Tukey’s post-hoc test *p <0.05, **P < 0.01, and ***P < 0.001. 
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4.2.4 Ectopic expression of TRPM2 channels confers mitochondrial 
fragmentation on HEK-293 cells 
The above data showed that silencing of TRPM2 expression prevents oxidative stress-
induced mitochondrial fragmentation. To confirm the role of TRPM2 channels, a 
recombinant approach was used. Previous studies have shown that HEK-293 cells do 
not express TRPM2 channels and can be engineered to express TRPM2 channels 
under the control of a tetracycline inducible promoter (Perraud et al., 2001). Thus these 
engineered cells, termed HEK-TRPM2tet cells, express TRPM2 channels when induced 
with tetracycline. HEK-TRPM2tet cells were incubated with 200 µM H2O2 and loaded 
with MitoTracker Red (mitochondrial marker) to examine mitochondrial morphology. 
Lower concentrations of H2O2 were used here because, unlike HUVECs, induced HEK-
TRPM2tet cells are highly susceptible to oxidant induced cell death (Manna et al., 2015). 
The results show no detectable effect of H2O2 on mitochondrial morphology of these 
cells (Figure 4.4A, labelled (-)TRPM2). However, when TRPM2 expression was induced 
by treating the cells with tetracycline, extensive fragmentation was seen (Figure 4.4B, 
labelled +TRPM2). To confirm that tetracycline treatment causes TRPM2 activation in 
HEK-TRPM2tet cells, calcium imaging was carried out. Figure 4.4C-D shows that 1 mM 
H2O2 caused a significant rise in cytosolic Ca
2+ in the cells induced to express TRPM2 
channels but not in the cells not expressing TRPM2 channels. The results confirm that 
mitochondrial fragmentation is dependent on TRPM2 channel activation.   
  
To conclude, H2O2 failed to induce mitochondrial fragmentation in HEK-293 cells lacking 
TRPM2 channels, but induction of TRPM2 expression led to significant mitochondrial 
fragmentation. These results confirm that H2O2-induced mitochondrial fragmentation is 
mediated by TRPM2 channels.  
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Figure 4.4 Mitochondrial fragmentation is dependent on TRPM2 channel activation 
(A-B) HEK-TRPM2tet cells (cells engineered to express TRPM2 upon induction with tetracycline) 
were incubated with SBS alone (CTRL) or 200 µM H2O2 for 90 min and then loaded with 
MitoTracker Red for 30 min before imaging. Representative confocal images show that H2O2 
induces no mitochondrial fragmentation in cells not expressing TRPM2 channels (-TRPM2; A), 
but extensive fragmentation in cells induced to express TRPM2 channels (+TRPM2; B), n=3. 
Scale bar, 10 µM. The middle panel shows the images merged with the corresponding DIC 
(differential interference contrast) images. Boxed sections are expanded in the far right panels; 
scale bar, 5 µm.  
(C) TRPM2-dependent Ca2+ increased in HEK-TRPM2tet cells. HEK-TRPM2tet cells were 
induced (+tet) or not-induced (-tet) to express TRPM2 channels.  Both groups of cells were 
loaded with Fura-2 AM for 1 hr at 37°C and washed for 30 min at room temperature. 
Fluorescence ratio (F340/F380) was recorded under control conditions and during the 
application of 1 mM H2O2 (shown as horizontal bar) in SBS containing 1.5 mM Ca
2+. Symbols 
represent mean fluorescence and the associated bars represent SEM.  
(D) Mean ± SEM of change in Ca2+ calculated from the data in (C), n = 3. Statistical analysis 
was performed by Student’s t-test, **P < 0.01. 
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4.2.5 TRPM2 channels mediate oxidative stress-induced mitochondrial 
fragmentation 
 High glucose induces formation of ROS in HUVECs 4.2.5.1
In diabetes, endothelial cells experience oxidative stress due to increased blood 
glucose levels (Ouedraogo et al., 2006). Studies have shown that exposure of 
endothelial cells to high glucose (HG) triggers mitochondrial fragmentation and that 
these effects are mediated by the increased ROS production (Shenouda et al., 2011; Yu 
et al., 2008). To confirm the role of TRPM2 channels in mitochondrial fragmentation 
under pathophysiological conditions, cells were incubated in normal and high glucose 
medium. Fasting plasma glucose levels in healthy individuals is <6.1 mM, while diabetic 
patients have plasma glucose levels >7.0 mM (Tirosh et al., 2005; American Diabetes, 
2004). In neonatal diabetes, glucose levels can exceed 30 mM concentration (Vaxillaire 
et al., 2004). Studies have shown cellular uptake of glucose is saturated at 30-35 mM 
glucose concentration (Heilig et al., 1995). Accordingly, in this study, 5.5 mM (control) 
and 33 mM glucose (representing diabetic levels) were used. Similar doses were used 
in previous studies (Ho et al., 2005; Lin et al., 2004). ROS production was determined 
by using the cell-permeant H2DCFDA. DCF levels were measured in HUVECs exposed 
to 5.5 mM glucose and 33 mM glucose for 48 hr and 72 hr. Mannitol was used as 
osmotic control. The data in Figure 4.5 show that there was a significant increase in the 
mean of DCF florescence/cell after 48 hr compared with the corresponding control. 
There was a small, but insignificant increase in ROS when the incubation period was 
extended to 72 hr.  
 
These data confirm that prolonged exposure to high glucose induces ROS production in 
HUVECs.  
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Figure 4.5 Glucose induces intracellular ROS generation  
(A) HG-induced ROS production. HUVECs were exposed to medium alone (CTRL) or medium 
with 28 mM mannitol plus 5 mM glucose, or medium with 33 mM glucose (HG). Incubation was 
for 48 hr or 72 hr at 37°C. Cells were stained with the cell-permeant 2',7'-
dichlorodihydrofluorescein diacetate (H2DCFDA) ROS reporter to detect mean DCF 
fluorescence per cell. Images were captured with an epifluorescent microscope (EVOS) and 
analysed by ImageJ software.  
(B) Mean ± SEM of fluorescence intensity/cell corresponding to data in (A), n = 3. Number of 
cells scored for each condition is ≥ 100 cells.  
Statistical analysis was performed by one-way ANOVA with Tukey’s post-hoc test, *p <0.05, **P 
< 0.01 and ***P < 0.001.  
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 Hyperglycaemic conditions cause effects similar to H2O2 on endothelial 4.2.5.2
cells 
To investigate whether TRPM2 channels mediate stress-induced endothelial 
mitochondrial fragmentation, pMito-Cherry was expressed in HUVECs. Effect of high 
glucose (HG) on mitochondrial morphology was assessed by measuring the aspect ratio 
(AR: length to width ratio) and form factor (FF: a measure of degree branching) of the 
mitochondria (Yu et al., 2008).  
 
Control cells showed an extensive mitochondrial network with long, branched tubular 
networks. High glucose (HG, 33 mM), but not mannitol (control for osmotic pressure 
effects), caused extensive mitochondrial fragmentation (Figure 4.6A and E). Changes in 
the length and branching of the mitochondrial network were quantified by determining 
the AR and FF. HG caused significant reduction in both the AR and the FF (Figure 4.6B, 
C and D). Inhibition of TRPM2 channels with 2-aminoethoxydiphenyl borate (2-APB) or 
suppression of TRPM2 expression using siRNA inhibited mitochondrial fragmentation 
significantly (Figure 4.6A and E).  
 
Taken together, these data revealed a previously unrecognised role for TRPM2 
channels in oxidative stress-induced mitochondrial fragmentation. 
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Figure 4.6 Inhibition of TRPM2 channels prevents high glucose-induced mitochondrial 
fragmentation 
(A) HUVECs were transfected with pMito-Cherry and incubated with 5 mM glucose (CTRL), or 
mannitol (28 mM + 5 mM glucose) or HG (33 mM, indicated with a horizontal bar) for 24 hr. 
Where indicated, cells were co-transfected with siRNA or treated with 37.5 µM 2-APB. 
Representative confocal images are shown; scale bar, 10 µm; n=3. Boxed regions are 
magnified in the lower panels. Scale bar, 5 µm. 
(B) Plots of form factor against aspect ratio calculated from ≥ 70 mitochondria, n=3. 
(C) Aspect ratio calculated from ≥ 70 mitochondria, n=3. 
(D) Form factor calculated from ≥ 70 mitochondria, n=3. 
(E) Percent cells displaying mitochondrial fragmentation determined from ≥ 130 cells, n=3.   
Bars are the means ± SEM, statistical analysis was performed by one-way ANOVA with Tukey’s 
post-hoc test, *p <0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.  
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4.2.6 Knock-out of TRPM2 channels prevents high glucose-induced 
mitochondrial fragmentation in mouse pulmonary endothelial cells 
The effect of HG on the mitochondria of primary endothelial cells isolated from the lungs 
of wild-type and TRPM2 knock-out (TRPM2 KO) mice was next examined. This was 
done to confirm the findings obtained from the cell lines. The identity of isolated 
endothelial cells was confirmed by immunostaining for the endothelial marker, CD-
31/PECAM-1 (green) (Li et al., 2014), and examining mitochondrial morphology by 
staining with MitoTracker Red (Figure 4.7). Similar to HUVECs, HG caused extensive 
mitochondrial fragmentation in primary endothelial cells (Figure 4.7A, B, C). By contrast, 
endothelial cells isolated from TRPM2 KO mice were remarkably resistant to HG-
induced mitochondrial fragmentation (Figure 4.7D, E, F). Interestingly, the form factor of 
mitochondria of TRPM2-deficient endothelial cells was significantly greater (~1.3-fold; p 
< 0.05) than that for mitochondria in wild-type endothelial cells; furthermore, this value 
changed little even after the HG challenge (Figure 4.7G).  
 
Finally, the effect of high glucose on the endothelial cells of intact aorta was examined. 
For this, aortas were dissected from mice, cut open longitudinally, exposed to high 
glucose and stained with MitoTracker Red. Confocal imaging of the endothelial layer of 
the sections (Figure 4.8A and B) showed extensive mitochondrial fragmentation in the 
endothelial cells of aortas derived from wild-type mice, and no detectable fragmentation 
in aortas of TRPM2 KO mice. These data demonstrate that endothelial cells in intact 
aortas respond to high glucose in the same way as the isolated cells and that TRPM2 
channels mediate high glucose-induced mitochondrial fragmentation. 
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Figure 4.7 Knock-out of TRPM2 channels prevents high glucose-induced mitochondrial 
fragmentation in mouse pulmonary endothelial cells 
(A) Primary endothelial cells isolated from lungs of wild-type mice were treated with mannitol 
and HG as described in Figure 4.6 and incubated for 3 days. The cells were then stained for 
mitochondria with MitoTracker Red and, after fixing with 2% PFA, immunostained with anti-
CD31 antibodies (green) to identify endothelial cells; nuclei were stained with DAPI (blue). 
Representative images are shown (8 mice: cells from 2-3 mice were pooled for each 
experiment; n =3). Scale bar, 10 µM. Boxed regions in the merged images are magnified in the 
bottom panels. Scale bar, 5 µm. 
(B) Plots of form factor against aspect ratio calculated from ≥ 70 mitochondria, n=3. 
(C) Aspect ratio calculated from ≥ 70 mitochondria, n=3. 
(D)  Primary endothelial cells isolated from lungs of TRPM2-KO mice were treated and stained 
as in (A) (7 mice: cells from 2-3 mice were pooled for each experiment; n =3). Scale bar, 10 µM. 
Boxed regions in the merged images are magnified in the bottom panels. Scale bar, 5 µm.   
(E) Plots of form factor against aspect ratio calculated from ≥ 70 mitochondria, n=3. 
(C) Aspect ratio calculated from ≥ 70 mitochondria, n=3. 
(G) Comparison of mitochondrial aspect ratio and form factor between the wild-type and 
TRPM2-deficient pulmonary endothelial cells during various treatments. 
Bars are the means ± SEM, statistical analysis was performed by one-way ANOVA with Tukey’s 
post-hoc test, *p <0.05, **P < 0.01 and ***P < 0.001. 
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Figure 4.8 Knock-out of TRPM2 channels prevents high glucose-induced mitochondrial 
fragmentation in endothelial cells of intact aortas 
Slices of aortas isolated from wild-type (TRPM2 WT) and TRPM2 knock-out (TRPM2 KO) mice 
were stained in situ for mitochondria with MitoTracker Red and fixed with 4% PFA. For high 
glucose, aortas were maintained in 33 mM glucose (HG) containing EGM-2 medium at 37°C for 
3 days. Images of the luminal aspect of the sections were taken. Scale bar, 10 µM. Boxed 
regions are magnified in the lower panels. Scale bar, 5 µm. 
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4.2.7 TRPM2 channels regulate mitochondrial fragmentation through Zn2+ 
ions 
As mentioned in the introduction, activation of TRPM2 channels raises the cytosolic 
levels of both Ca2+ and Zn2+ (Manna et al., 2015; Sumoza-Toledo and Penner, 2011; 
Takahashi et al., 2011). Previous studies have described a role for Ca2+ in mitochondrial 
fragmentation, but little is known about the role, if any, of Zn2+ in mitochondrial 
fragmentation. To examine the role of Zn2+, HUVECs were transfected with pMito-
Cherry and the effect of Zn2+ chelators was tested. The data in Figure 4.9 indicate that 
specific chelation of Zn2+ alone with a low (0.3 µM) concentration of TPEN (N,N,N',N'-
tetrakis (2-pyridinylmethyl)-1,2-ethanediamine) (Manna et al., 2015; Sensi et al., 2009) 
was sufficient to abolish the ability of HG to induce mitochondrial fragmentation. Higher 
concentrations of TPEN were found to be toxic (Ho et al., 2008). The role of TRPM2-
mediated Zn2+ rise on the mitochondria of mouse lung primary endothelial cells was 
next examined. Similar to HUVECs, HG caused extensive mitochondrial fragmentation 
in the primary endothelial cells; TRPM2 inhibition with 2-APB or siRNA as well as Zn2+ 
chelation prevented HG-induced mitochondrial fragmentation (Figure 4.10). These data 
indicate that HG induces endothelial mitochondrial fragmentation by affecting TRPM2-
mediated changes in Zn2+ homeostasis.  
 
For further confirmation of TRPM2-mediated mitochondrial fragmentation through Zn2+ 
ions, HUVECs were exposed to H2O2 in the presence and absence of Zn
2+ chelators 
(0.3 µM TPEN or 2 µM clioquinol). The results (Figure 4.11) show that the effect of H2O2 
on endothelial cells is similar to that of high glucose. 
 
To conclude, Zn2+ represents the molecular link between TRPM2 activation and 
endothelial mitochondrial fragmentation.  
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Figure 4.9 Zn2+ mediates mitochondrial fragmentation in HUVECs 
(A) Zn2+ chelation by TPEN prevents HG-induced mitochondrial fragmentation in HUVECs. 
Cells were transfected with pMito-Cherry and incubated with 5 mM glucose (CTRL) or HG (33 
mM) with and without of 0.3 µM TPEN. Representative confocal images are shown; scale bar, 
10 µm. Boxed regions are magnified in the lower panels. Scale bar, 5 µm. 
(B-C) Form factor (B), aspect ratio (C) calculated from ≥ 70 mitochondria, n =3.  
(D) Percentage of cells showing mitochondrial fragmentation, n/N = 3/130 cells. 
Bars are the means ± SEM, statistical analysis was performed by one-way ANOVA with Tukey’s 
post-hoc test (B-D); *p <0.05, **P < 0.01 and ***P < 0.001. 
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Figure 4.10 Zn2+ chelation prevents high glucose-induced mitochondrial fragmentation in 
primary endothelial cells isolated from lungs of wild-type mice  
Primary endothelial cells isolated from lungs of wild-type mice were treated with mannitol and 
HG as described in Figure 4.6 and incubated for 3 days in the presence and absence of a 
TRPM2 blocker (37.5 µM 2-APB) or a Zn2+ chelator (0.3 µM TPEN) or the cells pre-transfected 
with siRNA-TRPM2. Cells were then stained and fixed as described in Figure 4.7. Scale bar, 10 
µM; representative images are shown, the experiment was performed two times. Boxed regions 
in the merged images are magnified in the bottom panels. Scale bar, 5 µm. 
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Figure 4.11 Zn2+ chelation prevents H2O2-induced mitochondrial fragmentation  
(A) HUVECs were transfected with pMito-Cherry (mitochondrial marker) and incubated with 1 
mM H2O2 for 3 hr at 37°C in the presence and absence of zinc chelators (0.3 µM TPEN or 2 µM 
clioquinol). Representative confocal images are shown. Scale bar, 10 µm. Boxed regions are 
magnified in the lower panels. Scale bar, 5 µm.   
(B-C) Form factor (B), aspect ratio (C) calculated from ≥ 70 mitochondria, n =3.  
(D) Percentage of cells showing mitochondrial fragmentation, n/N = 3/100 cells. 
Bars are the means ± SEM, statistical analysis was performed by one-way ANOVA with Tukey’s 
post-hoc test *p <0.05 and **P < 0.01. 
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4.2.8 Zn2+-induced mitochondrial fragmentation is independent of 
extracellular Zn2+ entry 
The data presented above confirm that TRPM2-induced mitochondrial fragmentation is 
mainly mediated by Zn2+ as chelation of Zn2+ was able to prevent mitochondrial 
fragmentation. The source of this Zn2+ could be extracellular or intracellular. Previous 
studies have reported that activation of plasma membrane TRPM2 channels can induce 
Zn2+ entry (Yu et al., 2012). Therefore, the effect of depletion of extracellular Zn2+ with 
diethylenetriamine pentaacetate (DTPA, a membrane impermeable Zn2+ chelator) 
(Manna et al., 2015) on mitochondrial fragmentation was examined. Cells were exposed 
to H2O2 in the presence and absence of DTPA for 3 hr. The data in Figure 4.12 show 
that DTPA was unable to prevent mitochondrial fragmentation.  
 
Thus extracellular Zn2+ does not contribute to oxidative stress-induced changes in 
mitochondrial morphology.  
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Figure 4.12 H2O2-induced rise in mitochondrial Zn
2+ is not dependent on extracellular Zn2+ 
entry 
HUVECs were exposed for 3 hr at 37C to medium alone (CTRL) or to medium containing 1 mM 
DTPA with and without 1 mM H2O2. Cells were then stained for mitochondria (MitoTracker Red). 
Images show that H2O2 causes an increase in mitochondrial fragmentation. Mitochondrial 
fragmentation was unaffected by DTPA, indicating that extracellular Zn2+ entry does not cause 
mitochondrial fragmentation. Scale bar, 10 µm. n=2. Boxed regions in the images are magnified 
in the far bottom panels. Scale bar, 5 µm. 
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4.2.9 TRPM2 activation induces lysosomal membrane permeabilisation and 
redistribution of lysosomal Zn2+ to mitochondria 
 Lysosomes are the major source of free form of Zn2+ 4.2.9.1
The lack of effect of DTPA on H2O2-induced mitochondrial fragmentation suggests that 
the source of Zn2+ is intracellular. Within the cell, the majority of Zn2+ is normally protein 
bound (Wiseman et al., 2007). However, in some cells, including neuronal cells (Lee et 
al., 2009) and the INS-1 pancreatic β-cell line (Manna et al., 2015), free Zn2+ exists in 
lysosomes. To examine the intracellular distribution of free Zn2+, HUVECs were co-
stained for free Zn2+ and organelles. FluoZin3-AM (green), a Zn2+ specific dye was used 
to stain Zn2+; intracellular compartments were stained with organelle-specific dyes (red): 
LysoTracker Red for lysosomes, MitoTracker Red for mitochondria, and ER-Tracker for 
the ER. The resulting co-localisation data (Figure 4.13) show that under normal 
conditions, free Zn2+ is mainly concentrated in lysosomes compared with the other 
compartments including the cytoplasm.  
 
 
 
 
 
 
122 
 
 
Figure 4.13 Lysosomes are the major site of Zn
2+
 storage  
Fluorescence images of HUVECs co-stained for Zn2+ (FluoZin-3; green) and intracellular 
organelles (red): lysosomes (LysoTracker), mitochondria (MitoTracker) and the ER (ER 
Tracker). Merged images show marked localisation of Zn2+ to lysosomes (yellow), but not to 
mitochondria or the ER. Scale bar, 10 µm. Boxed regions in the merged images are magnified 
in the far right panels. Scale bar, 5 µm.  
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 Oxidative stress-induced LMP depends on TRPM2 activation  4.2.9.2
To examine the role of intracellular organelles in Zn2+ release, HUVECs were loaded 
with FluoZin-3-AM and LysoTracker Red or MitoTracker Red. When HUVECs were 
exposed to HG (33 mM) or H2O2 (1 mM), there was a marked decline in the lysosome-
associated Zn2+ (Figure 4.14A and Figure 4.15A and D). Remarkably, this decline in 
lysosomal Zn2+ was inhibited by siRNA targeted to TRPM2 channels, but not by 
scrambled siRNA (Figure 4.14A and Figure 4.15A). Pharmacological inhibitors (TRPM2 
blockers; 2-APB and PJ-34) showed results similar to those of siRNA-TRPM2 (Figure 
4.15A). The reduction in lysosomal Zn2+ staining was accompanied by a simultaneous 
decrease in LysoTracker staining (Figure 4.14B and Figure 4.15B). This suggests 
potential loss of membrane integrity (i.e., increased lysosomal membrane 
permeabilisation LMP) during oxidative stress. Although previous studies have shown 
increased LMP during oxidative stress (Boya et al., 2003; Boya and Kroemer, 2008; 
Repnik et al., 2014), little is known about the underlying mechanisms. The current 
notion seems to be that oxidative stress causes LMP through direct chemical damage of 
lysosomal membranes (Repnik et al., 2014). Contrary to this notion, evidence presented 
in this chapter suggests that LMP is a regulated process, as lysosomal Zn2+ loss is 
attenuated by TRPM2 inhibition. 
 
To confirm the unexpected role of TRPM2 in LMP, HEK-293-TRPM2tet cells were used. 
In the absence of induction of TRPM2 (Figure 4.16A and B, labelled -TRPM2), these 
cells were resistant to oxidant-induced LMP. However, when induced with tetracycline 
(+TRPM2), H2O2 caused a marked increase in LMP.  
 
To conclude, these data demonstrate that oxidative stress-induced LMP is dependent 
on TRPM2 activation. 
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 Redistribution of lysosomal Zn2+ to mitochondria 4.2.9.3
Figure 4.13 shows that there is little overlap between the FluoZin-3 stain and 
MitoTracker stain. This suggests that under normal conditions, mitochondria do not 
store appreciable amounts of free Zn2+. However, exposure of HUVECs to HG (33 mM) 
or H2O2 (1 mM) stress leads to a significant rise in mitochondrial Zn
2+ as well as an 
increase in mitochondrial fragmentation (Figure 4.14C and Figure 4.15C). Inhibition of 
TRPM2 channels attenuated both HG- and H2O2-induced rise in mitochondrial Zn
2+ 
(Figure 4.14C-D and Figure 4.15C-D). Precisely how HG and H2O2 promote the rise in 
mitochondrial Zn2+ is not known, but one possibility is that Zn2+ released during LMP is 
promptly taken up by the mitochondria.  
 
Taken together, these data reveal two novel findings: Firstly, LMP is not simply due to 
nonspecific oxidative attack on lysosomal membranes, but is regulated by TRPM2 
channels. Secondly, Zn2+ released during LMP is mobilised to mitochondria which, in 
turn, appears to trigger mitochondrial fragmentation.  
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Figure 4.14 High glucose induces Zn2+ redistribution to mitochondria and triggers 
mitochondrial fragmentation  
(A) HG causes a decrease in lysosomal Zn2+ and lysosomal number via activation of TRPM2 
channels. HUVECs were treated as in Figure 4.3A, and incubated for 48 hr. Cells were loaded 
with FluoZin-3-AM and LysoTracker to detect Zn2+ and lysosomes respectively. Representative 
confocal images are shown; scale bar, 10 µm. Boxed regions in the merged images are 
magnified in the far right panels. Scale bar, 5 µm.  
(B) Percent of LysoTracker positive lysosomes per cell, n/N = 3/≥110.  
(C) High glucose increases mitochondrial Zn2+ and fragmentation via TRPM2 channel activation. 
Experiments were performed as in (A) except that MitoTracker staining was used in place of 
LysoTracker.  
(D) Co-localisation of FluoZin-3 stain with MitoTracker; n/N values for various treatments are: 
CTRL, 3/155; Mannitol 3/91; HG, 3/119; scrambled siRNA, 3/108; siRNA-TRPM2, 3/148.  
Bars are the means ± SEM, statistical analysis was performed by one-way ANOVA with Tukey’s 
post-hoc test *p <0.05. 
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Figure 4.15 Activation of TRPM2 channels causes a reduction in lysosomal number and 
redistribution of Zn2+ to mitochondria 
(A) Inhibition of TRPM2 channels attenuates H2O2-induced decrease in the lysosomal number 
and lysosomal Zn2+. Live cell fluorescent images of HUVECs exposed to 1 mM H2O2 (4hr, 37°C) 
with and without the indicated TRPM2 inhibitors or pre-transfected with scrambled siRNA or 
siRNA targeted to TRPM2 channels (siRNA-TRPM2). Cells were stained for Zn2+ and 
lysosomes as described in the legend to Figure 4.14A. Scale bar, 10 µm. Boxed regions in the 
merged images are magnified in the far right panels. Scale bar, 5 µm.  
(B)  Percent LysoTracker positive lysosomes per cell, n/N = 3/≥48. 
(C) Inhibition of TRPM2 channels prevents H2O2-induced increase in mitochondrial Zn
2+. Live 
cell imaging of HUVECs was performed as described in (A) except cells were stained with 
MitoTracker Red, instead of LysoTracker, or labelled with Mito-Cherry. Scale bar, 10 µm. Boxed 
regions in the merged images are magnified in the far right panels. Scale bar, 5 µm. Arrows 
indicate fragmented mitochondria containing Zn2+.  
(D) Percent co-localisation of lysosomal and mitochondrial markers with FluoZin-3-Zn2+ 
following the indicated treatments; n/N values for various treatments are as follows: for 
lysosomes: CTRL, 3/139; H2O2, 3/121; PJ34, 3/48; 2-APB, 3/112; scrambled siRNA, 3/91; 
siRNA-TRPM2, 3/222; and for mitochondria: CTRL, 3/105; H2O2, 3/122; PJ34 = 3/100; 2-APB, 
3/88; scrambled siRNA, 3/127; siRNA-TRPM2, 3/68. 
Bars are the means ± SEM, statistical analysis was performed by one-way ANOVA with Tukey’s 
post-hoc test, *p <0.05, **P < 0.01, and ***P < 0.001. 
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Figure 4.16 H2O2 activation of TRPM2 channels reduce the number of LysoTracker 
positive lysosomes  
(A) LMP is dependent on TRPM2 expression. Not induced (-TRPM2) and induced (+TRPM2) 
HEK-TRPM2tet cells were exposed to SBS alone (CTRL) or SBS with 200 µM H2O2 for 90 min at 
37C. Cells were then loaded with LysoTracker for 30 min, washed and imaged.  
Representative confocal images are shown; also shown are images overlaid with DIC images. 
Scale bar, 10 µm. 
(B) Mean ± SEM  corresponding to (A) show that H2O2 induced a significant reduction in the 
number of lysosomes per cell in TRPM2 expressing cells, but not in cells lacking TRPM2 
expression (n/N =3/≥100 cells), **p <0.01, Student’s t-test. 
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4.2.10 A23187 induces early LMP, but delayed mitochondrial fission  
It has been reported that Ca2+ entry can activate lipases in lysosomes, thereby 
increasing the permeability of the lysosomes (Boya and Kroemer, 2008; Repnik et al., 
2014). The TRPM2 dependence of LMP observed above could therefore be attributed 
to Ca2+ entry via plasma membrane TRPM2 channels. Since TRPM2 activation 
increases cytosolic levels of both Ca2+ and Zn2+, it proved difficult to attribute H2O2-
induced LMP to TRPM-mediated Ca2+ entry alone. To circumvent this, calcium and zinc 
ionophores were used to raise the cytosolic concentrations of Ca2+ and Zn2+. Results 
from Ca2+ imaging (Figure 4.17A-C) show that application of exogenous A23187 
induces a significant rise of [Ca2+]i. Effect of length of A23187 treatment on the integrity 
of lysosomes and mitochondria was examined using LysoTracker Red and MitoTracker 
Red. Results (Figure 4.17D-E) show a significant reduction in the percentage of 
LysoTracker positive lysosomes after 2 hr exposure to A23187, followed by a further 
decrease after 4 hr exposure. This finding is in agreement with previous reports that 
Ca2+ entry increases the permeability of lysosomes (Boya and Kroemer, 2008; Repnik 
et al., 2014). Although in 2 hr, A23187 caused LMP, there was no apparent change in 
mitochondrial morphology.  
 
Mitochondrial fragmentation, however, was seen after 4 hr incubation with A23187.  
This could mean that Ca2+-induced LMP may be required for mitochondrial 
fragmentation. Since LMP releases Zn2+, the ability of Zn2+ chelator, TPEN, to prevent 
Ca2+-induced mitochondrial fission was examined. As predicted, TPEN was able to fully 
prevent the effect of A23187 on mitochondrial fragmentation (Figure 4.16F-G). These 
findings are consistent with the idea that Zn2+ released during LMP triggers 
mitochondrial fragmentation. Conversely, when HUVECs were loaded with Zn2+ using 
Zn-PTO for 2 hr, there was extensive mitochondrial fragmentation that could be rescued 
by TPEN) (Figure 4.17F-G). Taken together, these results indicate that intracellular Ca2+ 
rise induces LMP, resulting in the release of Zn2+, and the Zn2+ thus released causes 
mitochondrial fragmentation.    
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Figure 4.17 A23187 induces early LMP but late Zn2+-dependent mitochondrial 
fragmentation 
(A) Addition of A23187 (shown with a horizontal bar) causes a rise in cytosolic Ca2+.  
(B) Mean ± SEM of change in Ca2+ fluorescence calculated from the data in (A), n = 3.  
(C) Intracellular calcium imaging in HUVECs. Cells were treated for 2 hr at 37°C with medium 
alone (CTRL) or medium containing the calcium ionophore, A23187 (1 µM) plus Fluo-4-AM to 
detect Ca2+. Representative confocal images are shown; scale bar, 10 µm.  
(D) Raising the intracellular Ca2+ concentration induces LMP. HUVECs were treated for 2 hr and 
4 hr at 37°C with medium alone (CTRL) or medium containing the calcium ionophore, A23187 
(1 µM). Cells were then loaded with LysoTracker Red and imaged. Scale bar, 10 µm. Boxed 
regions are magnified in the lower panels. Scale bar, 5 µm.  
(E) Mean ± SEM of percent cells displaying LysoTracker positive lysosomes in CTRL and 
A23187 treated cells, n=3, N≥100 cells. 
(F) Longer incubation with A23187 is required to induce Zn
2+
-dependent mitochondrial fission. 
HUVECs were treated for 2 hr and 4 hr at 37°C with medium alone (CTRL) or medium 
containing the calcium ionophore, A23187 (1 µM) or the zinc ionophore, zinc pyrithione (0.7 µM 
Zn2+: 0.5 µM pyrithione). TPEN (0.3 µM) was included where indicated. Cells were then loaded 
with MitoTracker and imaged. Scale bar, 10 µm. Boxed regions are magnified in the lower 
panels. Scale bar, 5 µm.  
(G) Mean ± SEM of percent cells displaying mitochondrial fragmentation in A23187 treated cells 
and zinc pyrithione treated cells. Cells were treated as in (F), n/N = 3/170 cells. 
Statistical analysis was performed by Students t-test (B) or one-way ANOVA with Tukey’s post-
hoc test (E and G) or; *p <0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001.  
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4.2.11 TRPM2 channels are localised to mitochondria 
 Subcellular organelle fractionation to detect localisation of TRPM2 to 4.2.11.1
mitochondria 
To gain further insight into how TRPM2 channels promote redistribution of Zn2+ from 
lysosomes to mitochondria, subcellular localisation of TRPM2 channels was examined. 
For this, HA epitope-tagged TRPM2 (HA-TRPM2) channels were expressed in HEK-
MSR cells (Figure 4.18A-B). The organelles were fractionated from these cells by 
Optiprep density gradient centrifugation and the individual fractions were examined for 
TRPM2 presence and protein markers of lysosomes (Lamp-1), mitochondria (VDAC-1) 
and ER (calnexin) by western blotting. The results in Figure 4.18C show a band 
corresponding to the size of TRPM2 (~170 KDa) in the fraction positive for the 
lysosomal marker, Lamp-1. This is not surprising given the previous immunostaining 
data on lysosomal expression of TRPM2 channels in other cell types (Lange et al., 
2009; Manna et al., 2015) (see Chapter 3, Figure 3.5). Unexpectedly, the TRPM2 band 
was also observed in fractions positive for the mitochondrial marker protein VDAC-1. In 
fact, intensity of the TRPM2 band in the mitochondrial fractions was much stronger than 
that in the lysosomal fraction (Figure 4.18C). However, mitochondrial preparation was 
not pure as Lamp-1 bands were seen in fractions 7 and 8. This might be due to the 
fusion of lysosomes with mitochondria (Lee et al., 2012).  
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Figure 4.18 TRPM2 channels are present in mitochondria 
(A) Schematic of the topology of TRPM2 subunit showing the site of the hemagglutinin (HA) 
epitope insertion.  
(B) Immunodetection of TRPM2-HA expression in transiently transfected HEK-MSR cells. 
Western blot shows a ~170 KDa band corresponding to TRPM2-HA.  
(C) Western blot analysis of Optiprep density gradient fractions (1-11) of lysates of HEK-MSR 
cells expressing TRPM2-HA. Fractions were blotted for the HA epitope (TRPM2-HA) and 
markers of lysosomes, mitochondria and ER using the indicated antibodies.  
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 TRPM2-HA expression in mitochondria detected by immuno-4.2.11.2
fluorescence technique  
To confirm mitochondrial location, TRPM2-HA was transfected into HUVECs and 
stained with anti-HA antibodies (green) and MitoTracker Red. Merged images and the 
quantification data confirm the presence of TRPM2 channels in mitochondria (yellow in 
Figure 4.19B-C, left column). However, no such staining was observed with the hERG 
potassium channel, also tagged with the HA-epitope in the analogous position (S1-S2 
loop) (Figure 4.19D), indicating that insertion of the HA tag at this position is unlikely to 
cause mis-targeting of TRPM2 to mitochondria. Furthermore, TRPM2 channels tagged 
at the N- (FLAG tag) or the C- (EE tag) terminus with different epitopes showed similar 
mitochondrial localisation (Figure 4.19A-C, middle and right columns). These results 
provide the first demonstration of TRPM2 localisation to mitochondria.  
 
For TRPM2 lysosomal expression, HA-TRPM2 was transfected into HUVECs and 
stained with anti-HA antibodies (green) and anti-CD-63 (lysosomal marker, red) 
antibodies. The merged image shows localisation of TRPM2 to lysosomes, a finding 
that is consistent with previous reports in other cell lines (Lange et al., 2009; Manna et 
al., 2015) (Figure 4.19E). 
 
To conclude, TRPM2 is not only expressed in lysosomes, but also in mitochondria. 
Insertion of an HA tag does not cause mis-targeting of TRPM2 to mitochondria. 
 
 
137 
 
 
138 
 
Figure 4.19 TRPM2-HA immune-co-localisation to mitochondrial and lysosomes 
(A) Schematic of the topology of TRPM2 subunit showing the sites of the EE and FLAG epitope.  
(B) Immunolocalisation of tagged TRPM2 channels to mitochondria. HUVECs were transfected 
with TRPM2 tagged with the HA, FLAG or EE epitopes. Cells were loaded with MitoTracker 
(red), fixed with 2% PFA and permeabilised with 0.25% Triton X-100. Cells were then 
immunostained using antibodies against the epitopes. Representative confocal images are 
shown. Scale bar, 10 µm. Boxed regions in the merged images are magnified in the lower 
panel. Scale bar, 5 µm.  
(C) Mean ± SEM of data from (B) expressed as the percentage of co-localisation of TRPM2-HA 
immunostaining with MitoTracker.  
(D) HA-tagging does not mis-target TRPM2 channels to mitochondria. HEK-MSR cells 
transfected with TRPM2-HA or hERG-HA were stained for the HA-epitope and mitochondria as 
in (B). Representative images show co-localisation of TRPM2-HA, but not of hERG-HA 
channels, with MitoTracker. Scale bar, 10 µM. Boxed regions in the merged images are 
magnified in the lower panels. Scale bar, 5 µm. 
(E) Immunolocalisation of tagged TRPM2 channels to lysosomes. HUVECs were transfected 
with pcDNA3-TRPM2-HA, fixed with 2% PFA, permeabilised with 0.25% Triton X-100. Cells 
were incubated with rat anti-HA (1:500) and mouse anti-CD63 (1:500) sequentially and stained 
with Cy3 anti-rat conjugated secondary antibody (1:500) and AlexaFlour488 anti-mouse (1:500) 
conjugated secondary antibodies. Cells were imaged by confocal microscopy, scale bar, 10 µm. 
Boxed regions are magnified. Scale bar, 5 µm. 
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4.2.12 Mitochondrial TRPM2 channels mediate Zn2+ influx and 
mitochondrial fission 
 Mitochondrial Ca2+ uniporter (MCU) 4.2.12.1
The data presented above suggested that Zn2+ uptake by mitochondria triggers 
mitochondrial fragmentation. Previous studies have reported that the mitochondrial Ca2+ 
uniporter (MCU), which is located in the organelle’s inner membrane, mediates 
mitochondrial Zn2+ uptake (Kirichok et al., 2004; Malaiyandi et al., 2005). The role of 
MCU in H2O2-induced Zn
2+ uptake by mitochondria and mitochondrial fragmentation 
was examined using an MCU blocker and HEK-MSR cells transfected with TRPM2-HA.  
HEK-293 cells are known to express MCU natively (Madesh et al., 2013). Figure 4.20 
shows that H2O2 leads to uptake of Zn
2+ by mitochondria and mitochondrial 
fragmentation in HEK-MSR-TRPM2-HA cells. However, inhibition of MCU with 
ruthenium red (RuR) failed to inhibit H2O2-induced increase in mitochondrial Zn
2+ and 
fragmentation, thus excluding a role for the uniporter in oxidative stress-induced 
mitochondrial Zn2+ influx. These data therefore suggest that there is another transporter 
or an ion channel to mediate mitochondrial Zn2+ uptake. 
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Figure 4.20 H2O2-induced rise in mitochondrial Zn
2+ is Ca2+ uniporter-independent 
HEK-MSR cells expressing TRPM2-HA were not treated (CTRL) or treated with 300 µM H2O2 
for 3 hr in the absence or presence of 5 µM ruthenium red (RuR). Cells were then stained for 
Zn2+ (FluoZin-3) and mitochondria (Mito-Cherry). Merged confocal images show that H2O2 
caused an increase in mitochondrial Zn2+ (yellow puncta, shown with arrows) that was 
unaffected by the Ca2+ uniporter blocker, RuR. The images also show that RuR failed to prevent 
mitochondrial fragmentation. Scale bar, 10 µm. Boxed regions in the merged images are 
magnified in the far right panels. Scale bar, 5 µm. Representative images are shown; the 
experiment was performed three times. 
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 TRPM2 channels mediate mitochondrial Zn2+ uptake  4.2.12.2
Since TRPM2 channels are located in mitochondria (Figure 4.18 and Figure 4.19) and 
TRPM2 channels are known to conduct Zn2+ (Yu et al., 2012), the possibility that 
TRPM2 channels could contribute to mitochondrial Zn2+ uptake during oxidative stress 
was investigated. For this, the cytoplasmic levels of free Zn2+ were raised in HUVECs 
using Zn-PTO, and changes in mitochondrial Zn2+ were examined. In this experiment, 
H2O2 was not included to activate TRPM2 channels because Zn-PTO, as has been 
shown previously (Clausen et al., 2013), and as was confirmed here (Figure 4.21C), can 
potently induce oxidative stress required to activate TRPM2 channels. The results show 
that Zn-PTO indeed induced Zn2+ accumulation in the mitochondria (Figure 4.21A), and 
the expected mitochondrial fragmentation (rescued by TPEN as in Figure 4.17F). 
Importantly, these effects of Zn-PTO were completely blocked by siRNA targeted to 
TRPM2 channels and by the anti-oxidant, N-acetyl cysteine (NAC) (Figure 4.21A-B). 
Absence of Zn2+ in TRPM2-depleted cells suggests that under this experimental 
condition, Zn-PTO does did not reach the mitochondria to raise mitochondrial Zn2+. 
Thus these data suggest that TRPM2 channels mediate mitochondrial Zn2+ entry and 
fragmentation.  
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Figure 4.21 Mitochondrial TRPM2 channels are essential for mitochondrial Zn2+ uptake 
and fragmentation 
(A) Fluorescent images of HUVECs treated for 2 hr with Zn-PTO (0.7 µM Zn2+: 0.5 µM 
pyrithione) in the absence or presence of TPEN (0.3 μM TPEN) or N-acetyl cysteine (NAC, 10 
mM), or transfected with scrambled or TRPM2-siRNA. Cells were stained for Zn2+ (green) and 
mitochondria (red). Scale bar, 10 µm. Boxed regions in the merged images are magnified in the 
lower panels. Scale bar, 5 µm; arrows indicate localisation of free Zn2+ in mitochondria.  
(B) Mean ± SEM of data from (A) expressed as percentage of cells displaying mitochondrial 
fragmentation, n/N =3/100.  
(C) Zn-PTO increases ROS production. HUVECs were treated as in (A) and ROS production 
measured using the H2DCFDA reporter, n/N = 3/100.  
Statistical analysis in B and C was performed by one-way ANOVA with Tukey’s post-hoc test, *p 
<0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001.  
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 Zn2+ uptake by isolated mitochondria 4.2.12.3
Direct Zn2+ uptake by mitochondria isolated from HEK-293 cells overexpressing TRPM2 
channels was examined in the presence and absence of H2O2 (TRPM2 activation). For 
this, mitochondria were isolated from HEK-TRPM2Tet cells, loaded with FluoZin-3-AM 
and placed in a glass bottom dish; increase in fluorescence in response to Zn2+ addition 
was then recorded by confocal microscopy (Malaiyandi et al., 2005). The results show 
that under control conditions, exogenous Zn2+ addition caused a significant increase 
(~0.3-fold) in Zn2+ fluorescence. However, H2O2 stimulus caused a further increase in 
the fluorescence (to ~0.8-fold) (Figure 4.22A-C), which could be attributed to TRPM2 
mediated Zn2+ uptake. Further evidence using TRPM2 inhibitors and TRPM2-/- cells is 
required to confirm the role of TRPM2 channels in mitochondrial Zn2+ uptake.  
 
Figure 4.22 Zn2+ uptake by mitochondria isolated from HEK-293 cells overexpressing 
TRPM2 channels 
(A-B) Mitochondria isolated from tetracycline-induced HEK-TRPM2tet cells were loaded with 
FluoZin-3 for 20 min at 37°C. Confocal images were taken before (CTRL) and 15 min after 
addition of 30 µM ZnCl2 alone or 30 µM ZnCl2 plus 200 µM H2O2. Scale bar, 10 µm.  
(C) Mean ± SEM of data from (A) and (B) expressed as fluorescence (FluoZin3-Zn) intensity of 
the imaged fields, n= 3. Statistical analysis was performed by Student’s t-test, *p <0.05 and **p 
<0.01.  
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4.2.13 TRPM2-dependent rise in mitochondrial Zn2+ promotes Drp1 
recruitment 
Previous studies have shown that mitochondrial fragmentation is initiated by the 
recruitment of Drp1, a GTPase that catalyses mitochondrial fragmentation (Archer, 
2013; Friedman and Nunnari, 2014; Slupe et al., 2013; Youle and van der Bliek, 2012). 
It was hypothesised that TRPM2-dependent mitochondrial Zn2+ uptake induces Drp1 
recruitment. To test this, HUVECs were transfected with Drp1-GFP and the recruitment 
of Drp1-GFP from the cytoplasm to mitochondria was examined. The results 
demonstrate that HG, but not mannitol, promoted Drp1 mitochondrial recruitment, as 
measured by the co-localisation of MitoTracker Red fluorescence with Drp1-GFP 
(Figure 4.23A-B). HG-induced Drp1-GFP recruitment was suppressed by siRNA 
targeted to TRPM2 channels, but not by the scrambled siRNA. Under these conditions, 
HG treatment failed to induce recruitment of the dominant negative Drp1-GFP (Figure 
4.23A-B). These data support a role for TRPM2 channels in Drp1 recruitment. Whether 
Zn2+ contributes to Drp1 recruitment was next investigated. Chelation of Zn2+ with TPEN 
markedly inhibited HG-induced Drp1-GFP recruitment (Figure 4.23A-B). Furthermore, 
delivery of Zn2+ via pyrithione stimulated mitochondrial recruitment of Drp1-GFP, but not 
its dominant negative version (Figure 4.23C-D).  
 
Similar results were obtained when siRNA directed to a different region of the gene, 
siRNA-2, was used to suppress TRPM2 expression. Figure 4.24 A-C shows that siRNA-
2-TRPM2 completely suppressed Drp1-GFP recruitment in HUVECs. Finally, silencing 
of TRPM2 expression also prevented H2O2 (direct oxidative stress) induced Drp1-GFP 
recruitment to mitochondria (Figure 4.25). 
 
Taken together, the data indicate that TRPM2-mediated rise in mitochondrial Zn2+ 
promotes Drp1 recruitment and subsequent mitochondrial fragmentation.  
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Figure 4.23 High glucose-induced Drp1 recruitment is mediated by TRPM2 channels and 
Zn2+ 
(A) Drp1-GFP recruitment to mitochondria is TRPM2 dependent. HUVECs transfected with 
Drp1-GFP or dominant negative (DN)-Drp1-GFP were treated as in Figure 4.12. Confocal 
images show cells stained with MitoTracker red. Scale bar, 10 µm. Boxed regions in the merged 
images are magnified in the bottom panels. Scale bar, 5 µm.  
(B) Mean ± SEM of percentage co-localisation of GFP with MitoTracker calculated from the data 
in (A), n = 3.  
(C) Zn2+ induces Drp1-GFP recruitment to mitochondria. HUVECs transfected with Drp1-GFP or 
DN-Drp1-GFP were treated with Zn-PTO as in Figure 4.21A for 1 hr and stained for 
mitochondria. Representative confocal images are shown. Scale bar, 10 µm. Boxed regions in 
the merged images are magnified in the right panels.  
(D) Mean ± SEM of percentage co-localisation of GFP with MitoTracker Red calculated from the 
data in (C), n = 3. Statistical analysis was performed by one-way ANOVA with Tukey’s post-hoc 
test, *p <0.05, **p <0.01 and ***P < 0.001.  
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Figure 4.24 High glucose-induced Drp1 recruitment is mediated by TRPM2 channels  
(A) Demonstration of silencing of TRPM2 mRNA expression by RNAi. 1: PCR product from 
TRPM2 plasmid. Lanes 2-3: RT-PCR products from mRNA isolated from HUVECs transfected 
with scrambled (negative control) siRNA (lane 2) or siRNA-2 targeted to TRPM2 (lanes 3). 
(B) HUVECs were transfected with Drp1-GFP alone or together with scrambled siRNA or 
siRNA-2 targeted to TRPM2, as indicated. Cells were exposed to EGM-2 without (CTRL) or with 
additional glucose (HG, 33 mM, shown with a vertical bar) for 24 hr, before staining with 
MitoTracker Red. Representative merged (GFP and MitoTracker Red) images are shown. Scale 
bar, 10 µm. Boxed regions in the merged images are magnified in the right panels. Scale bar, 5 
µm. Arrows show recruitment of Drp1 to mitochondria (yellow). 
(C) Mean ± SEM of percentage co-localisation of GFP with MitoTracker calculated from the data 
in (B), n = 3. Statistical analysis was performed by one-way ANOVA with Tukey’s post-hoc test, 
*p <0.05 and **p <0.01.  
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Figure 4.25 H2O2-induced Drp1 recruitment is mediated by TRPM2 channels 
HUVECs were transfected with Drp1-GFP alone or together with siRNA-targeted to TRPM2, as 
indicated. Cells were exposed to EGM-2 alone (CTRL) or EGM-2 with 1 mM H2O2 for 2 hr, 
before staining with MitoTracker Red. Representative merged (GFP and MitoTracker Red) 
images are shown. Scale bar, 10 µm. Boxed regions in the merged images are magnified in the 
bottom panels. Scale bar, 5 µm. Arrows show recruitment of Drp1 to mitochondria (yellow).  
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 Discussion 4.3
Emerging evidence suggests that increased mitochondrial fragmentation is a common 
defect in the majority of late age-onset diseases (Archer, 2013; Dorn, 2015). Oxidative 
stress, which increases as age increases, is an important trigger of mitochondrial 
fragmentation, but the underlying signalling mechanism is largely unknown. In this 
chapter, a key role for TRPM2 channels and mobilisation of mitotoxic free Zn2+ from 
lysosomes to mitochondria in mitochondrial fragmentation was demonstrated. The key 
findings are as follows: (i) oxidative stress-induced mitochondrial fragmentation is 
mediated by TRPM2 channels; (ii) knock-out of TRPM2 channels prevents high 
glucose-induced mitochondrial fragmentation in mouse pulmonary endothelial cells; (iii) 
chelation of Zn2+ alone was sufficient to prevent TRPM2-mediated mitochondrial 
fragmentation; (iv) TRPM2 activation induces lysosomal membrane permeabilisation 
and redistribution of lysosomal Zn2+ to mitochondria; (v) TRPM2 channels are localised 
to mitochondria where they mediate Zn2+ influx and mitochondrial fission; and (vi) 
TRPM2-dependent rise in mitochondrial Zn2+ promotes Drp1 recruitment. These 
findings have important implications for health, because mitochondrial fragmentation is 
associated with several age-related chronic illnesses including neuronal (Alzheimer’s, 
Parkinson’s), cardiovascular (atherosclerosis, myocardial infarction) and 
metabolic/inflammatory (diabetes) disorders. These results identify TRPM2 channel as 
a novel target that could be explored for therapeutic intervention of age-related 
illnesses.   
   
In the current chapter, HUVECs were subjected to high glucose- and H2O2-induced 
oxidative stress, and their effects on mitochondrial dynamics were examined. Using 
pharmacological agents, RNA interference, and TRPM2 knock-out mice, it was 
demonstrated that the ROS-sensitive TRPM2 channel mediates HG- and H2O2-induced 
mitochondrial fragmentation (Figure 4.3, Figure 4.4, Figure 4.5, Figure 4.6 and Figure 
4.7). It is known that activation of TRPM2 channels raises the cytoplasmic levels of Ca2+ 
and Zn2+ (Manna et al., 2015; Sumoza-Toledo and Penner, 2011; Takahashi et al., 
2011). Although Ca2+ is the most widely used signalling ion, also implicated in 
mitochondrial dynamics (Cereghetti et al., 2008; Han et al., 2008; Slupe et al., 2013; 
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Szabadkai et al., 2006), it was found that chelation of Zn2+ alone was sufficient to 
prevent mitochondrial fragmentation (Figure 4.8, Figure 4.9 and Figure 4.10). Although 
the data obtained from HUVECs were sufficient to generate statistically significant 
results, there were not enough cells (≤ 20 cells) to perform significance tests on the 
primary cell data. Furthermore, the mitochondrial network in isolated primary cells is not 
as distinct as the cell lines to allow meaningful analysis of mitochondrial fragmentation.   
 
Next, the question of where the Zn2+ signal was generated from, and how it was 
transmitted to mitochondria, was investigated. Data showed that the Zn2+ signal 
originates in lysosomes, and that oxidative stress causes a marked decrease in 
lysosomal Zn2+ (Figure 4.11, Figure 4.12 and Figure 4.13) with a concomitant rise in 
mitochondrial Zn2+ (Figure 4.12 and Figure 4.13).  
 
Furthermore, chemical inhibition and RNAi silencing of TRPM2 channels prevented the 
mobilisation of lysosomal Zn2+ to mitochondria (Figure 4.12 and Figure 4.13) as well as 
mitochondrial fission. Taken together, these findings suggest that mobilisation of 
lysosomal Zn2+ to mitochondria may contribute to mitochondrial fission. Although inter-
organelle Ca2+ redistribution, mediated by channels, transporters and pumps, have 
been described in the Ca2+ signalling field (Clapham, 2007), such dynamics are not 
known for Zn2+. FluoZin-3 was used in these experiments as a Zn2+ reporter to 
determine the Zn2+ signal. It has demonstrated that FluoZin-3 failed to detect any 
fluorescence if the Ca2+ level is ≤ 10 mM (Gee et al., 2002). The estimated 
concentration of lysosomal Ca2+ is less than 1 mM (Xu and Ren, 2015). Thus, the 
fluorescence detected by FluoZin-3 is most likely from Zn2+, but not Ca2+. Thus the 
findings presented in this chapter reveal an intriguing role for inter-organelle Zn2+ 
dynamics (regulated by TRPM2 channels) in mitochondrial dynamics.  
 
The decrease in lysosomal Zn2+ was accompanied by a decrease in LysoTracker 
staining (Figure 4.12 and Figure 4.13). LysoTracker uptake by lysosomes depends on 
the low pH of this organelle or its integrity. Thus an increase in pH or lysosomal 
membrane permeabilisation (LMP) can account for the decrease in oxidative stress 
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induced decrease in LysoTracker staining. As will be shown in the next Chapter (Figure 
5.4), oxidative stress also causes release of cathepsin B into the cytoplasm, which is a 
biochemical indicator of LMP (Boya et al., 2003; Boya and Kroemer, 2008; Repnik et al., 
2014), the underlying mechanisms are not clear. It has long been assumed that LMP is 
a result of nonspecific attack of oxidants on the lipids of lysosomal membranes. 
However, recent studies (Boya and Kroemer, 2008; Repnik et al., 2014) suggest that 
oxidants can activate phospholipase A2, leading to the hydrolysis of lysosomal 
membrane lipids and LMP (Zhao et al., 2001). Importantly, these lipases are activated 
by the cytosolic entry of extracellular Ca2+ (Boya and Kroemer, 2008). Given the finding 
from the current chapter that inhibition of TRPM2 channels attenuates LMP, it seemed 
reasonable to speculate that Ca2+ entry through the plasma membrane TRPM2 
channels promotes LMP. Consistent with this idea, data from elevation of cytosolic 
levels of free Ca2+ (using ionophores, A23187) induced LMP after 2 hr, while 
mitochondrial fragmentation was induced after 4 hr (Figure 4.15). However, Zn2+ 
chelation was sufficient to prevent Ca2+-induced mitochondrial fragmentation. 
Furthermore, direct elevation of cytosolic levels of free Zn2+ (using pyrithione) was 
enough to induce mitochondrial fragmentation within 2 hr (Figure 4.16). These findings 
led to the fundamentally important conclusion that ROS-induced mitochondrial 
fragmentation is regulated by TRPM2-mediated Zn2+ signalling but not Ca2+ signalling. 
Moreover, this finding also identified a regulatory role for TRPM2 channels in oxidant-
induced LMP.  
 
LMP causes release of lysosomal contents, including Zn2+, into cytoplasm. Although 
previous studies have reported that mitochondrial Ca2+ uniporter mediates entry of 
cytosolic Zn2+ into mitochondria (Malaiyandi et al., 2005), its inhibition with ruthenium 
red failed to prevent H2O2-induced mitochondrial fragmentation (Figure 4.20). Given that 
mitochondrial Zn2+ rise is TRPM2 dependent, the possibility that TRPM2 channels might 
be localised to mitochondria was examined. Evidence from biochemical 
immunocytochemical and functional studies (Figure 4.18, Figure 4.19 and Figure 4.22) 
supports TRPM2 expression in mitochondria. Remarkably, in the absence of TRPM2 
expression, oxidant-induced mitochondrial Zn2+ influx, as well as mitochondrial 
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fragmentation, were completely abolished (Figure 4.21). Taken together, the data 
suggest that Zn2+ released during LMP could enter mitochondria via mitochondrial 
TRPM2 channels. 
 
How TRPM2-mediated Zn2+ entry regulates mitochondrial fragmentation was next 
investigated. Previous studies have shown that oxidative stress causes mitochondrial 
membrane depolarisation and that depolarisation drives mitochondrial fission by 
inducing cytoplasmic Drp1 recruitment to mitochondria (Archer, 2013; Cereghetti et al., 
2008; Friedman and Nunnari, 2014; Slupe et al., 2013; Youle and van der Bliek, 2012). 
It is also known that excess Zn2+ causes mitochondrial depolarisation by inhibiting the 
electron transport chain (Sensi et al., 2009). These previous studies led to posit that 
TRPM2-mediated mitochondrial Zn2+ entry promotes Drp1 recruitment. Consistent with 
this speculation, in the absence of TRPM2-mediated rise in mitochondrial Zn2+, 
oxidative stress failed to induce Drp-1 recruitment (Figure 4.23, Figure 4.24 and Figure 
4.25). Previous studies have shown that excess mitochondrial fission is associated with 
mitochondrial membrane permeabilisation (MMP) and cell death (Suen et al., 2008), 
which will be investigated in the next chapter (chapter 5). Thus the finding that TRPM2-
mediated rise in mitochondrial Zn2+ promotes Drp1 recruitment and therefore 
mitochondrial fission represents an important signalling mechanism underlying oxidative 
stress-induced apoptosis.   
 
In summary, the discovery of a signalling role for TRPM2 channels and inter-organelle 
Zn2+ dynamics in mitochondrial fragmentation (Figure 4.26) provides important insights 
and new treatment avenues for a large group of late age-onset diseases 
(neurodegenerative diseases, cardiovascular disease, diabetes and cancer) because 
aging is associated with an increase in oxidative stress and mitochondrial 
fragmentation.  
  
153 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.26 Schematic illustrating the role of TRPM2 channels and inter-organelle Zn2+ 
dynamics in oxidative stress-induced mitochondrial fragmentation  
High glucose-induced rise in intracellular ROS leads to activation of plasma membrane TRPM2 
channels and Ca2+ influx. The resultant rise in intracellular Ca2+ triggers lysosomal 
permeabilisation and Zn2+ release. Zn2+ thus released enters mitochondria via TRPM2 channels 
to induce recruitment of cytoplasmic Drp1, thereby increasing mitochondrial fragmentation. 
Genetic/chemical manipulations used to elucidate the mechanism are indicated. Similar results 
were obtained when exogenous oxidative stress (H2O2) was used as TRPM2 activator.   
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 Preliminary data to be confirmed in the future 4.4
4.4.1 ROS-induced mitophagy is TRPM2 dependent 
ROS are known to induce mitophagy (Scherz-Shouval and Elazar, 2007), where 
damaged and dysfunctional mitochondria are removed by lysosomes and eventually 
degraded (Scherz-Shouval and Elazar, 2007; Scherz-Shouval and Elazar, 2011; Youle 
and Narendra, 2011). This process is crucial to protect the cell from oxidative stress and 
to prevent cell death (Scherz-Shouval and Elazar, 2007). The potential role of TRPM2 
channels in oxidative stress-induced mitophagy was examined. HUVECs were co-
transfected with LAMP-1-GFP (lysosomal marker, green) and Mito-Cherry 
(mitochondrial marker, red) and exposed to H2O2 in the presence and absence of 
TRPM2 blockers. Parallel studies were also performed where HUVECs were 
transfected with control or TRPM2-directed siRNA. The results show that H2O2 not only 
causes mitochondrial fragmentation, but also leads to mitophagy; the latter is evident 
from the presence of mitochondria (Mito-Cherry labelled) in the lysosomes (LAMP-1-
GFP labelled). TRPM2 blockers, in addition to silencing TRPM2-siRNA, prevented 
mitochondrial fragmentation and mitophagy (Figure 4.28). These data suggest that 
TRPM2 channels mediate ROS-induced mitophagy. However, these data are from 
preliminary experiments (performed twice) that need to be repeated using 
complementary biochemical studies.   
 
To conclude, TRPM2 activation channels not only play a role in mitochondrial 
fragmentation but also in mitophagy.  
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Figure 4.27 H2O2-induced mitophagy is prevented by inhibition of TRPM2 channels 
HUVECs were co-transfected with Lamp-1-GFP and pMito-Cherry and incubated with 1 mM 
H2O2 for 3h at 37°C in the presence and absence of TRPM2 blockers (10 μM PJ-34 or 150 μM 
2-APB). Alternatively, cells were pre-transfected with siRNA targeted to TRPM2 channels. 
Representative confocal images are shown. Scale bar, 10 µm. Boxed regions are magnified in 
the right panels. Scale bar, 5 µm.   
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 │TRPM2-mediated, Ca2+-potentiated Zn2+ release causes 5
mitochondrial ROS amplification and endothelial cell 
apoptosis 
 Introduction 5.1
Reactive oxygen species (ROS) such as superoxide (O2
•−) and hydrogen peroxide 
(H2O2) play important roles in the normal physiology and patho-physiology of most 
organisms (Bedard and Krause, 2007; Li and Shah, 2004; Sena and Chandel, 2012; 
Trachootham et al., 2008). At low levels, they play beneficial roles by mediating cell 
signalling and survival (Trachootham et al., 2008), but at chronic high levels, they can 
cause cellular damage (D'Autreaux and Toledano, 2007; Sena and Chandel, 2012). 
Chronic elevation of ROS is associated with the pathogenesis of most age-related 
illnesses, including neuronal (Alzheimer’s, Parkinson’s) (Trushina and McMurray, 2007), 
cardiovascular (atherosclerosis, myocardial infarction) (Li and Shah, 2004; Lum and 
Roebuck, 2001) and metabolic/inflammatory (diabetes and hypertension) disorders 
(Giacco and Brownlee, 2010). A common feature of many of these illnesses is ROS-
induced increase in cell death (Li and Shah, 2004). Prevention of excessive ROS 
production could therefore be regarded as a potential strategy to increase the healthy 
lifespan of organisms (Balaban et al., 2005; Giorgio et al., 2007). 
 
There are many cellular mechanisms that contribute to vascular endothelial 
mitochondrial ROS generation, including NAD(P)H oxidase, xanthine oxidase, 
uncoupled endothelial nitric oxide (NO) synthase (eNOS) and mitochondrial electron 
leakage (Du et al., 1999; Finkel and Holbrook, 2000; Griendling, 2005; Li and Shah, 
2004). However, the mitochondrial electron transport chain is the site of ROS 
generation in the most mammalian cells (Li and Shah, 2004). Electron transport chain 
consists of four protein complexes located in the inner mitochondrial membrane: 
complex I, complex II, complex III and complex IV. Superoxide (O2
•−) is generated by 
complex I and complex III (Finkel and Holbrook, 2000). It diffuses into the matrix of the 
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mitochondria and into the intermembrane space, while some superoxide escapes to the 
cytosol via voltage-dependent mitochondrial anion channel (VADC) (Raha and 
Robinson, 2000). Superoxide is converted to hydrogen peroxide (H2O2) by   superoxide 
dismutase (SOD), which is subsequently detoxified to water (H2O) by glutathione 
peroxidase (GPX) (Raha and Robinson, 2000). Recently, mitochondrial ROS generation 
has received more consideration as a potential key regulator for many diseases 
(Chouchani et al., 2014; Lin and Beal, 2006; Newsholme et al., 2007; Zhang and 
Gutterman, 2007).   
 
ROS-induced apoptotic cell death is complex, involving several intracellular organelles 
(Du et al., 1999; Ferri and Kroemer, 2001). In the ER, ROS cause misfolding of proteins 
and induce the unfolded protein response (Haynes et al., 2004). In the nucleus, ROS 
induce cumulative damage to nuclear DNA (Kim et al., 2005; Yu et al., 2002). In the 
mitochondria, ROS induce depolarisation of membrane potential (ψm), breakdown of the 
mitochondrial network and mitochondrial membrane permeabilisation (MMP) (Boya et 
al., 2003; Ferri and Kroemer, 2001; Suen et al., 2008). MMP results in the release of 
apoptotic factors including cytochrome c into the cytoplasm (Boya et al., 2003; Suen et 
al., 2008; Wang, 2001). ROS also act on lysosomes, causing lysosomal membrane 
permeabilisation (LMP) and release of pro-apoptotic cathepsins (Boya et al., 2003; Ferri 
and Kroemer, 2001). Although some of these events are thought to cause cell death 
independently, there appears to be cross-talk between different organelles during ROS-
induced apoptosis. For example, DNA damage leads to chronic activation of the DNA 
repair enzyme poly-ADP ribose polymerase (PARP). PARP transfers ADP-ribose 
moieties from NAD+ to damaged proteins that are subsequently released by PARG (Kim 
et al., 2005). ADP-ribose triggers cell death by activating the mitochondria-mediated 
pathway. Similarly, cathepsins released during LMP can activate the t-bid protein that 
induces MMP and release of apoptotic factors (Kroemer et al., 2007). Thus molecular 
signals generated in the nucleus and lysosomes appear to cause cell death by acting on 
mitochondria.   
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In this chapter, I hypothesised that TRPM2 channels play a role in ROS-induced cell 
death by increasing LMP and MMP. To address this aim, human umbilical vein 
endothelial cells (HUVECs) were exposed to H2O2 or high concentration of glucose 
(diabetic conditions) as it has been shown previously that high glucose leads to 
apoptotic cell death by increasing cellular levels of ROS (Du et al., 1998). The role of 
TRPM2 channels in H2O2- and glucose-induced cell death was examined using 
pharmacological and RNAi approaches. TRPM2 channels generate signals, Ca2+ and 
Zn2+, both of which are associated with cell death (Manna et al., 2015; Ye et al., 2014). 
Therefore, this chapter also examined the role of Ca2+ and Zn2+ signals in the induction 
of endothelial cell death.  
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 Results 5.2
5.2.1 TRPM2-mediated, Ca2+-potentiated Zn2+ release causes endothelial 
cell apoptosis 
It has been well established that H2O2 activation of TRPM2 channels causes death of 
many cell types (Sumoza-Toledo and Penner, 2011; Takahashi et al., 2011). This has 
been attributed to a rise in cytosolic Ca2+ (Hara et al., 2002; Perraud et al., 2001; 
Sumoza-Toledo and Penner, 2011; Takahashi et al., 2011) as well as Zn2+ (Manna et 
al., 2015; Ye et al., 2014). Thus the role of TRPM2 channels and the two ions were 
examined in endothelial cell death using a cell death assay based on Hoechst 33342 
and propidium iodide (PI) staining (Manna et al., 2015); Hoechst 33342 stains all cells 
(blue), whereas PI stains dead cells (red), allowing determination of percent cell death. 
 
Figure 5.1A-B shows that H2O2 (1 mM; 6 hr) treatment causes a marked increase in cell 
death. Silencing of TRPM2 channels with siRNA, or inhibition with 150 µM 2-APB, or 
chelation of Zn2+ with 0.3 µM TPEN and 2 µM clioquinol, or chelation of Ca2+ with 2.5 
µM BAPTA-AM and 2 mM EGTA, reduced endothelial cell death significantly. This 
finding indicates that H2O2-induced extracellular Ca
2+ entry plays a significant role in 
oxidant-induced cell death. This finding is indeed in agreement with the numerous 
reports that TRPM2-mediated Ca2+ entry promotes cell death (Sumoza-Toledo and 
Penner, 2011; Takahashi et al., 2011). However, it does not explain the finding that 
chelation of Zn2+ alone can inhibit cell death. These findings led to the speculation that 
TRPM2-mediated Ca2+ entry augments Zn2+ release.  
 
To test this, H2O2-induced Zn
2+ release was examined by loading HUVECs with 
FluoZin3-AM and measuring the increase in fluorescence (due to rise in free Zn2+ 
levels) with FlexStation II. The results show that in the absence of extracellular Ca2+, 
H2O2 caused a small but significant increase in Zn
2+ release (Figure 5.1C-D). However, 
this increase was markedly enhanced by extracellular Ca2+ (Figure 5.1E-F), supporting 
the idea that Ca2+ entry augments Zn2+ release.  
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Cell death can occur by apoptosis or necrosis (van Engeland et al., 1998; Vanden 
Berghe et al., 2010). Images in Figure 5.1A suggest that cell death occurred 
predominantly by apoptosis. H2O2 caused marked changes to nuclear morphology and 
plasma membrane integrity. Compared with the normal nuclear morphology in control 
cells, cells treated with H2O2 showed significant nuclear fragmentation, which is a 
hallmark of apoptosis. Besides nuclear fragmentation, some cells showed loss of 
plasma membrane integrity, which is reflected by the fact that nuclei of these cells were 
stained with PI. Such phenotype indicates secondary necrosis, which follows apoptosis. 
A few others showed normal-looking nuclei, but stained red, indicating potential 
necrosis. To differentiate between various forms of cell death, cells were co-stained with 
PI and FITC-labeled annexin V (Figure 5.2); the latter binds phosphatidylserine exposed 
to the outer leaflet of the phospholipid bilayer and reports apoptosis (van Engeland et 
al., 1998). The results (Figure 5.2) confirm that cell death during the H2O2 treatment 
occurred predominantly by apoptosis as evident from annexin V staining. Again, both 
TRPM2 inhibitors (PJ34 and 2-APB) and the Zn2+ chelator, TPEN, prevented H2O2-
induced apoptotic cell death. Collectively, these findings led to the conclusion that Ca2+-
potentiated Zn2+ release contributes to cell death (apoptosis). 
 
In diabetes, endothelial cells are exposed to high glucose conditions. Studies have 
shown that high glucose has a number of deleterious effects on endothelial cells and 
that these are largely mediated by an increase in ROS production (Du et al., 1998).  
Given that H2O2 is a ROS, it is reasonable to speculate that the effects of high glucose 
would be similar to those of H2O2. To test this, HUVECs were exposed to normal (5 
mM) and high (33 mM) glucose (HG) media or to a medium containing 5 mM glucose 
and 28 mM mannitol (to exclude any effects from osmotic changes). The results show 
that HG causes a significant increase in endothelial cell death. Furthermore, these 
effects were fully rescued by TRPM2 inhibition with 2-APB, PJ34 and siRNA targeted to 
TRPM2, as well as by Zn2+ chelation with TPEN (Figure 5.3A-B). 
 
Taken together these data indicate that high glucose causes endothelial cell death 
through TRPM2-mediated changes in Zn2+ homeostasis. Whilst Ca2+ does contribute to 
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cell death, the data presented here suggest that its action is perhaps not direct. By 
augmenting the release of Zn2+, extracellular Ca2+ entry appears to drive cell death. 
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Figure 5.1 Extracellular Ca2+ entry augments H2O2-induced Zn
2+ release and endothelial 
cell death 
(A) H2O2-induced cell death is dependent on TRPM2 activation, Zn
2+ and Ca2+ entry. HUVECs 
were exposed to medium alone (CTRL) or to medium with1 mM H2O2 for 6 hr at 37°C in the 
presence of TRPM2 inhibitors or metal ion chelators (Zn2+ chelators: 0.3 µM TPEN or 2 µM 
clioquinol;  Ca2+ chelators: 2.5 µM BAPTA-AM or 2 mM EGTA). Where indicated cells were 
transfected with scrambled siRNA or siRNA-TRPM2 prior to exposure to H2O2. Cells were 
stained with Hoechst 33342 (blue) and propidium iodide (PI) (red) to detect total number of cells 
and dead cells respectively. Images were captured with an epifluorescent microscope (EVOS). 
Scale bar, 10 µm. 
(B) Mean ± SEM of percent cell death following the indicated treatments as in (A), n = 3. 
Number of cells scored ≥ 170 cells.   
Statistical analysis was performed by one-way ANOVA with Tukey’s post-hoc test, *p <0.05, **P 
< 0.01, and ***P < 0.001, and ****P < 0.0001.  
(C) H2O2-induced Zn
2+ release from HUVECs. HUVECs, loaded with FluoZin-3-AM, were 
exposed to 3 mM H2O2 (time over which H2O2 was applied is indicated by the horizontal bar) 
and Zn2+ fluorescence (530 nm) was recorded using FlexStation II (Molecular Devices). The 
recording solution was Ca2+-free SBS. Symbols represent mean values and errors bars 
represent SEM. 
(D)  Mean ± SEM of change in Zn2+ fluorescence calculated from the data in (C), n = 3. 
(E) Experiment was performed as in (C) except that the recording solution contained 1.5 mM 
Ca2+.  
(F) Mean ± SEM of change in Zn2+ fluorescence calculated from the data in (E), n = 3.  
Statistical analyses (D and F) were performed by Student’s t-test, *p <0.05. 
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Figure 5.2 H2O2 causes apoptotic cell death in a TRPM2-dependent manner  
(A) HUVECs were exposed to the medium alone (CTRL) or to H2O2 (plus or minus the indicated 
compounds: 10 µM PJ-34 or 150 µM 2-APB or 0.3 µM TPEN) and stained with Hoechst 33342 
(blue), PI (red) and annexin-V-Alexa488 (green) to get a measure of total number of cells, 
necrotic cells and apoptotic (green arrow) cells respectively. Images were captured by confocal 
laser scanning microscope. Scale bar, 10 µm.  
(B) Mean ± SEM of percent cell death by apoptosis (cells stained with annexin-V-Alexa488), 
secondary necrosis (cell stained with both annexin-V-Alexa488 and PI) and necrosis (cell stained 
with PI) following the indicated treatments as in (A); n/N=2/≥ 170 cells.   
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Figure 5.3 TRPM2 inhibition and Zn2+ chelation prevent high glucose-induced death of 
HUVECs  
(A) High glucose-induced cell death is dependent on TRPM2 activation and Zn2+. Cells were 
exposed to medium alone (CTRL) or medium with 28 mM mannitol plus 5 mM glucose, or 
medium with 33 mM glucose (HG) plus or minus the indicated treatments. Incubation was for 48 
hr at 37°C. Cells were transfected with scrambled siRNA or siRNA-TRPM2 before exposure to 
glucose. Cells were stained with Hoechst 33342 (blue) and propidium iodide (PI) (red) to detect 
total number of cells and dead cells respectively. Images were captured with an epifluorescent 
microscope (EVOS). Scale bar, 10 µm. 
(B) Mean ± SEM of percent cell death corresponding to data in (A), n = 3. Number of cells 
scored ≥ 300 cells.    
Statistical analysis was performed by one-way ANOVA with Tukey’s post-hoc test, *p <0.05, **P 
< 0.01, ***P < 0.001 and ****P < 0.0001.  
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5.2.2 Role of TRPM2 channels in lysosomal membrane permeabilisation 
(LMP) and mitochondrial membrane permeabilisation (MMP) 
Previous studies have suggested that oxidative stress leads to LMP, which in turn leads 
to MMP and, finally, to cell death (Boya et al., 2003; Galluzzi et al., 2009). As outlined in 
the previous section, TRPM2 activation by H2O2 induces endothelial cell death. The aim 
of this section was to examine whether TRPM2 channels regulate LMP and MMP. LMP 
was assessed by examining the release of lysosomal cathepsins B into the cytoplasm; 
MMP was determined by examining the release of mitochondrial cytochrome c into the 
cytoplasm. The results show that TRPM2 channel inhibition prevented H2O2-induced 
LMP and MMP as judged by the inhibition of cytosolic release of cathepsin B and 
cytochrome c respectively (Figure 5.4). Given the previous evidence that LMP triggers 
MMP (Boya et al., 2003), it is reasonable to suggest that the primary site of TRPM2 
action in relation to cell death is likely lysosomes. These results suggest that activation 
of TRPM2 channels causes cell death by inducing LMP and MMP.  
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Figure 5.4 H2O2-induced lysosomal membrane permeabilisation (LMP) and mitochondrial 
membrane permeabilisation (MMP) is dependent on TRPM2 activation  
(A) HUVECs were not treated (CTRL) or treated with H2O2 (1 mM) in the presence and absence 
of 150 µM 2-APB before immunostaining for cathepsin B and the nucleus with DAPI (see 
materials and methods); representative fluorescent images are shown. Cytoplasmic staining of 
cathepsins B indicates LMP; inhibition by 2-ABP indicates a role for TRPM2 channels. 
(B) Fluorescence intensity per cell of cathepsin B stain from 63 cells, n = 3.  
(C) HUVECs were not treated (CTRL) or treated with H2O2 in the absence or presence of 150 
µM 2-APB before immunostaining for cytochrome c. Representative images are shown. Scale 
bar, 10 µm. Increase in the cytoplasmic levels of cytochrome c indicates MMP.  
(D) Fluorescence intensity per cell of cytochrome c from 81 cells, n = 3.  
Bars are the means ± SEM, statistical analysis in (B) and (D) were performed by one-way 
ANOVA with Tukey’s post-hoc test, **P < 0.01. 
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5.2.3 TRPM2 plays a role in intracellular ROS production 
Mitochondria are the major site of ROS production. The mechanism of ROS production 
and its metabolism in mitochondria is well understood (Lesnefsky et al., 2001). 
However, what regulates mitochondrial ROS production is unclear. The results in 
Chapter 4 demonstrated that oxidative stress induces accumulation of Zn2+ in 
mitochondria and that this is TRPM2 dependent. Since Zn2+ is known to increase 
mitochondrial ROS production by inhibiting the electron transport chain (Donadelli et al., 
2009), it is conceivable that TRPM2-mediated rise in mitochondrial Zn2+ contributes to 
mitochondrial ROS production. To test this possibility, the effect of depletion of TRPM2 
channels using siRNA on high glucose-induced intracellular ROS generation was 
examined. HUVECs were initially maintained in EGM-2 medium containing 5.5 mM 
glucose (control; CTRL). For high glucose experiments, cells were incubated in 33 mM 
glucose. ROS generation was measured by using the cell-permeant 2',7'-
dichlorodihydrofluorescein diacetate (H2DCFDA). This dye is a stable nonpolar 
compound (Bass et al., 1983). It diffuses into the cells and where it is hydrolysed to 
yield dichlorodihydrofluorescein (DCFH). Intracellular ROS oxidises H2DCF to the 
fluorescent compound DCF. The intensity of the fluorescence is proportional to the 
amount of ROS. The data in Figure 5.5A show that HG, but not mannitol, caused a 
significant increase in intracellular ROS which could be quenched with NAC. 
Importantly, siRNA-TRPM2, but not scrambled siRNA, completely inhibited cytosolic 
ROS production, indicating a role for TRPM2 channels in HG-induced ROS production.  
 
In order to test if TRPM2-mediated Zn2+ entry into mitochondria causes ROS 
production, HUVECs were transfected with scrambled siRNA (negative control) or with 
siRNA-TRPM2. Cells were incubated with Zn-PTO (Zn-PTO; 0.7 µM Zn2+: 0.5 µM 
pyrithione) to increase the cytosolic levels of Zn2+ in the cell. The data in Figure 5.5B 
show that silencing of TRPM2 expression blocked Zn-PTO-induced ROS production 
significantly, just like TPEN and NAC. Taken together, these data indicate that TRPM2 
channel activation and Zn2+ elevation upregulate intracellular ROS production. 
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Figure 5.5 Intracellular ROS generation is mediated by TRPM2 activation 
(A) HG-induced ROS production is prevented by the silencing of TRPM2 expression. HUVECs 
were exposed to medium alone (CTRL) or to medium with 28 mM mannitol plus 5 mM glucose, 
or to medium with 33 mM glucose (HG) plus or minus 10 mM NAC. Incubation was for 48 hr at 
37°C. Cells were transfected with scrambled siRNA or siRNA-TRPM2 before exposure to 
glucose. Cells were stained with the H2DCFDA ROS reporter to detect DCF fluorescence. 
Images were captured with an epifluorescent microscope (EVOS) and analysed by the ImageJ 
software. Data are presented as Mean ± SEM of fluorescence intensity/cell, n = 3. Number of 
cells scored ≥ 100. 
(B) Zinc pyrithione-induced ROS production is prevented by the silencing of TRPM2 expression. 
HUVECs were treated for 1 hr with zinc pyrithione (Zn-PTO; 0.7 µM Zn2+: 0.5 µM pyrithione) in 
the absence or presence of TPEN (0.3 μM TPEN) or N-acetyl cysteine (NAC, 10 mM), or 
HUVECs were transfected with scrambled or TRPM2 siRNA. Cells were stained and analysed 
as in (A). Data are presented as Mean ± SEM of fluorescence intensity per cell, n = 3. Number 
of cells scored ≥ 100. 
Statistical analysis was performed by one-way ANOVA with Tukey’s post-hoc test, *p <0.05, **P 
< 0.01and ***P < 0.001.  
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5.2.4 Mitochondrial ROS production 
It has been well established that mitochondria are the major source of ROS (reactive 
oxygen species) in most mammalian cells (Li and Shah, 2004). Mitochondrial ROS are 
mainly generated by two complexes of the mitochondrial transport chain, complex I, 
which is the NADH-ubiquinone oxidoreductase, and complex III, which is the uniquinol-
cytochrome c oxidoreductase (Finkel and Holbrook, 2000). Production of mitochondrial 
ROS contributes to oxidative damage to the membrane, DNA and mitochondrial 
proteins. The results in Figure 5.6 indicate that HG increases total ROS production, but 
does not indicate whether these ROS are of mitochondrial origin. To address this, 
MitoSOXTM Red, a reagent specific for mitochondrial ROS (Munusamy and MacMillan-
Crow, 2009), was used. It is a fluorogenic dye targeted to mitochondria specifically. It is 
suitable for live cells and produces red fluorescence when attacked by superoxide 
(Munusamy and MacMillan-Crow, 2009). HUVECs were initially maintained as 
maintained in Figure 5.3. The data show that HG, but not mannitol, causes an increase 
in mitochondrial ROS production, a finding that is in agreement with previous findings 
(Munusamy and MacMillan-Crow, 2009; Sun et al., 2010). This effect was prevented by 
TRPM2-siRNA; thus, TRPM2 channels appear to regulate mitochondrial ROS 
production. NAC (antioxidant)-treated cells, as expected, showed no MitoSOX Red 
staining (Figure 5.6A-B).  
 
To confirm the role of TRPM2 channels in mitochondrial ROS production, the HEK-
TRPM2tet recombinant cell system was used. The results (Figure 5.6C-D) show that 
glucose has no effect on mitochondrial ROS production in not-induced (-TRPM2) cells, 
but cause a significant increase in cells induced to express TRPM2 channels 
(+TRPM2).  
 
Similar results were obtained when cells were subjected to direct oxidative stress using 
H2O2 (Figure 5.6E-G). No difference was seen in the mean of MitoSOX Red intensity 
between control (CTRL) cells and cells treated with H2O2 in the absence of induction of 
TRPM2 channels (Figure 5.6E and G). By contrast, in cells induced to express TRPM2 
channels, H2O2 caused an increase in mitochondrial ROS production (Figure 5.6F and 
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G). Interestingly, there is a marked shrinkage of nuclei which is a sign of apoptosis 
(Kroemer et al., 1998). This result is consistent with previous reports where H2O2 was 
shown to increase mitochondrial ROS generation (Tochigi et al., 2013). However, the 
present study indicates, for the first time, that TRPM2 ion channels play a key role in 
high glucose- and hydrogen peroxide-induced mitochondrial ROS production.  
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Figure 5.6 TRPM2 channels regulates mitochondrial ROS production 
(A) TRPM2 channels mediate mitochondrial ROS generation. HUVECs were treated as in 
Figure 5.6. Mitochondrial ROS were determined by loading cells with 1 µM MitoSoxTM Red 
fluorescent dye for 30 min at 37°C. Cells were washed, fixed with 2% PFA and blocked with 
PBS-1% ovalbumin. Images were captured using a confocal microscope and analysed by 
ImageJ. The data show that silencing of TRPM2 channels prevented high glucose-induced Mito-
ROS production. Scale bar, 10 µm. Boxed regions are magnified. Scale bar, 5 µm. 
(B) Mean ± SEM of fluorescence intensity/cell corresponding to data in (A), n = 3. Number of 
cells scored ≥ 180 cells.  
(C) HEK-TRPM2tet cells were incubated with medium alone (CTRL) or with medium containing 
30 mM glucose for 18 hr. Staining was performed as in (A). Representative confocal images 
show that high glucose induces significant increase in Mito-ROS levels in cells expressing 
TRPM2 channels (+TRPM2), but not in the cells not expressing TRPM2 channels (-TRPM2). 
Scale bar, 5 µm. 
(D) Mean ± SEM of fluorescence intensity/cell corresponding to data in (C), n = 3. Number of 
cells scored ≥ 400. 
(E-F) HEK-TRPM2tet cells were incubated with SBS alone (CTRL) or SBS containing 200 µM 
H2O2 for 90 min. Staining was performed as in (A). Representative confocal images show that 
H2O2 induces no Mito-ROS production in cells not expressing TRPM2 channels (-TRPM2), but a 
marked increase in Mito-ROS levels in cells induced to express TRPM2 channels (+TRPM2). 
Scale bar, 10 µm.  
(G) Mean ± SEM of fluorescence intensity/cell corresponding to data in (E and F), n = 3. 
Number of cells scored ≥ 400. 
Statistical analysis (B, D and G) was performed by one-way ANOVA with Tukey’s post-hoc test, 
*p <0.05 and **P < 0.01.  
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5.2.5 Effect of Oxidative stress on plasma membrane TRPM2 ion channels  
It is not known whether oxidative stress affects the steady-state levels of TRPM2 
channels. To address this, the effect of oxidative stress on the surface expression of 
HA-tagged TRPM2 channels was examined. HEK-MSR cells were transfected with 
TRPM2-HA and incubated with 100 µM H2O2 overnight (~18 hr) or with 33 mM glucose 
for 48 hr (to allow sufficient intracellular ROS generation). TRPM2-HA expression was 
detected by staining the permeabilised cells with anti-HA antibodies. Images in Figure 
5.7 show that in untreated cells (control) there was no detectable staining of TRPM2-HA 
channels at the cell surface, with the majority of staining being intracellular. By contrast, 
in both H2O2 and high glucose treated cells, there was clear staining of the cell surface. 
However, for reasons unclear, when unpermeabilised cells were stained for the 
extracellular HA epitope, there was no discernible membrane staining. These data 
suggest that oxidative stress may increase the plasma membrane expression of TRPM2 
channels. However, further studies, including quantification of imaging data and surface 
biotinylation assays (Mankouri et al., 2006), are required to support this conclusion.  
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Figure 5.7 H2O2 enhanced detection of plasma membrane expression of TRPM2 channels 
HEK-MSR cells were transfected with TRPM2-HA and incubated with 100 µM H2O2 overnight 
(18 hr) or with 33 mM glucose for 48 hr at 37°C. Cells were fixed, permeabilised, incubated with 
rat anti-HA, and stained with Alexa Fluor488 conjugated secondary antibody (A) or Cy3 
conjugated secondary antibody (B).  
Images show plasma membrane expression of TRPM2 channels (indicated with white arrows) 
in H2O2 (A) or HG (B) treated cells. Blue staining corresponds to nuclei. Scale bar, 10 µm, 
Boxed regions are magnified. Scale bar, 5 µm. Representative images are shown; experiment 
was performed three times. 
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5.2.6 Internalisation of TRPM2 channels 
There are no previous reports on the internalisation of plasma membrane TRPM2 
channels. If the channels are internalised, like most membrane proteins, they are 
expected to enter endosomes. For these experiments, HeLa cells were transfected with 
TRPM2-HA or hERG-HA. The latter was used as a positive control, as previous studies 
have shown that hERG-HA is efficiently internalised in these cells (Karnik et al., 2013). 
Transferrin receptor is routinely used as a marker of endosomes; when transferrin binds 
its receptor, the ligand-receptor complex is internalised by clathrin-mediated 
endocytosis (Mukherjee et al., 1997; Rajendran et al., 2010). Fluorescent-labelled 
transferrin is often used as marker to detect clathrin-coated endosomal vesicles 
(Mankouri et al., 2006; Mukherjee et al., 1997; Rajendran et al., 2010). To examine the 
internalisation of TRPM2-HA channels, surface TRPM2 channels were labelled with 
anti-HA antibodies and the internalised antibodies were detected using fluorescent 
secondary antibodies. AlexaFluor488-labelled transferrin was included during 
internalisation to see if the internalised TRPM2 channels entered the same 
compartments as transferrin. The results (Figure 5.8) show that TRPM2-HA channels 
were indeed internalised and that internalisation of TRPM2 channels was greater in the 
presence of H2O2, as revealed by the increase in the number of transferrin-positive 
endosomes containing TRPM2-HA channels (i.e. colocalisation between internalised 
TRPM2-HA and endocytosed fluorescent transferrin). However, in the control, from 
looking at different fields, internalisation of TRPM2 channels could not be seen. This 
might be due to less membrane expression of TRPM2 or the cells not being transfected. 
These data suggest that TRPM2 channels undergo clathrin-mediated endocytosis. 
However, the impact of H2O2 on the trafficking of TRPM2 channels, and the underlying 
mechanisms, need further investigation.  
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Figure 5.8 TRPM2 channels are internalised into transferrin positive vesicles  
HeLa cells were transfected with hERG-HA (control; CTRL) or TRPM2-HA. The cells were 
blocked with 1% ovalbumin for 1 hr at 4°C. Cells were then incubated with rat anti-HA 
antibodies in the presence and absence of 200 µM H2O2 for 2 hr at 37°C. Alexa Fluor
488-
conjugated transferrin was added during the last 15 min of incubation. Cells were fixed, 
permeabilised and the channels labelled with Cy3 conjugated anti-rat secondary antibodies.  
Representative confocal images are shown. Scale bar, 10 µM, n=2. Boxed regions are 
magnified. Scale bar, 5 µm. 
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 Discussion  5.3
Oxidative stress leads to programmed cell death by generating a complex array of 
signals from different organelles of the cell (Avery, 2011; Ferri and Kroemer, 2001). In 
this chapter, the effect of H2O2 and high glucose (diabetic) stress on Ca
2+ and Zn2+ 
dynamics and endothelial cell death (apoptosis) was investigated. The key findings are 
as follows: (i) activation of TRPM2 channels promotes cell death via apoptosis by 
affecting the dynamics of both Ca2+ and Zn2+; (ii) TRPM2 activation and Ca2+ entry are 
important to enhance Zn2+ release from an intracellular source; (iii) chelation of Zn2+ 
alone was sufficient to prevent endothelial cell death; (iv) H2O2-induced cell death 
involves TRPM2-mediated LMP and MMP; (v) inhibition of TRPM2 channels prevents 
high glucose-induced mitochondrial ROS production, revealing an unsuspected role for 
TRPM2 channels in mitochondrial ROS generation; and, finally, (vi) H2O2 enhances 
TRPM2 translocation to the membrane. These findings have important implications for 
diabetes and a number of other degenerative diseases, where ROS generation features 
as a key pathological event.  
 
5.3.1 TRPM2-mediated Zn2+ release enhances endothelial cell death 
It has been reported that activation of TRPM2 channels by H2O2 induces apoptotic 
endothelial cell death because of cellular Ca2+ overload (Sun et al., 2012). However, the 
results of the present study show that besides BAPTA-AM and EGTA, Zn2+-specific 
chelators (TPEN and clioquinol) were able to inhibit H2O2-induced apoptosis of 
HUVECs. Since chelation of Zn2+ alone was found to be sufficient to prevent cell death, 
these findings suggest that Zn2+ plays a major role in endothelial cell death. These 
results are consistent with the previous studies on the INS-1 pancreatic β- cell line 
(Manna et al., 2015).  
 
Besides increasing the cytosolic levels of Ca2+, H2O2 also caused an increase in the 
levels of free Zn2+ (Figure 5.1), a result that is consistent with the previous report with 
INS-1 cells (Manna et al., 2015) and the data presented in Chapter 4. The source of this 
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cytotoxic Zn2+ is likely intracellular because cell death occurred in the absence of free 
form of Zn2+ in the extracellular solution.  
 
It has been reported previously that H2O2 causes DNA fragmentation and nuclear 
condensation which are apoptotic signs (Kapuscinski, 1995; Zhang and Xu, 2000). 
These effects of H2O2 have been shown to be reduced by silencing TRPM2 expression 
(Sun et al., 2012). The data presented in Figure 5.1 and Figure 5.2 indicate that H2O2-
induced cell death is not only blocked by TRPM2 blockers and TRPM2-siRNA, but also 
by Zn2+ chelators. The data were confirmed by using a more physiologically relevant 
system (Figure 5.3), where cell death induced by high glucose (Ho et al., 2000) was 
reduced by blocking TRPM2 channels with PJ-34 and 2-APB and by silencing TRPM2 
channels with TRPM2 siRNA. Notably, Zn2+ chelators blocked endothelial cell death 
significantly. These findings represent the first demonstration of the role of TRPM2 ion 
channels and Zn2+ in high glucose-induced endothelial cells death. 
 
5.3.2 Inhibition of TRPM2 channels prevents H2O2-induced LMP and MMP  
Current evidence indicates that LMP leads to MMP, and MMP, in turn, causes apoptosis 
(Boya and Kroemer, 2008). However, how LMP signals MMP is not fully understood. 
Previous studies reported that cathepsins released during LMP activate t-bid and 
promote recruitment of pro-apoptotic Bax proteins to the outer mitochondrial membrane 
(Boya et al., 2003; Boya and Kroemer, 2008). By forming pores in the outer membrane, 
Bax induces MMP and release of pro-apoptotic factors including cytochrome c (Boya 
and Kroemer, 2008). However, prevention of LMP with TRPM2 blockers was able to 
prevent MMP; this suggests that Zn2+ released during LMP likely serves as a signal for 
MMP (Figure 5.4). Consistent with this idea, as shown in the previous chapter’s Figure 
4.12 and Figure 4.13, Zn2+ released during LMP accumulates in mitochondria and Zn2+ 
is a known inducer of MMP (Sensi et al., 2009). Regardless of the mechanism, 
however, the data indicate that LMP is not a nonspecific mechanism (Boya et al., 2003; 
Boya and Kroemer, 2008), but instead it is a regulated process involving TRPM2-
mediated signalling. Thus TRPM2-regulated Zn2+ is the potential elusive molecular link 
between LMP and MMP.   
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5.3.3 The TRPM2 channel is a key regulator of ROS production 
It has been previously reported that high glucose-induced apoptosis is mediated by 
intracellular ROS production (Du et al., 1999). However, the underlying mechanism is 
still not clear. The current chapter investigated whether activation of TRPM2 channels 
enhances ROS production in endothelial cells, and if so, whether depletion of TRPM2 
channels can prevent ROS generation during oxidative stress. The rationale behind this 
is the finding that TRPM2 channels mediate free Zn2+ accumulation in mitochondria 
(Chapter 4) and the fact that free Zn2+ inhibits the electron transport chain at sites where 
ROS are generated (Clausen et al., 2013). HUVECs were incubated with high glucose 
and ROS was monitoring by DCF-fluorescence dye. The results demonstrate that high 
glucose triggers ROS production (Figure 5.5A). This finding is in agreement with the 
previous studies (Ho et al., 2006). Importantly, silencing of TRPM2 channels with siRNA 
prevented high glucose-induced ROS generation.  
 
To test the idea that TRPM2-mediated Zn2+ entry into mitochondria is responsible for 
ROS generation, HUVECs were treated with Zn-PTO to raise cytosolic Zn2+, and the 
effect of silencing TRPM2 was examined. Zn-PTO caused a significant increase in 
intracellular ROS production, an effect that was prevented by Zn2+ chelator and 
antioxidant (Figure 5.5B); this finding is consistent with a previous report (Seo et al., 
2001). As predicted, siRNA-TRPM2 caused a significant reduction in ROS generation. 
Thus, the present findings demonstrate a role for TRPM2 channels in ROS generation. 
 
There are many endogenous sources of ROS production. Oxidants are generated from 
different cytosolic enzyme systems including NAD(P)H oxidase (NOX), xanthine 
oxidase, uncoupled endothelial nitric oxide (NO) synthase (eNOS) and mitochondrial 
electron leakage (Griendling, 2005; Li and Shah, 2004) and as result of the intracellular 
metabolism in mitochondria and peroxisomes (Finkel and Holbrook, 2000). The data 
presented in Figure 5.5A-B demonstrated that high glucose and raising intracellular Zn2+ 
cause a rapid increase in total cellular ROS production, and silencing of TRPM2 
channels prevents these effects. It is possible that the rise is due to ROS production by 
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the mitochondria rather than NOX activation, because previous reports have shown that 
Ca2+ influx, but not intracellular Zn2+, activates NOX (Clausen et al., 2013).  
 
It is also possible that Ca2+ entry through plasma membrane TRPM2 channels 
increases cytoplasmic ROS by activating NOX5 by binding to EF hand motifs (Nauseef, 
2008) as NOX5 is expressed in endothelial cells (BelAiba et al., 2007). Cytoplasmic 
ROS could in turn induce mitochondrial ROS production and amplify ROS generation 
through the process of ROS-induced ROS release (RIRR) (Zorov et al., 2014). 
However, according to the data presented in the current chapter, cytoplasmic ROS were 
not at detectable levels by DCF staining. It might due to the low level of NADPH 
oxidation. 
 
The main source of mitochondrial ROS (O2
•−) is respiratory complexes I and III which 
are located in the inner mitochondrial membrane (Clausen et al., 2013; Finkel and 
Holbrook, 2000). Complex I receives electrons from NADH and generates NAD+ (Yu 
and Bennett, 2014). These electrons are then transported to complex III via ubiquinone 
and finally to O2 to generate water (Yu and Bennett, 2014). During this process, 
however, some electrons can escape to generate O2
•−.  O2
•− is converted to H2O2 by 
MnSOD and H2O2 is reduced to water by GPXs or catalase (Yu and Bennett, 2014) (see 
section 1.2.2). Being membrane permeable, H2O2 can escape into the cytoplasm. 
  
Studies have shown that during pathological situations such as diabetes and 
Alzheimer’s, the concentration of free Zn2+ is elevated in the primary pancreatic islet 
beta-cells and neuronal cells (Bellomo et al., 2011; Weiss et al., 2000). Zn2+ enables the 
production of ROS by inhibiting complex I. Inhibition of complex I prevents electron 
transport to complex III (Kushnareva et al., 2002). Therefore, its accumulation at 
complex I enhances ROS production (Kushnareva et al., 2002). So, it is possible that 
the observed rise in ROS (Figure 5.5A-B) is from the inhibition of complex I. In the 
previous chapter, it was shown that TRPM2 channels can exist in mitochondria where 
they promote Zn2+ entry into mitochondria. Thus Zn2+ entry through mitochondrial 
TRPM2 channels could inhibit complex I leading to ROS generation from mitochondria 
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(Figure 5.6) and the subsequent increase in cytosolic ROS. ROS is thought to escape 
from mitochondria via mitochondrial permeability transition pore (mPTP) (Zorov et al., 
2014). Thus these findings provide a mechanistic insight into the regulation of 
mitochondrial ROS production. 
 
5.3.4 Oxidative stress-enhanced detection of TRPM2 membrane 
expression  
Studies have shown that trafficking of ion channels, receptors and transporters to the 
plasma membrane and subsequent endocytosis can be affected by ligands (Simons 
and Toomre, 2000; Valluru et al., 2005). Little is known about trafficking of TRPM2 
channels. The results of this chapter show that the presence of H2O2 and high glucose 
treatment makes TRPM2 channels in the plasma membrane detectable (Figure 5.7). 
Although TRPM2 channels bearing an extracellular HA-tag were used in these studies, 
for reasons unclear, surface expression was not apparent in nonpermeabilised cells, but 
could be detected in permeabilised cells. Thus independent evidence using surface 
protein biotinylation experiments needs to be obtained to confirm H2O2 induced increase 
in surface expression of TRPM2 channels.  
 
The Finding in Figure 5.7 was further confirmed by performing internalisation 
experiments where endocytosis of TRPM2-HA channels was followed along with the 
transferrin receptor, a well-established marker of endocytosis. The results demonstrated 
endocytosis of TRPM2-HA channels (Figure 5.8). Co-localisation of the internalised 
channels with the transferrin receptor suggested that TRPM2 channels are internalised 
via clathrin-mediated endocytosis (CME). Although endocytosis of several ion channels 
by CME has been demonstrated (Mankouri et al., 2006; Shimkets et al., 1997), this is 
the first demonstration of TRPM2 endocytosis. The increase in endosomal/lysosomal 
localisation in H2O2-treated cells was consistent with the presence of plasma membrane 
TRPM2 channels. However, it is possible that oxidative stress slows endocytic 
trafficking of TRPM2 channels, thereby increasing the steady-state expression of 
TRPM2 channels at the plasma membrane. Trafficking of TRPM2 channels was studied 
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by overexpressing TRPM2 channels and using the anti-HA antibody. However, 
overexpression of proteins may affect the trafficking pathway (Phan et al., 2008). Thus, 
further studies on the trafficking of natively expressed TRPM2 channels are required.   
 
The contribution of increased plasma membrane trafficking to H2O2 signalling via 
TRPM2 activation and cell death remains to be examined. One would expect that 
increased trafficking to the cell surface would increase net Ca2+ influx, Ca2+-induced 
Zn2+ release and cell death. To test this idea requires understanding of the mechanism 
by which oxidative stress enhances trafficking of TRPM2 channels to the plasma 
membrane and specific tools to inhibit such trafficking. Regardless of the mechanism, 
the results suggest that dynamic regulation of membrane TRPM2 channels may play a 
key role in cell death. 
 
To conclude, the results presented in the current chapter demonstrate that H2O2 and 
high glucose stress can induce endothelial cell apoptosis by affecting Zn2+ homeostasis. 
The results also demonstrate a regulatory role for TRPM2 channels in mitochondrial 
ROS production (Figure 5.9). They also show that oxidative stress induces plasma 
membrane trafficking of TRPM2 channels. Finally, the data provide preliminary 
evidence that TRPM2 channels are internalised via clathrin-mediated endocytosis. The 
latter results suggest that oxidative stress-induced changes in trafficking of TRPM2 
channels may play an important role in apoptosis and require further investigation. 
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Figure 5.9 Possible pathway of TRPM2-mediated endothelial cell death 
Activation of TRPM2 channels during oxidative stress (H2O2 or high glucose) induces Ca
2+ influx 
across plasma membrane. Rise in intracellular Ca2+ initiates Zn2+ release into the cytoplasm. 
Ca2+ entry triggers LMP leading to MMP (cytochrome c release) and, in turn, to cell death. Cell 
death can be blocked by TRPM2 inhibitors (PJ-34 and 2-APB) or intracellular Zn2+ chelators 
(TPEN and clioquinol) or intracellular Ca2+ and Zn2+ chelator (BAPTA-AM). Oxidative stress 
induces amplification of mitochondrial ROS, which is regulated by activation of mitochondrial 
TRPM2 channels.  
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 │ Conclusion and further experiments 6
 Summary of key findings 6.1
The data presented in Chapter 3 showed that the commercial anti-TRPM2 antibodies 
were not suitable to label TRPM2 channels in the plasma membrane of intact cells, as 
this antibody has been raised to an intracellular epitope and displays significant non-
specific labelling in immunocytochemistry experiments. An HA epitope was therefore 
inserted into the S1-S2 extracellular loop of the TRPM2 channel using the PCR 
technique. The resultant construct, called TRPM2-HA, was used to transfect cells and 
examine intracellular distribution of the channel. It was found that TRPM2 channel 
expression was robust and the transfected cells showed a band with a size of ~170 
kDa, which is in agreement with the previous findings (Fonfria et al., 2004). Previous 
studies have shown that the TRPM2 ion channel is not only a plasma membrane ion 
channel but also a lysosomal ion channel (Lange et al., 2009; Manna et al., 2015). 
However, TRPM2-HA membrane expression was not detected by immunostaining of 
intact (unpermeabilised) cells. Patch clamp recording, however, revealed TRPM2 
currents in TRPM2-HA-transfected HEK293 cells, demonstrating that insertion of an 
HA-epitope does not disrupt the function of the channel. Thus, the inability to detect 
TRPM2-HA at the plasma membrane by immunostaining is not due to the absence of 
the channel. In summary, the data in Chapter 3 showed that the TRPM2-HA construct is 
functional and suitable for trafficking studies. However, it proved difficult to conduct 
endocytosis experiments (originally envisaged) as there was a lack of detectable 
TRPM2-HA staining at the plasma membrane.  
 
The data presented in Chapter 4 represented the results of the investigation of the 
second aim. Specifically, the second aim was to determine whether oxidative stress-
induced TRPM2 activation mediates mitochondrial fragmentation. Part of the second 
aim was also to determine whether the TRPM2 channel plays a role in the intracellular 
dynamics of Zn2+, which has previously been shown to mediate oxidative stress-induced 
pancreatic β-cell death (Manna et al., 2015). To address this aim, live cell imaging, 
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immunostaining, ion imaging, biochemical and immuno-gold labelling techniques were 
carried out.  
 
The data presented in Chapter 4 showed that oxidative stress induced mitochondrial 
fragmentation in human umbilical vein endothelial cells (HUVECs) exposed to high 
glucose levels and that the effect was mediated by TRPM2 channels; pharmacological 
inhibition of TRPM2 function and RNAi silencing of TRPM2 expression prevented 
endothelial mitochondrial fragmentation. Furthermore, knock-out of TRPM2 channels 
prevented mitochondrial fragmentation in mouse pulmonary endothelial cells. These 
findings show for the first time the role of TRPM2 channels in mitochondrial 
fragmentation. Previous findings indicated that TRPM2 activation increased cytosolic 
levels of free Ca2+ and Zn2+. Interestingly, however, chelation of Zn2+ alone was 
sufficient to prevent TRPM2-mediated mitochondrial fragmentation. This effect of Zn2+ in 
mitochondrial fragmentation after TRPM2 activation has not been previously reported; 
therefore, it was examined in greater detail. Through a combination of fluorescent Zn2+ 
imaging and labelling of intracellular organelles, it was demonstrated that free Zn2+ is 
largely stored in the lysosomes. Surprisingly, oxidative stress caused a marked 
decrease in lysosomal Zn2+, with a concomitant rise in mitochondrial Zn2+. Chemical 
inhibition and RNAi silencing of TRPM2 channels prevented lysosomal Zn2+ release and 
uptake by the mitochondria. Elevation of cytosolic Zn2+ using Zn2+-ionophore also 
caused a rise in mitochondrial Zn2+ and fragmentation. Thus rise in mitochondrial Zn2+ 
appears to trigger mitochondrial fragmentation. The lysosomal Zn2+ decrease was 
accompanied by a decrease in the number of lysosomes. The direct effect of Zn2+ on 
mitochondrial fragmentation has been previously reported (Park et al., 2014), but the 
manner by which TRPM2 channel activation leads to changes in mitochondrial 
dynamics through the Zn2+ ion is a new finding. These data provide new insights into 
the relationship between Zn2+, LMP and mitochondrial fragmentation.  
 
Elevation of cytosolic levels of free Ca2+ (using ionophore A23187) demonstrated that 
Ca2+ induces LMP within 2 hr, while mitochondrial fragmentation occurred after 4 hr. 
However, Zn2+ chelation was sufficient to prevent Ca2+-induced mitochondrial 
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fragmentation, and the elevation of cytosolic levels of free Zn2+ (using pyrithione) was 
enough to induce mitochondrial fragmentation within 2 hr. Thus, it is possible that Ca2+ 
entry through TRPM2 channels induces LMP and Zn2+ release. The resultant rise in 
cytosolic Zn2+ leads to mitochondrial fragmentation. Previous findings showed that direct 
Zn2+ uptake by the mitochondria is mediated by the mitochondrial Ca2+ uniporter (MCU) 
(Malaiyandi et al., 2005); however, blocking the MCU with ruthenium red failed to 
prevent oxidative stress-induced mitochondrial Zn2+ uptake, suggesting the presence of 
other mechanisms. 
 
Since mitochondrial Zn2+ rise is TRPM2 dependent and there is evidence that TRPM2 
channels mediate Zn2+ uptake, mitochondria were examined for TRPM2 expression. A 
combination of biochemical and immunocytochemical techniques demonstrated 
presence of TRPM2 in the mitochondria. Furthermore, in the absence of TRPM2 
channels, Zn2+ failed to enter the mitochondria and cause mitochondrial fragmentation. 
However, the TRPM2 channel lacks canonical mitochondrial targeting signals (Diekert 
et al, 1999; Omura, 1998). A recent study has shown that the canonical transient 
receptor potential 3 (TRPC3) channel lacks targeting motifs, yet the channel is capable 
of trafficking to mitochondria (Feng et al., 2013).  
     
While the data presented in Chapter 4 support a role for Zn2+ in mitochondrial 
fragmentation, a role for Ca2+ cannot be fully excluded because FluoZin-3 dye can not 
only bind Zn2+ (KD 15 nM) (Zhao et al., 2008) but also bind Ca
2+ although at 
supraphysiological concentrations (Bastian and Li, 2007). This is a limitation of the dye 
as Zn2+ reporter.   
 
Studies have shown that Drp1, a protein responsible for mitochondrial fission, is 
recruited from cytoplasm to mitochondria during oxidative stress (Ishihara et al., 2009; 
Loson et al., 2013; Qi et al., 2013). Accordingly, the role of TRPM2 channels and Zn2+ in 
Drp1 recruitment to mitochondria was examined. The data showed that TRPM2 
activation-dependent rise in mitochondrial Zn2+ promotes Drp1 recruitment. In the 
absence of TRPM2 or in the presence of a Zn2+ chelator, oxidative stress failed to 
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induce Drp1 recruitment to mitochondria. In summary, TRPM2 channel activation works 
as an upstream signal for Drp1 recruitment during oxidative stress. The data in Chapter 
4 thus presented the discovery of a novel mechanism where activation of TRPM2 
channels causes a redistribution of Zn2+ from lysosomes to mitochondria, resulting in 
endothelial mitochondrial fragmentation. 
 
The last aim of the thesis was to investigate the mechanisms by which elevated 
cytosolic Ca2+ and Zn2+ results in endothelial cell death during high glucose stress. 
Previous report showed that TRPM2 activation leads to Ca2+ entry-induced endothelial 
cell death (Sun et al., 2012). Another report illustrated that high glucose leads to 
apoptotic cell death by increasing cellular levels of ROS (Du et al., 1998). To address 
the aim of Chapter 5, endothelial cells were exposed to H2O2 or a high concentration of 
glucose (diabetic conditions), and the role of TRPM2 channels in H2O2- and glucose-
induced cell death was examined using pharmacological and RNAi approaches.  
 
The data in Chapter 5 showed that the activation of TRPM2 channels promotes cell 
death via apoptosis by affecting the dynamics of both Ca2+ and Zn2+. It was found that 
Ca2+ entry via TRPM2 channels is important to enhance Zn2+ release from intracellular 
sources, leading to cell death. Intracellular Zn2+ chelation was enough to prevent 
oxidative stress-induced cell death. This finding is in agreement with the previous 
reports (Manna et al., 2015; Ye et al., 2014), but the interplay between Ca2+ and Zn2+ 
was not clear. High glucose and H2O2-induced increase in LMP (cathepsin B release 
into the cytoplasm) and MMP (cytochrome c release) were prevented by inhibition of 
TRPM2 channels. 
 
Previous reports have shown that high glucose-induced apoptosis is mediated by 
intracellular ROS production, but the mechanism is still not clear (Du et al., 1999). The 
possibility that TRPM2 channel activation enhances ROS generation was examined. A 
combination of ROS monitoring with fluorescent probes and live cell imaging indicated 
that inhibition of TRPM2 channels indeed prevents high glucose-induced mitochondrial 
ROS production. This finding revealed a previously unrecognised role of TRPM2 
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channels in mitochondrial ROS generation. Taken together, the data presented in this 
chapter provided a novel mechanism by which diabetic stress causes apoptotic cell 
death via TRPM2 channel activation and mitochondrial ROS production.  
 
These results likely have implications for endothelial cell death in pathophysiological 
situations such as diabetes, where oxidative stress increases and induces endothelial 
diseases including atherosclerosis, stroke and peripheral vascular disease (PAD). The 
development of TRPM2 inhibitors is an important new direction to be investigated in the 
future.  
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Figure 6.1 Mitochondria-mediated apoptosis is TRPM2 dependent 
Oxidative stress induces TRPM2 activation in the plasma membrane thereby increasing Ca2+ 
entry. Excess intracellular Ca2+ induces lysosomal membrane permeability (LMP) by 
oxidation of membrane lipids directly or through activation of lipases (Johansson et al., 2010; 
Zhao et al., 2001). This leads to the release of hydrolases as well as zinc. Excess 
intracellular Zn2+ is taken up by mitochondria through mitochondrial TRPM2 channels. 
Silencing of TRPM2 expression or chelation of Zn2+ prevents Zn2+ redistribution from 
lysosomes to mitochondria. Zn2+ accumulation in mitochondria triggers mitochondrial ROS 
production and mitochondrial membrane permeability (MMP). Increase in mitochondrial Zn2+ 
leads to Drp1 recruitment to mitochondria and mitochondrial fragmentation. Finally, 
mitochondrial fragmentation leads to cell death. Cell death could be blocked by silencing 
TRPM2 expression or by TRPM2 inhibitors (PJ-34 and 2-APB), intracellular Zn2+ chelators 
(TPEN and clioquinol), and intracellular Ca2+ and Zn2+ chelator (BAPTA-AM). The sites of 
genetic intervention and pharmacological inhibition are shown. 
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 Future work  6.2
The data presented in Chapter 4 showed that high glucose-induced mitochondrial 
fragmentation is mediated by TRPM2 channels. It would be interesting to examine if 
the damage could be reversed with chemical or biological inhibitors of TRPM2 
channels. 
 
Studies have shown that mitochondrial fragmentation increases in diabetic animals 
(Makino et al., 2010; Vincent et al., 2010; Wang et al., 2012). It would be interesting 
to investigate if knock-out of TRPM2 channels in diabetic animals would mitigate 
these effects. 
 
The data presented in Chapter 4 revealed a previously unrecognised role for TRPM2 
channels in mitochondrial dynamics. TRPM2 mediated changes in intracellular Zn2+ 
redistribution from lysosomes to mitochondria appears to underlie oxidative induced 
mitochondrial fragmentation. TRPM2 expression in mitochondria could be detected 
by biochemical and imaging techniques. However, there is no direct evidence that 
mitochondrial TRPM2 channels mediate Zn2+ entry into mitochondria. Direct patch 
clamping electrophysiology could provide evidence for this, but patching 
mitochondria is technically challenging (Kirichok et al., 2004).  
 
Previous studies have shown that ROS production enhances mitophagy (Scherz-
Shouval and Elazar, 2007; Scherz-Shouval and Elazar, 2011; Youle and Narendra, 
2011). Preliminary data presented in Chapter 4 demonstrated that ROS-induced 
mitophagy is TRPM2 dependent. These data need to be confirmed using 
biochemical and microscopy-based studies, using autophagosome markers such as 
LC3 (Kim et al., 2007; Mizushima, 2004).  
 
The data presented in Chapter 5 demonstrated that TRPM2 inhibition prevents H2O2- 
and high glucose-induced mitochondrial ROS production. However, other groups 
have reported conflicting, mitochondrial ROS level was higher in KO TRPM2 
myocytes compared with WT TRPM2 myocytes (Miller et al., 2014). Further studies 
into the role of TRPM2 channels in mitochondrial ROS production using endothelial 
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cells isolated from wild-type and TRPM2 knock-out mice may help address this 
controversy. Furthermore, the mechanism by which TRPM2 channels regulate 
mitochondrial ROS production remains to be investigated. 
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 │ Appendix  7
ClustalW2 sequence alignment of human TRPM2-HA with Clone 1 of TRPM2-HA 
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ClustalW2 sequence alignment of human TRPM2-HA with Clone 5 of TRPM2-HA 
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